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Polyhydroxybutyrate (PHB)-based copolymers have attracted great interest 
due to its natural biodegradability and potential biomedical applications. The PHB-
based copolymers are generally synthesized from high molecular weight microbial 
PHB which has been found in many microorganisms as intracellular carbon source 
and energy storage material. An alternative synthetic approach is via ring opening 
polymerization (ROP) of β-butyrolactone (β-BL) monomer, which can lead to PHB 
block copolymers with well-defined architecture. In this thesis, PHB-based block 
copolymers of different functional groups and macromolecular architectures were 
synthesized. The supramolecular self-assembly behavior of PHB-based block 
copolymers and cyclodextrins (CDs) were studied, and the potential of the self-
assembled nanostructures and hydrogels to be used in drug delivery applications were 
evaluated. 
PHB-PEG-PHB triblock copolymers were synthesized via ROP of β-BL from 
PEG-macroinitiators. The well-defined low-molecular-weight PHB-PEG-PHB 
triblock copolymer favored the formation of block-selected polypseudorotaxanes with 




of PHB leads to the formation of extensive and strong hydrogel network, similar to 
hydrogels formulated with high molecular weight PEG. The micelles formed by PHB-
PEG-PHB triblock copolymers can be used to deliver hydrophobic drugs. The PHB-
PEG-PHB/α-CD hydrogels with good rheological properties could be used as 
hydrophilic drug carriers.  
PHB and PEG block copolymers of star architecture were synthesized and 
their self-assembly behavior was studied. The novel amphiphilic PHB-based star-
block copolymers consist of sPEG cores and PHB-adamantyl peripheries. The design 
of heterofunctionalized PHB precursors via well-controlled ROP of β-BL is key to the 
facile synthesis of the star-block copolymers. The amphiphilic star-block copolymers 
were found to self-assemble into very stable nanogel-like large compound micelles 
(LCMs) in aqueous medium. Their stability against dilution renders these LCMs ideal 
candidate for drug delivery. On the other hand, more remarkably, in the presence of 
heptakis(2,6-Di-O-Methyl)-β-Cyclodextrin (DM--CD), the self-assembled particles 
took the form of vesicles. The favorable adamantane (Ada)/-CD host-guest 
interaction and the star architecture of sPEG-PHB star-block copolymer are critical 
factors leading to such unique self-assembly behavior. The host-guest approach of 
nanoparticle modification demonstrated here encompasses a robust and modular 
strategy that could be adopted for synthesis of other functional nanoparticles. 
Star-block copolymers consisting of α-CD cores and PHB-adamantyl 
peripheries (CD-s-PHB) were also found to form vesicles in the presence of sufficient 
DM-β-CD through Ada/β-CD host-guest interaction. The self-assembly behavior of 
the star-block copolymers and their complexes with DM-β-CD was investigated. The 




assembled morphologies from CD-s-PHB with different terminal groups in the 
presence of DM-β-CD. The resultant uniform nano-sized vesicles were used as carrier 
for delivery of an anticancer drug, doxorubicin hydrochloride (DOX). Compared to 
free DOX, DOX-loaded nanovesicles exhibited improved intracellular uptake and in 
vitro cytotoxicity in Hela cells, suggesting their potential to be used as drug delivery 
system. 
All in all, functionalized PHB-based block copolymers of different 
macromolecular architectures were synthesized and their supramolecular self-
assemblies mediated by CDs host-guest chemistry have great potential to be used as 
drug delivery systems. 
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CHAPTER 1 INTRODUCTION 
This thesis considers some supramolecular self-assembled polymeric materials 
with promising applications in drug delivery. In this chapter, we will present the 
research background, the objectives and scope of the study, and a summary of the 
contents of the thesis.  
 
1.1 Research Background 
Modern advances in polymer science have led to a series of revolutions in 
biology and medicine since the pioneering work by Staudinger and Carothers in the 
1920s and 1930s.
1
 Developments in polymer science have brought not only 
discoveries about biological macromolecules but also the creation of polymeric 
substances for a wide range of biomedical applications. Nowadays, it is possible for 
polymer chemists to prepare tailor-made polymers with desirable properties for 
biomedical applications such as drug delivery and tissue engineering.  
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The use of polymers as agents in drug delivery applications has been under 
development for a few decades, from the earliest polymer-based rate-controlling 
membranes as drug delivery devices and implants during the 1970s and 1980s, to the 
commercialized microscopic degradable polymer depot drug delivery systems (DDSs) 
in the 1990s, on to the current polymeric nanostructures.
2
 The development of 
polymer-based drug carriers may overcome the principle challenge in chemotherapy 
that many drugs suffered with poor solubility,
3, 4
 unfavorable pharmacokinetics and 
poor biodistribution profiles.
5, 6
 It would be ideal to build all desirable 
pharmacological features into one drug molecule, but it would be simpler and perhaps 
more effective to accomplish this by associating the biological action of the drug with 
the physicochemical characteristics of a polymeric carrier to obtain the desired 
pharmacological features, as suggested by Ringsdorf and co-workers.
7, 8
  
Recently, a variety of polymeric drug delivery systems, such as polymeric 
micelles, polymer vesicles and polymeric hydrogels can be readily prepared via facile 
self-assembly of amphiphilic block copolymers. Molecular self-assembly is a process 
where molecules adopt an ordered organization driven by noncovalent interactions, 
such as hydrogen bonding, π-π stacking and hydrophobic forces.9 The diversity of 
polymer chemistry provides possibilities to tune the properties of these self-assembled 
structures with a “bottom up” approach. It is critical to synthesize well-defined 
polymers with various architectures to achieve low polydispersity for certain ordered 
structures with precisely controlled functionalities through self-assembly. The 
discovery of the living polymerization technique
10, 11
 made a great contribution for 
providing innovative synthetic methodologies/strategies to prepare well-defined 
polymers with precise control of molecular architectures. Besides polymerization 
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techniques, coupling methods are another kind of frequently used techniques in 
material synthesis and polymer functionalization. As one of the most attractive 
coupling methods, click chemistry has been proven to be a powerful tool for polymer 
functionalization, due to its high fidelity, quantitative yields, tolerance to a variety of 
functional groups and applicability under mild reaction conditions.
12-16
 The 
combination of polymerization techniques and click chemistry has greatly expanded 
the range of available materials. 
To date, a variety of nanostructures with various shapes and intricacies have 
been reported.
17-21
 These advancements were built upon a solid understanding on the 
interactions amongst various segments in block copolymer and the surrounding 
environment as well as the influence of these interactions on nanostructure 
morphology.
22, 23
 In addition, the ability to create block copolymers with ever 
increasing complexity and functionality, empowered by an extensive array of 
controlled/living polymerization techniques and efficient coupling strategies, has also 
contributed to the developments.
24-26
 However, the relationship between polymer 
architecture and resultant self-assembled nanostructure is often not straightforward, 
more so with complex polymer architecture.
27, 28
 Moreover, being a supramolecular 
event, the course of block copolymer self-assembly could be altered in the presence of 
other supramolecular interactions.
29





 etc.) and polymers with cyclodextrins 
(CDs) has been widely employed to construct noncovalently connected 
nanoassemblies for drug delivery applications. 
Amphiphilic block copolymers consisting of polyesters such as Poly (ε-
caprolactone) (PCL), Polylactide (PLA) and Polyhydroxybutyrate (PHB) have 
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attracted great interest due to their biodegradability and potential biomedical 
applications.
33-36
 Among these polyesters, PHB which has been found in many 
microorganisms as intracellular carbon source and energy storage material is the only 
naturally occurring one.
37-39
 Its natural biodegradability and excellent biocompatibility is 
highly desirable for drug delivery applications. Recent studies on PHB have focused on 
the synthesis of linear PHB block copolymers and their applications as biodegradable 
drug carriers in the formulation of hydrogels or nanoparticles.
40-42
 Though the 
synthesis of PHB-based linear block copolymers were widely reported, only a few 
studies were carried out on their self-assembly behavior in aqueous solution. More 
importantly, reports on star-block copolymer of PHB are rare,
36, 43
 not to mention 
studies on self-assembly behavior.  
 
1.2 Objectives and Scope of Study 
The aim of this research was to develop PHB-based block copolymers of 
different functional groups and macromolecular architectures, and investigate their 
supramolecular self-assembly behavior involving cyclodextrins (CDs). The 
supramolecular self-assemblies of PHB-based block copolymers and CDs were 
further explored for potential drug delivery applications. The possibility of applying 
these supramolecular self-assemblies as drug carriers was tested through in vitro 
experiments. The in vivo experiments are beyond the scope of this thesis. 
The specific objectives of this research are: 
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 To synthesize well-defined PHB-PEG-PHB linear triblock copolymers via a 
controlled ring-opening polymerization approach. 
 To develop methodologies for the facile synthesis of well-defined PHB-based 
amphiphilic star-block copolymers through a combinatorial strategy consisting 
of controlled ring-opening polymerization and click chemistry. 
 To characterize both the linear and star block copolymers obtained and examine 
their self-assembly behavior in aqueous solutions.  
 To investigate the supramolecular self-assembly behavior of PHB-based block 
copolymers and cyclodextrins. 
 To develop supramolecular self-assemblies including hydrogels and 
nanostructures as drug delivery systems. 
 
1.3 Organization of the Thesis  
Encompassing the objectives outlined in section 1.2, the detailed research 
works on the PHB-based block copolymers and their supramolecular self-assemblies 
will be presented in the following chapters.  
Chapter 2: Literature review on the topic of polymeric self-assembling systems for 
drug delivery, block copolymer architectures and their synthetic strategies, followed 
by a brief summary of recent synthesis and self-assembly studies of PHB-based block 
copolymers, and supramolecular self-assemblies resulting from host-guest chemistry 
involving cyclodextrins for drug delivery applications.    
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Chapter 3: Report on the synthesis of PHB-PEG-PHB triblock copolymers and their 
micellization behavior in aqueous solutions. Both the self-assembled micelles and the 
PHB-PEG-PHB/α-CD based supramolecular self-assemblies will be assessed for their 
potential to be applied as drug delivery systems. 
Chapter 4: Highlight on the facile synthesis of well-defined PHB-based amphiphilic 
PEG-core star-block copolymers through a combinatorial strategy consisting of 
controlled ring-opening polymerization and click chemistry. Their self-assembly 
behavior and cyclodextrin-directed morphology transformation will be studied. The 
self-assembled nanogels-like large compound micelles will be explored as a drug 
delivery vector in dilute aqueous solution. 
Chapter 5: Exploration on PHB-based amphiphilic CD-core star-block copolymers 
with various functional groups. Their supramolecular self-assembly behavior will be 
discussed. The self-assembled nanovesicles will be assessed for their promising 
applications as anti-cancer drug carriers.   
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CHAPTER 2 LITERATURE REVIEW 
This thesis mainly focus on the design of PHB-based block copolymers and 
their self-assembly with cyclodextrins as drug carriers, so the literature review will 
introduce the recent progress on (a) developing polymeric drug delivery systems, (b) 
the synthesis strategies for block copolymers, (c) the self-assembly of biodegradable 
PHB block copolymers, and (d) the formation of cyclodextin-based supramolecular 
self-assemblies as drug delivery systems.   
 
2.1 Polymeric Drug Delivery Systems 
Despite massive efforts in drug discovery, surprisingly few molecules make it 
through the drug development process and ultimately obtain marketing approval.
1, 2
 It 
has been estimated that 40-70 % of all new drug candidates discovered are lipophilic 
or hydrophobic.
3, 4
 In addition to their poor solubility, many of the drugs suffer from 
unfavorable pharmacokinetics and poor biodistribution profiles, which remain a 
principle challenge for pharmaceutical scientists.
5, 6
 It would be ideal to build all 
desirable pharmacological features into one drug molecule, but it would be simpler 
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and perhaps more effective to accomplish this by associating the biological action of 
the drug with the physicochemical characteristics of a polymeric carrier to obtain the 
desired pharmacological features, as suggested by Ringsdorf and co-workers.
7, 8
  
While development of new drugs continues, increasing attention is being 
given to develop delivery systems for administering drugs.
9, 10
 The aim of drug 
carriers is to carry sufficient drugs to reach disease sites and maintain drug 
concentration for an extended period of time to cure diseases in a sustained manner.
11
 
The controlled drug delivery systems (DDSs) has evolved from macroscopic 
“controlled” drug delivery devices and implants to microscopic degradable polymer 
depot DDSs to the current nanoscopic era of targeted nano-carriers.
12
 Numerous 
DDSs have been developed in the past few decades. Three types of the most 
promising polymer-based DDSs including polymeric micelles, polymer vesicles and 
hydrogels will be reviewed in this section. 
 
2.1.1 Polymeric Micelles 
Micelles are colloidal aggregates formed by surfactant molecules or 
amphiphilic copolymers spontaneously in aqueous solutions above a critical micelle 
concentration (CMC). In aqueous solutions, surfactant molecules or amphiphilic 
copolymers self-assemble into micelles with a hydrophobic inner core and a 
hydrophilic outer shell, as shown in Figure 2.1.
13, 14
 The driving force is to attain a 
systemic minimum free energy by removing hydrophobic blocks from the aqueous 
environment. Compared to surfactant micelles, polymeric micelles formed by higher-
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molecular-weight amphiphilic copolymers are generally more stable with remarkably 
lower CMCs. 
As one of the first reported polymer self-assemblies as DDS, polymeric 
micelles
15
 have many advantages, such as high structural stability, high water 
solubility and excellent biocompatibility, and enhanced tumor accumulation due to 
the “enhanced permeation and retention” (EPR) effect associated with their small size 
(typically 10~100 nm).
16, 17
 EPR effect was discovered by Maeda and Matsumura, 
wherein nano-scale carriers are entrapped within fast-growing solid tumors due to 
leaky vasculature.
18-22
 Polymeric micelles, as nanoscale drug carriers with hydrophilic 





Figure 2.1. Schematic drawing of the core-shell structure of a polymeric micelle and its 
dimensions. 
 
Ringdorf and co-workers first reported the use of polymeric micelles as drug 
carriers in early 1980s.
8, 25, 26
 Since then, numerous polymeric carrier systems have 
been designed for the delivery of therapeutic agents. Considering polymeric micelles 
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qualified for biomedical applications, the material should be innoxious to body and 
have some other excellent properties. For the hydrophilic segment, the most 
commonly used polymer is poly(ethylene glycol) (PEG) which can enhance micellar 
stability and circulation time due to its high water solubility and good 
biocompatibility.
27
 For hydrophobic drug loading, the most common materials are 
biodegradable polyesters, such as Poly(ε-caprolactone) (PCL) and polylactides (PLA). 
Block copolymers of PLA-PEG and PCL-PEG of various macromolecular 





 into the inner core of micelles through hydrophobic interations.
33-37
 
Besides small molecule drugs, micelles also have advantages in delivering proteins 
and nucleic acid drugs like DNA and siRNA. Pioneering work from Kataoka‟s group 
has significantly advanced polyion complex micelles (PIC micelles) for the delivery 
of proteins and nucleic acid drugs.
38-46
 PIC micelles are formed by condensing 
polyanionic nucleic acid drugs with block bopolymers consisting of cationic segments 
and hydrophilic chains. The distinct feature of the PIC micelles is that the hydrophilic 
polymer shell can protect the polyion complex core from interaction with blood 
components. 
During the past decade, several anticancer agent-incorporated polymeric 
micelle systems have been studied in clinical trials. SP1049C, doxorubicin-loaded 
poly(ethylene glycol)-poly(propylene oxide)-poly(ethylene glycol) (PEG-PPO-PEG, 
Pluronic) micelles has demonstrated superior activity in preclinical studies and a 
slower clearance in Phase I pharmacokinetic study compared to doxorubicin.
6
 The 
notable antitumor activity and favorable safety profile of SP1049C observed in the 
phase II study indicating that further evaluation in patients with adenocarcinoma of 
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the esophagus and GEJ are warranted.
47
 Preclinical and clinical studies of NK012, an 
SN-38-loaded PEG–poly(glutamic acid) polymeric micelles, also showed favorable 
safety profile and promising clinical antitumor activity.
48
 The phase I and II studies of 
NK105, a paclitaxel (PTX)-incorporated PEG-polyaspartate block copolymer micelle, 
proved the concept for the modest activity and tolerability of a new DDS formulation 
for PTX.
49, 50
 Promising clinical antitumor activities have also been demonstrated in 
the clinical studies of some other polymeric micelle formulations, such as NK911 (a 
micelle-encapsulated doxorubicin), Genexol-PM (polymeric micelle-formulated PTX) 
and NC-6004 (cisplatin-incorporated polymeric micelles).
51-54
 Those clinical results 
have proven the practical utility of polymeric micelles as DDS and also provided a 
strong foundation on further developments in this field. 
Currently, increasing attention in polymeric micelle-based DDS is being given 
to multifunctional micelles which are supposed to achieve site-specific targeted drug 
delivery and on-command triggered release.
17, 55, 56
 An optimized multifunctional 
polymeric micelle was proposed to bear therapeutic drugs for anticancer therapy, 
targeting ligands for active targeting, imaging moieties for tracking in the body, and 
stimuli-responsive polymers for triggered release,
57
 as shown in Figure 2.2. Some in 
vitro and in vivo work on multifunctional micelles has been reported, which should 
further advance the promising field of polymeric micelle-based DDS.
58-61
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Figure 2.2. Schematic drawing of optimized multifunctional polymeric micelle, bearing 
therapeutic drugs for anticancer therapy, targeting ligands for active targeting, imaging 
moieties for tracking in the body, and stimuli-responsive polymers for triggered release. 
 
Although recent advances in polymeric micelle-based DDS has demonstrated 
great potential, there remain some challenges to realize the full potential. Site-specific 
targeted drug delivery provides attractive advantages but is equally challenging, 
including validating molecular targets, overcoming physiological barriers, and 
developing appropriate techniques for conjugating targeting ligands to micelle 




2.1.2 Polymer Vesicles 
Polymer vesicles (also named polymersomes), the vesicular self-assembly of 
polymers, exhibit enclosed membrane structure.
62
 The architecture, with an aqueous 
inner cavity and a hydrophobic membrane layer, provide capacity to load both water 
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Figure 2.3. Schematic drawing of the polymer vesicle architecture, with an aqueous 
inner cavity and a hydrophobic membrane layer. 
 
Polymer vesicles are a relatively new class of nanocarriers, though their low-
molecular-weight counterparts, liposomes, have been developed into drug carriers 
over the last several decades.
64-66
 Compared to liposomes, polymer vesicles possess 
superior mechanical and physical properties.
67
 Polymer vesicle membranes are thicker 
than conventional lipid vesicles formed from low molecular weight amphiphiles. The 
increase in membrane thickness leads to vesicles with greater bending rigidities, better 
mechanical properties and less membrane permeability. The membrane thickness of 
polymer vesicles can be easily tuned by controlling the degree of polymerisation in 
the hydrophobic block. This reduced permeability may enhance the polymer vesicles‟ 
benefit in drug delivery by decreasing the rate of release. Membranes with different 
permeabilities can be designed by adjusting wall thickness and the relative polarity of 
the hydrophobic membrane.
68
 Furthermore, the diversity of copolymer chemistry 
provides possibilities to tune the polymer vesicle membrane properties to design ideal 
candidates for application in drug delivery.
69, 70
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In aqueous solution, amphiphilic block copolymers can form various ordered 
nanostructures by self-assembly. The ratio of hydrophilic block fraction to 
hydrophobic block fraction controls the morphology of these assemblies. Specific 
morphologies can be targeted according to a dimensionless packing parameter, p, 
originally developed for small amphiphilic molecules in aqueous solution. As 
illustrated in Figure 2.4,
71
 the dimensionless packing parameter (p) depends on the 
optimal area of the head group (a0), the volume of hydrophobic chains (v) and the 
length of hydrophobic chain (lc), which can be expressed in equation 2.1: 
                                  p = v/a0lc                                                                    (Eq 2.1) 
 
Figure 2.4. The chain volume v and chain length lc set limits on how the fluid chains can 
pack together, on average, inside an aggregate. Thus, the preferred molecular 
conformation depends on a0, v, and lc. [This image was reproduced with permission 
from ref.
71
 ( Israelachvili, J. N. 2011) © 2011 Elsevier] 
 
As a general rule, membrane structures (vesicles) are favoured when 1/2 ≤ p ≤ 
1, cylindrical micelles will be formed when 1/3 ≤ p ≤ 1/2, and p ≤ 1/3 yields spherical 
micelles, as shown in Figure 2.5.
72-74
 The trends are also followed by amphiphilic 
block copolymers, although block copolymers are generally preferred to be 
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characterized by the more synthetically accessible block fraction. By adjusting the 
packing factor of block copolymers through changes in the hydrophilic block fraction 
(fhydrophilic), the morphology of the resultant assemblies can be tuned to form vesicles 
when fhydrophilic is around 35±10 %, while micelle is formed when fhydrophilic  > 45%.
62
 
Following the pioneering work by Eisenberg's group,
75-80
 the self-assembly of 
linear block copolymers into vesicles has been widely studied. Eisenberg and co-
workers have prepared polymer vesicles from a variety of different amphiphilic block 
copolymer systems, such as poly(styrene)-b-poly(acrylic acid) (PS-b-PAA),
81
 
poly(acrylic acid)-block-polystyrene-block-poly(4-vinyl pyridine) (PAA-b-PS-b-
P4VP),
82
 poly(ethylene oxide)-b-poly(caprolactone)-b-poly(acrylic acid) (PEO-PCL-
PAA),
83
 and poly(ethylene oxide)-block-polystyrene-block-poly(2-diethylaminoethyl 
methacrylate) (PEO-b-PS-b-PDEA).
84
 The preparation methods, formation 
mechanisms and vesicle properties have been systematically studied.
62, 81-83, 85-103
 In 
recent years, an increasing number of linear block copolymers have also been 







 PEO-polybutadiene and PEO-PPO-PEO.
107
 
Compared to linear block copolymers, studies on the self-assembly of non-linear 
block copolymers into polymer vesicles are relatively less.
108-112
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Figure 2.5. Various self-assembled structures formed by amphiphilic block copolymers 
in a block-selective solvent. The type of structure formed is due to the inherent 
curvature of the molecule, which can be estimated through calculation of its 
dimensionless packing parameter, p. [This image was reproduced with permission from 
ref.
72
 (Blanazs, A. 2009) © 2009 Wiley-VCH] 
 
The potential applications of polymer vesicles as DDS has been evaluated by 
many researchers, and they have proven that polymer vesicles are potential candidates 




 proteins and nucleic 
acid.
121-127
 The development of polymer vesicles has been very rapid in the past 
decade. Although polymer vesicles are still in the early stages of research, clinical 
trials may not be too far away if the rapid development continues. 
 
2.1.3 Hydrogels 
Hydrogels are generally defined as three-dimensional polymer networks 
swollen by large amounts of water or biological fluids.
128
 The polymer networks can 
be formed by chemical crosslinking (covalent bonds) or physical crosslinking (such as 
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crystallization, aggregation, ionic bonding, and hydrogen bonding), by which 
hydrogels are divided into chemical gels and physical gels. Hydrogels were first 
reported by Wichterle et al. in 1960,
129
 who suggested hydrophilic gels as 
biocompatible materials for biological use. Since then numerous hydrogel systems has 
been developed for a wide range of applications in pharmaceutical and biomedical 




Hydrogels used as drug delivery systems have many advantages, including 
good tissue compatibility, easy manipulation of solute permeability,
135
 and the 
capability of delivering large molecular weight protein- / peptide-based drugs. In 
recent years, much attention has been paid to “smart” hydrogels that can respond to a 
number of stimuli, such as temperature, pH, ionic strength, molecular recognition, 
sound, pressure, light and electric fields.
136-138
 The responsive behavior was 
determined by the chemical structure of the polymer network. For example, pH-
sensitive hydrogels usually contain weakly acidic or basic pendent groups in the 
polymer networks, such as Poly (N,N‟-dimethylaminoethylmethacrylate) and 
poly(methacrylic acid) (shown in Figure 2.6). Thermo-sensitive polymers that 
undergo a reversible volume phase transition with temperature change, such as 
poly(N-isopropylacrylamide) and pluronics, are frequently used to form temperature-
sensitive hydrogels.
137, 139, 140
 Among all types of stimuli-responsive hydrogel systems, 
temperature- and pH- sensitive hydrogels are probably the most widely studied 
systems for drug delivery. Some researchers have developed dual-responsive 
hydrogels by combining the two types of stimuli.
141-145
 
































Figure 2.6. Chemical structures of some pH- and temperature-sensitive polymers. 
 
The conventional hydrogel-based drug delivery systems are usually formed 
outside the body and then administered by implantation. Nowadays, an increasing 
number of hydrogel systems are made injectable, which is expected to reduce the 
invasiveness and surgical costs.
146-149
 As an example, a stimuli-responsive hydrogel 
can be designed to undergo quick sol-gel transition at physiological conditions (37
o
C, 
pH 7.4, etc.), which can be administered by injecting the sol-state hydrogel with drugs 
to the target tissue without surgical or implantation procedures, as illustrated in Figure 
2.7.
150
 Through pre-encapsulation prior to in situ-hydrogel formation, the injectable 
hydrogel systems may help to address the issues affecting the biological activity of 
the entrapped sensitive biomolecules that the conventional covalently gelling 
hydrogels faced. Despite these advantageous properties, polymers employed to 
prepare injectable hydrogels need to meet several requirements. The sol-state 
hydrogel must have low viscosity to facilitate injection and drug encapsulation; the 
sol-gel transition should happen quickly to prevent dissolution; the hydrogels must be 
biodegradable and the degradation products should be biocompatible; the hydrogels 
should have appropriate physical and mechanical properties for application. 
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Figure 2.7. An illustration of administrating injectable hydrogel to target tissue. [This 
image was reproduced with permission from ref.
150
 (Huynh, C. T. 2011) © 2011 
American Chemical Society] 
 
Significant progress has been made in the past few decades and many 
hydrogel products have been developed for drug delivery.
128
 However, several 
challenges remain to improve the practical usage of hydrogel drug delivery systems in 
the clinic. The high water content of hydrogels limits the quantity of hydrophobic 
drug loading, and the drug release from hydrogels is often rapid due to large pore 
size.
151
 The ease of clinical usage is another big challenge, although some hydrogels 
can be made injectable, many can not avoid surgical or implantation procedures. 
Besides, a more complete understanding of cell-hydrogel interactions is necessary to 




2.2 Block Copolymers  
Block copolymers are macromolecules contain sequences, or blocks, of two or 
more chemically distinct repeating units in the same polymer chain.
154, 155
 The 
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development of this area originated with the discovery of “living polymers” in 1956 
by Szwarc,
156
 which made possible the production of block copolymers by sequential 
addition of monomers. Since then, block copolymers have been widely studied and 
demonstrated to be great potential candidates for biomedical applications and some 
other advanced technologies like computer technology and nanotechnology.
157
 This 
section will give a review of the synthetic methodologies and strategies to produce 
block copolymers with various architectures. 
 
2.2.1 Synthetic Methodologies 
Numerous polymeric materials had been created in the last few decades due to 
the immense development in polymer science. One of the greatest contributions is the 
discovery of the living polymerization technique,
158, 159
 which provides innovative 
synthetic methodologies/strategies to prepare well-defined polymers with a precise 
control of their molecular architectures. The very first concept of ''Living Polymers'' 
was introduced by Szwarc who discovered living anionic polymerization in 1956.
156, 
160
 In this report, Szwarc reported on experiments carried out with styrene as the 
monomers. Additionally, living polymers with the structure shown in Figure 2.8 were 
formed. 
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Since then, numerous functional polymer materials with wide applications 
have been successfully synthesized by living anionic polymerization.
160-164
 One of the 
most successful polymers is poly(ethylene oxide) (PEO), also known as PEG, which 
is the most commonly used segment of amphiphilic block copolymer (Refer to section 
2.1.1). The synthesis of PEO by anionic polymerization of ethylene oxide (EO) is 
shown in Figure 2.9.
165
 The anionic polymerization proceeds via the ring opening of 
cyclic monomer, which is called anionic ring-opening polymerization (AROP). 
 
Figure 2.9. The synthesis of PEO by anionic polymerization of ethylene oxide (EO). 
 







 were thereafter found to 
operate in the living manner. Among these polymerization techniques, controlled/ 
“living” radical polymerizations (CLRP) are the most popular approaches since they 
are applicable to a wide variety of monomers under robust condition.
173-178
 Figure 
2.10 showed the mechanisms of the three most frequently studied CLRP techniques, 
including nitroxide-mediated radical polymerization (NMP, first reported by Otsu and 
Tazaki in 1982)
179-181
, atom transfer radical polymerization (ATRP, first reported by 
Matyjaszewski and co-workers in 1995)
182-186
 and reversible addition-fragmentation 
chain transfer (RAFT, first reported by Rizzardo and co-workers in 1998).
187-190
 For 
all the three mechanisms, a dynamic equilibrium between low concentrations of 
growing free radicals and predominant dormant species is established through the 
activation-deactivation process. The dormant species of NMP, ATRP and RAFT are 
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alkoxyamines, alkyl halides and degenerative transfer thioesters, respectively. The 
fast exchange between active and dormant species establishs a steady state of growing 
free radicals, which provides control over molecular weight (MW), polydispersity 
(PDI) and polymer architecture. CLRP or the combination of CLRP with other 
techniques have been widely employed in the synthesis of well-defined polymers with 
complex architectures, which will be discussed in section 2.2.2. 








Figure 2.10. General mechanisms of (a) NMP [This image was reproduced with 
permission from ref.
181
(Scianname, V. et al. 2008) © 2008 American Chemical Society], 
(b) ATRP [This image was reproduced with permission from ref.
182
 (Wang, J. S. et al. 
1995) © 1995 American Chemical Society] and (c) RAFT [This image was reproduced 
with permission from ref.
187
 (Chiefari, J. et al. 1998) © 1998 American Chemical Society].  
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Besides polymerization techniques, coupling methods are another kind of 
frequently used technique in material synthesis and polymer functionalization. Click 
chemistry, which was first introduced by Sharpless and co-workers in 2001,
191
 is 
among the most attractive coupling methods. The basic reaction of „Sharpless-type 
click reaction‟ is a variant of the 1,3-dipolar cycloaddition reaction pioneered by 
Huisgen in the 1960's.
192
 As a prime example of click chemistry, a proposed 
mechanism of the most well-studied Cu(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC) was shown in Figure 2.11.
193-195
 The CuAAC was propsed to proceed 
through three steps: (a) the formation of Cu(I) acetylides from Cu
I
 species, 1-alkynes, 
and a base, (b) followed by the reaction of Cu(I) acetylides with organic azides to 
produce Cu
I
 triazolides, (c) and the final proteolysis of Cu
I
 triazolides to obtain a 1,4-
substituted 1,2,3-triazole. 
 
Figure 2.11. The proposed mechanism of the Cu(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC). [This image was reproduced with permission from ref. 
194
 (Binder, W. H. et al. 
2008) © 2008 Wiley-VCH]. 
 
 Chapter 2: Literature Review 
27 
The click chemistry is a powerful tool for the conjugation of ligands onto 
polymers, due to its high fidelity, quantitative yields, tolerance to a variety of 
functional groups and applicability under mild reaction conditions.
196-200
 The 
combination of polymerization techniques and click chemistry has greatly expanded 
the range of available materials, which topic will be discussed in section 2.2.2. 
 
2.2.2 Block Copolymer Architectures and Synthetic Strategies 
Block copolymers with well-defined molecular architectures are very useful in 
developing clear structure-property relationships and making theoretical and empirical 
predictions.
201-206
 The evolution of living polymerizations and coupling methods has 
prompted the synthesis of well-defined block copolymers with various 
architectures.
164, 207-210
 This section will give a review on the synthetic strategies 
employed to construct both linear block copolymers and nonlinear block copolymers 
with complex architectures.  
 
2.2.2.1 Linear block copolymers 
The simplest architecture of a block copolymer is linear diblock, A-B, containing 
blocks of two chemically distinct repeating units (A and B) in the same polymer chain. 
Structurally different linear block copolymers, such as triblock and multiblock 
copolymers, can be obtained by arranging A and B in different sequences or adding more 
blocks (Figure 2.12). 
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Figure 2.12. Some common architectures of linear block copolymers. A ( ), B ( ) and 
C ( ) are polymer repeating units. 
 
In the past two decades, numerous linear block copolymers have been 
constructed and their structure-property relationships
211-225
 have been widely studied. 
Hatton and co-workers synthesized a series of diblock, triblock, and random 
methacrylic polyampholytes to observe their solution
226
 behavior and the effect of 
block size and sequence on the micellization.
211
 Eastwood and Dadmun investigated 
the ability of di-, tri-, penta-, and hepta- multiblock copolymers to compatibilize the 
polystyrene/poly(methyl methacrylate) interface compared to a random copolymer.
214
 
Wu et al. synthesized a series of symmetric poly(styrene-b-isoprene)(n) multiblocks 




CLRP techniques have been proven to be useful tools for the synthesis of 
various block copolymers, such as poly(N-isopropylacrylamide)-poly(methacrylic 
acid) block copolymers,
227





 poly (methyl methacrylate)-b-
polyurethane-b-poly (methyl methacrylate) triblock copolymers,
230, 231
 poly(methyl 
methacrylate-b-n-butyl methacrylate-b-styrene) tri-/penta- block copolymers
232
 and 
poly(4-acryloylmorpholine)/poly 2-(N-carbazolyl)ethyl acrylate random block 
copolymers.
233
 Thanks to the versatility of modern synthetic methodologies, linear 
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block copolymers are easy to prepare today. They nowadays are frequently used as 
linear analogues
203, 234-241
 for more complex block copolymers which will be 
discussed in the following section. 
 
2.2.2.2 Nonlinear block copolymers 
Nonlinear block copolymers have attracted increasing attention from both 
theoretical and practical viewpoints.
242, 243
 They bring additional complexity to the 
investigations of structure-property relationships and exhibit potential to realize new 
properties from the additional structural variables, which would improve our ability to 
modulate macromolecular properties through chemical design.  
Among nonlinear block copolymers, star-shaped copolymers have attracted 
much attention for their favorable properties. Compared to their linear analogues, star-
block copolymers have more compact structure, higher functionality and unusual 
solution properties with lower viscosity.
244
 Despite their favorable properties, the 
synthesis of star-block copolymers is much more difficult than linear block 
copolymers. The combination of two or more synthetic tools provides the potential to 
design versatile nonlinear block copolymers with complex architectures.
210, 245-247
 The 
structures of two common star-shaped and some other complex architectures of 
nonlinear block copolymers are shown in Figure 2.13. 
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Figure 2.13. Star-shaped and some other architectures of nonlinear block copolymers. 
A ( ) and B ( ) are polymer repeating units. 
 
The main avenue to star polymers used to be the living anionic polymerization, 
but more recently, CLRP and click chemistry have emerged as powerful tools for the 
synthesis and functionalization of star-block copolymers.
158, 161, 162, 164, 248-255
 As the 
inventors of ATRP, Matyjaszewski's group has done a lot of work on the construction 
of star polymers by ATRP or the combination of ATRP and other techniques.
255-260
 In 
2006, they synthesized a series of star-block copolymers via an "in-out" method or 
cross-linking macromonomers by ATRP,
261, 262
 or by a combination of ATRP and the 
"click" reactions.
263, 264
 In 2008, Matyjaszewski and co-workers synthesized a series 
of well-defined 3-arm star block copolymers and studied their thermoplastic elastomer 
behavior compared with their linear counterparts.
265
 In 2010, star-like block 
copolymers for high temperature thermoplastic elastomers applications
258
 and photo-
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cross-linkable thermoresponsive star polymers designed for control of cell-surface 
interactions were reported by this group.
259
 In addition to ATRP, RAFT and click 
chemistry have proved to be effective methods for synthesizing star polymers. A large 
number of studies on synthesizing star polymers through RAFT and click chemistry 
strategies have been reported.
266-277
 Among these studies, Stenzel and co-workers 
have done excellent work on exploring the principle design routes and pathways to 
star polymers in the context of theoretical design criteria for the RAFT approaches 
and the combinatorial RAFT and click chemistry approaches.
253, 278-284
 Besides ATRP, 
RAFT and click chemistry, ring-opening polymerization and living anionic 
polymerization are also frequently combined with the other techniques to develop 
combinatorial strategies for star polymer synthesis. 
Nonlinear block copolymers with other complex architectures recently have 











 which makes new interesting 
materials available for both research studies and potential applications. 
 
2.3 PHB-based Biodegradable Block Copolymers 
Polyhydroxybutyrate (PHB) and related polyhydroxyalkanoate (PHA) are a 
class of natural biodegradable and biocompatible polyester.
300-302
 PHB-based 
copolymers have attracted great interest due to its natural biodegradability and 
potential biomedical applications.
303-306
 The PHB-based copolymers are generally 
synthesized from high molecular weight microbial PHB which has been found in 
many microorganisms as intracellular carbon source and energy storage material.
307-
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309
 An alternative synthetic approach is via ring opening polymerization (ROP) of β-




Recent reports have focused on the synthesis of linear PHB block copolymers 
and their applications as biodegradable drug carriers in the formulation of hydrogel or 
nanoparticle.
314-316
 It was reported that nanoparticles self-assembled from PHB block 
copolymers exhibited very low critical micelle concentration (CMC) due to the highly 
hydrophobic PHB, and the self-assembly behavior was discussed in terms of the 
relationship between their chemical composition and properties.
317, 318
  
Among linear PHB block copolymers, PHB-PEG containing biocompatible 
PEG as a hydrophilic segment and biodegradable PHB as a hydrophobic one has 
received considerable attention. Jeong et al.
319
 conjugated PHB with PEG by the 
transesterification reaction to form block copolymer. Zhao et al.
320, 321
 prepared 
PHB/PEG multiblock copolymers through one-step copolymerization using a 
coupling agent, the crystallization and biodegradation behavior was studied. Kawalec 
et al.
322
 synthesized triblock PHB-PEG-PHB by anionic ROP using PEG as 
macroinitiator. Chen et al.
316, 323, 324
 prepared nanoparticles from PHB-PEG-PHB as 
potential drug carriers based on the triblock copolymers. Li‟s group325-333 studied the 
properties of a series of triblock and multiblock PHB-PEG copolymers and evaluated 
their potential as candidate biomaterials.  
Though the synthesis of PHB-based linear block copolymers were widely 
reported, only a few studies were carried out on their self-assembly behavior in 
aqueous solution. More importantly, reports on star-block copolymer of PHB are 
rare,
306, 334, 335
 not to mention studies on self-assembly behavior. Therefore, it is 
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desirable from both theoretical and practical viewpoints to design PHB-based 
copolymers with more complex architectures.  
 
2.4 Cyclodextrin-based Supramolecular Self-assemblies  
Cyclodextrins (CDs) are cyclic oligosaccharides (Figure 2.14) composed of 6, 
7, or 8 D(+)-glucose units linked by -1,4-linkages and named -, -, or γ-CD, 
respectively.
336
 They are cup-shaped molecules with a hydrophobic cavity and a 
hydrophilic exterior. The geometry of CDs gives a hydrophobic inner cavity having a 
depth of ca. 7.9 Å, and an cavity width of ca. 4.7-5.3, 6.0-6.5, and 7.5-8.3 Å for -, -, 
or γ-CD, respectively.337, 338 
 
Figure 2.14. Molecular structure of cyclodextrins (CDs) and a schematic drawing of 
their corresponding dimensions. 
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2.4.1 Inclusion complexation 
CDs have many practical applications in pharmacy and engineering
336, 339
 as 
they can form supramolecular inclusion complexes by entrapping organic molecules 
(guests) in the hydrophobic cavity of the cyclodextrin (host).
340
 Several small drug 
molecules
341-344











 etc.) and polymers (such as PEG and 
Pluronics)
351-354
 have been reported to form CD/guest inclusion complexes driven by 
host-guest interactions. The driving forces include the extrusion of enthalpy-rich 
water molecules from CD cavity, vander Waals interaction, hydrophobic interaction, 
hydrogen bonding, etc.  
Formation of CD/guest supramolecules is a result of equilibrium between free 
guests, CD molecules and the CD/guest inclusion complexes, as shown in Figure 2.15. 
The equilibrium is governed by a constant K, which is usually named the association 
constant. The value of K mainly depends on the size of guest molecules and CD 
cavity, and the mutual fitness.
355
 As an example, the adamantane (Ada)/-CD 




 at room temperature 
because that size of Ada perfectly fits the cavity of β-CD.356  
 
Figure 2.15. Schematic representation of the equilibrium of inclusion complex 
formation (1:1) between CD and a guest molecule. 
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The supramolecular structures based on CDs and polymers have drawn 
increasing attention since the first preparation of -CD&PEG inclusion complexes.351, 
352, 357, 358
 -, -, and γ-CD were reported to form inclusion complexes with various 
polymers.
359-363
 The complexes in which cyclic compounds are threaded onto 
polymeric chains capped with bulky terminal groups or remain uncapped are called 
polyrotaxanes and polypseudorotaxanes, respectively (Figure 2.16).
364
 Polyrotaxanes 
and pseudo-polyrotaxanes have inspired interesting developments of novel 





Figure 2.16. Schematic representation of (a) polypseudorotaxane, (b) polyrotaxane 
structures.  
 
Recent progress on the CD-based supramolecular self-assemblies including 
the construction of nano-assemblies through host-guest interactions as drug/gene 
carriers, and the design of polyrotaxanes/polypseudorotaxanes to form supramolecular 
hydrogels for controlled drug delivery, will be reviewed in the following sections. 
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2.4.2 Supramolecular Nanoassemblies and Their Application as DDS 
In light of their complex capacity, CD-containing polymers have been 
exploited to construct host-guest nanoassemblies. The strong complexes formed by 
Ada derivatives with β-CD have been the subject of numerous studies.340, 370-375 Jiang 
and co-workers synthesized a class of β-CD-containing polymers which were used to 
prepare noncovalently connected micelles or vesicles in aqueous solution driven by 
inclusion complexation between β-CD and Ada, and further modification can be 
achieved due to the presence of β-CDs on the surfaces of the nanoassemblies.376-379 
Zhang et al. reported the formation of dual thermoresponsive noncovalently 
connected micelles based on inclusion complexation between Ad-poly(propylene 
glycol) (PPG) and star-shaped poly(N-isopropylacrylamide) with a CD core. 
Compared to the conventional polymeric micelles, the property of the noncovalently 




Polyrotaxane (PR) and pseudo-PR-based nanoassemblies have also been 
reported to be used as DDS. Ha et al.
382, 383
 developed hollow nanospheres through 
the self-assembly of alginate-graft-PEG and α-CD complexes for enzyme 





 obtained nano-sized spherical particles through the self-assembly of 
PR-based triblock copolymers, which may be used as smart materials for controlled 
drug delivery. Liu et al.
386
 prepared nano-sized vesicles through the inclusion 
complexation between α-CD and PEO-b-poly(2-methacryloyloxyethyl 
phosphorylcholine) in aqueous media, and the anticancer drug, doxorubicin, was 
successfully loaded into the vesicles. Li and co-workers
337, 362, 387-389
 designed a series 
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of cationic PRs with multiple cationic α- or β-CDs threaded on P(EO-r-PO) or PEO-
PPO-PEO chains for efficient gene delivery. 
The excellent biocompatibility of CDs makes CD-containing polymers good 
candidates to construct host-guest nanoassemblies for drug/gene delivery. Davis and 
co-workers developed a series of cationic β-CD-containing polymers with low 
cytotoxicity, which can condense nucleic acid drugs to form nano-sized polyplexes 
for gene therapy.
390-397
 To endow the polyplexes with properties appropriate for 
tumor-targeted gene delivery application, polythethylene glycol (PEG) stabilization 
agent and human transferrin targeting ligand were conjugated to the surface of 
polyplexes through the employment of β-CD/Ada inclusion complexation.398-402 The 




It is convenient to construct multifunctional nanoassemblies through inclusion 
complexation. The stabilization agents and targeting groups can be introduced 
through surface modification as Davis and co-workers did. The triggered drug release 
can be realized by utilizing stimuli-responsive inclusion complexes. For example, 
azobenzene/CDs inclusion complexes have been frequently employed to develop 
photo-switched supramolecular nanoassemblies, the photo-responsive self-assembly 
and disassembly behaviors have great potential in the field of controlled drug 
release.
345, 405-408
 CDs‟ complexing capacity with several drugs provides CD-
containing cationic polymers with the ability to deliver small molecule drugs and 
nucleic acid drugs simultaneously. Deng et al. synthesized star-shaped cationic 
polymers consisting of β-CD core and poly(amidoamine) dendron arms for the 
entrapment of hydrophobic anti-cancer drug (methotrexate) and the co-delivery of 




 The high flexibility of CD-containing nanoassemblies 
provides attractive advantages for their application as DDS.  
 
2.4.3 Supramolecular Hydrogels and Their Application as DDS 
PR and pseudo-PR-based supramolecular hydrogels formed by CD/polymer 
inclusion complexes have attracted great interest since the first report of sol-gel 
transition during inclusion complex-formation between -CD&PEG in aqueous-
solution by Li et al. in 1994.
410
 A series of -CD&PEG pseudo-PR-based hydrogels 
were then prepared and found to be thixotropic and reversible, and the in vitro release 
studies of model drug from the hydrogels showed them applicable as injectable 
DDS.
314, 365, 411-414
 More recently, Ma et al.
415-419
 prepared a class of -CD&PEG 
pseudo-PR-based hydrogels. Their abilities to be used as DDS were evaluated by the 
in vitro delivery of model protein drug (bovine serum albumin), bioactive lysozyme, 
plasmid DNA, polymeric prodrug (PEGylated indomethacin), and the co-delivery of 
anticancer drug and growth factor. Jiang and co-workers
420, 421
 developed -CD&PEG 
pseudo-PR-based hybrid hydrogels which exhibited greatly improved rheological 
properties. Although -CD&PEG is the most widely studied pseudo-PR for 
constructing supramolecular hydrogels,
141, 338, 414, 422-432
 some other pseudo-PRs, such 
as β-CD/PPG and β-CD/PCL,433-436 have also been employed to prepare hydrogels.   
Besides PR and pseudo-PR, host-guest pairs, such as β-CD/Ada,437-440 γ–
CD/pyrene
441
 and β-CD/Cholesterol348 can also serve as cross-links to form 
supramolecular hydrogels. For example, Van de Manakker et al.
347, 348, 442, 443
 
described the formation of hydrogel after mixing 8-arm star-shaped PEG end-
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modified with β-CD and cholesterol. The protein release behavior of the hydrogel 





 supramolecular hydrogel 
by employing CD/ferrocene or azobenzene host-guest pairs. As reviewed in section 
2.1.3, stimuli-responsive “smart” hydrogels that can respond to a number of stimuli 
have several advantages for drug delivery. CD-based supramolecular hydrogels with 






141, 430, 436, 451-453
 have been widely studied. The sol-gel transition 
of these hydrogels can trigger drug release, which is desirable for drug delivery 
applications. 
The above literature survey indicates that the CD-based supramolecular self-
assemblies including micelles, vesicles and hydrogels could be very useful materials 
as DDSs. 
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CHAPTER 3 MICELLIZATION OF POLY[(R,S)-3-
HYDROXYBUTYRATE]-POLY(ETHYLENE GLYCOL)-
POLY[(R,S)-3-HYDROXYBUTYRATE] AMPHIPHILIC 
TRIBLOCK COPOLYMERS AND THEIR HYDROGEL 
FORMATION WITH ALPHA-CYCLODEXTRIN FOR 
DRUG DELIVERY  
3.1 Introduction  
Injectable hydrogel is an increasingly important material in biomedical 
applications as drug delivery depot as well as injectable scaffold. For many in vivo 
applications, the development of hydrogels that can be easily administered via simple 
injection procedure is of great significance as it provides a minimally invasive route 
for implantation of hydrogel.
1-3
 Many of the current strategies are based on sol-gel 
transition of low viscosity polymer solution that is triggered by physiological 
condition, such as body temperature and pH.
4-7
 On the other hand, in-situ gelation can 




 crosslinking of low viscosity 
precursors soon after injection. The use of thixotropic hydrogels, that exhibit 
diminishing viscosity under shear stress and time dependant restoration upon 
relaxation, presents another alternative.
12
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Regardless of the various methods, the mechanical properties of hydrogels 
formed after administration will dictate their usefulness. An ideal injectable hydrogel 
should have its mechanical properties quickly build up after administration and 
maintain sufficient strength and stiffness over its service lifetime. Supramolecular 
hydrogel based on α-CD/PEG pseudo-PR has great potential for drug delivery since 
α-CD and PEG are both biocompatible. However, a major drawback on its in vivo 
application is the requirement of high molecular weight PEG that is greater than 10 
kDa, which was proved difficult to be eliminated from the body through renal 
filtration. To circumvent this problem, efforts have been made by using biodegradable 
block or graft copolymers that contain PEG segments as the polymeric guest or 
through the use of hydrophobically modified low molecular weight PEG.
13-18
   
In a previous study, our laboratory has reported the synthesis of series of well-
defined amphiphilic triblock copolymers that have two atactic PHB segments 
sandwiching one PEG block.
19
 By exploiting molecular recognition to drive -CD 
molecules over atactic PHB chain that has slightly larger cross-sectional diameter 
over their cavity size, block-selected polypseudorotaxanes with -CD preferentially 
threaded on the middle PEG block were formed. At sufficiently low -CD coverage 
over the PEG segment, the obtained polypseudorotaxanes formed hydrogel, instead of 
precipitate. Although this could be easily understood as a result of increasing 
hydrophilicity from more PEG exposure on the polypseudorotaxane, the strength of 
hydrogels obtained were not expected of those with host polymer of  low molecular 
weight around 5000 Da.   
To verify the hypothesis that the enhancement was endowed by hydrophobic 
association of telechelic PHB segments, the self assembly behavior of PHB-PEG-
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PHB was assessed. In this work, well-defined triblock copolymers that have two 
atactic PHB segments sandwiching one PEG block were synthesized. Two PHB-PEG-
PHB copolymers with different hydrophobicity were prepared. The micellization 
behavior of the PHB-PEG-PHB copolymers were assessed using fluorescence 
spectroscopy, dynamic light scattering and transmission electron microscopy. The 
relatively hydrophobic PHB-PEG-PHB was found to form nano-sized micelles (~30 
nm) which have high capacity for hydrophobic drug (paclitaxel) encapsulation. The 
more hydrophilic low-molecular-weight PHB-PEG-PHB (ca Mn 5000) was found to 
form supramolecular hydrogel with -CD at significantly low solid loading but still 
rival or surpass hydrogels obtained from high molecular weight PEG (Mn 27000) in 
terms of rheological properties. The drug release behavior of this supramolecular 
hydrogel was evaluated by loading a hydrophilic anticancer drug, 5-fluorouracil. 
 
3.2 Experimental Section  
3.2.1 Materials  
(a) Chemicals 
Poly(ethylene glycol)s (PEG) with Mn of ca. 3000 Da and Mw of ca 35000 Da 
were obtained from Aldrich and Merck, respectively; while methoxy poly(ethylene 
glycol) (MPEG) with Mn of ca. 5000 Da was obtained from Sigma. They were 
purified by dissolving in dichloromethane followed by precipitation in diethyl ether 
and further dried under high vacuum at 40 C for 48 h. The Mn and polydispersity 
index (PDI) of the two PEGs were found to be 3.25 kDa and 1.03, 27.0 kDa and 1.13, 
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respectively; while MPEG has Mn and PDI of 4.70 kDa and 1.02, respectively. (R,S)-
β-butyrolactone (> 95 %, Tokyo Kasei Inc) was dried over and vacuum distilled from 
CaH2 twice before use. Pristine α-cyclodextrin (> 98 %, Tokyo Kasei Inc) was dried 
under vacuum at 100 
o
C overnight before storing in dry box for further use. 5-
Fluorouracil (5-FU, ≥ 99 %, Sigma), Paclitaxel (PTX, 99.5 %, LC Laboratories), 
2,2,6,6-Tetramethyl-1-piperidinyloxy (TEMPO, 99 %, Aldrich), sodium hypochlorite 
(NaClO, available chlorine ≥ 4 %, Aldrich), hydrochloric acid (HCl, 1 N, Aldrich), 2-
iodoethanol (99 %, Aldrich), sodium bromide (NaBr, 99 %, Alfa Aesar), sodium 
hydroxide (NaOH, 99 %, Merck), sodium carbonate (Na2CO3, 99.9 %, BDH), 
dimethylsulfoxide (DMSO, anhydrous, ≥ 99.9 %, Aldrich), ethanol (99.9 %, Merck), 
diethyl ether (99.9 %, J. T. Baker), hexane (99.8 %, J. T. Baker) and chloroform 
(99.8 %, Tedia) were used as received. 
 
(b) Cells 
Human cervical cancer cell line HeLa was purchased from ATCC (Rockville, 
MD) and maintained in Dulbecco‟s Modified Eagle‟s Medium (DMEM) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 100 units/mg 
penicillin, 100 g/mL streptomycin at 37 C and 5 % CO2.  
 
3.2.2 Synthesis Methods  
Synthesis of PHB-PEG-PHB triblock copolymers. Two of PHB-PEG-PHB 
copolymers were synthesized from PEG-macroinitiators via anionic ring-opening 
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polymerization of (R,S)--butyrolactone in DMSO at room temperature under dry N2 
atmosphere, as reported previously
20
 and shown in Scheme 3.1. The macroinitiators 
were endowed with sodium carboxylate functionality on both ends of the PEG chain 
through a TEMPO-mediated oxidation of commercially available hydroxyl-
terminated PEG and subsequent neutralization with Na2CO3. In a typical example, the 
ring-opening polymerization was carried out as follow: 1.609 g of dried PEG-
macroinitiator (Mn 3.32 kDa, 0.485 mmol) was first dissolved in 46 mL of DMSO 
followed by addition of 0.86 mL of -butyrolactone (10.6 mmol) at room temperature. 
The extent of monomer conversion was followed closely using 
1
H NMR spectroscopy. 
At monomer conversion of 91.5 %, the polymerization was quenched by adding an 
excess of 2-iodoethanol. Solvent DMSO was then removed by distillation and the 
residue re-dissolved in chloroform, filtered and precipitated into n-hexane to afford 
the final copolymer. Yield: 2.346 g (94.9 %). GPC (THF): Mn = 4.47 kDa, PDI = 1.07. 
1
H NMR (400 MHz, CDCl3):  1.26 – 1.31 (m, -OCH(CH3)CH2CO2- of PHB block), 
2.43 – 2.62 (m, -OCH(CH3)CH2CO2- of PHB block), 3.43 – 3.70 (m, -OCH2CH2O- of 
PEG block), 3.81 (t, -CO2CH2CH2OH of end group), 4.09 (s, -OCH2CO2- of PEG 
block), 4.20 (t, -CO2CH2CH2OH of end group), 5.23 – 5.32 (m, -OCH(CH3)CH2CO2- 
of PHB block).   
Preparation of polymeric micelles. Two PHB-PEG-PHB polymers were 
synthesized and represented by the notation H-E-H(10-74-10) and H-E-H(36-174-36), 
respectively, as shown in Table 3.1. H-E-H(10-74-10) micelles were prepared by 
direct dissolution in water. H-E-H(36-174-36) micelles were prepared in DMSO-
water mixed solvent (1:99) due to the relatively poor water solubility.  
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Preparation of supramolecular hydrogels. Supramolecular hydrogels of the 
PHB-PEG-PHB triblock copolymer were prepared according to formulations listed in 
Table 3.2.  Generally, a required amount of the block copolymer was first dissolved in 
deionized water before mixing with a certain volume of saturated α-CD solution 
(0.145 mg/mL).  The concentration of total solutes for all the formulations was fixed 
at 11.2 % (w/v).  The solution was then sonicated for 10 minutes and then kept at 4 
o
C 
for at least 1 day before further characterizations. MPEG with Mn of 4.70 kDa and 
high molecular weight PEG with Mn of 27.0 kDa were also used to prepare similar 
hydrogels as controls. 
 
3.2.3 Characterization Methods 
Molecular characterizations. Gel permeation chromatography (GPC) 
measurements were performed at 40 °C  with a Shimadzu SIL-10A and LC-20AD 
system equipped with two Phenogel 5 100 and 10000 Å columns (size: 300 × 4.6 
mm) connected in series and a Shimadzu RID-10A refractive index detector. THF) at 
a flow rate of 0.3 mL/min was used as the mobile phase. Monodispersed PEG 
standards were used to calibrate the system. Proton nuclear magnetic resonance (
1
H 
NMR, 400 MHz) spectra were obtained on a Bruker AV-400 NMR spectrometer at 
room temperature and chemical shifts reported in ppm with reference to solvent peak 
(CHCl3: δ 7.26 ppm). 
Thermal analysis. Thermogravimetric analyses (TGA) were done on a TA 
Instruments SDT 2050, by heating the samples at a rate of 20 °C min
-1
 from room 
temperature to 800 °C in a dynamic nitrogen atmosphere (flow rate = 120 mL/min). 
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Dynamic light scattering (DLS) measurements. The size of micelles was 
measured on a Zetasizer Nano ZS (Malvern Instruments Ltd., MA, USA), with a laser 
light wavelength of 633 nm at a 173 scattering angle. The particle size measurements 
were performed at 25 C in duplicate. 
Transmission electron microscopy (TEM). Micelle morphology of PHB-
PEG-PHB was visualized on JEOL JEM-3010F FasTEM field emission transmission 
electron microscope, operating at an acceleration voltage of 300 kV. The sample was 
prepared by depositing a drop of micelle solution containing 0.05 wt% of 
phosphotungstic acid onto a 200 mesh carbon coated copper grid. The sample was 
kept in a dry box for 48 h for drying at room temperature before imaging. 
Determination of critical micellization concentration (CMC). CMC of 
PHB-PEG-PHB was determined by fluorescence probe technique. Working solutions 
of the block copolymers with concentrations from 10 to 1.0 × 10
-4
 mg/mL were 
prepared through serial dilution with deionized water. The polymer solutions were 
then transferred to vials containing pyrene that was previously deposited from its 
ethanol solution through solvent evaporation. The aqueous solutions, with a final 
pyrene concentration of 6.0 × 10
-7
 M, were equilibrated for at least 2 hours at 25 
o
C 
before subjected to fluorescence measurement. Fluorescence excitation spectra of 
pyrene in the block copolymer solutions were recorded on a Shimadzu RF-5301 PC at 
25 
o
C from 290 to 360 nm with emission wavelength set at 373 nm. CMC was 
determined graphically based on the sudden change in intensity ratios at 336 and 333 
nm (I336/I333) with increasing polymer concentration. 
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Determination of gelation time. Time required for hydrogel formation was 
estimated using vial-tilting method.
21
  All of the hydrogel samples were prepared as 
described above, but with the total volume scaled down to 1 mL.  The sol to gel 
transition was timed soon after the 10 minute sonication step until a non-flowing mass 
was formed.  During this transition, the vials were tilted periodically and the moment 
when their content stopped flowing for 30 second was regarded as the gelation time. 
Wide-angle X-ray diffraction. X-ray diffraction (XRD) measurements were 
carried out on a Bruker GADDS diffractometer with an area detector operating under 
Cu K (1.5418 Å) radiation (40 kV, 40 mA) at room temperature. The samples were 
scanned from 5 to 40 (2).  Hydrogel samples were first transferred onto clean glass 
slides and then mounted onto a sample holder using double-sided adhesive tape.  
Lyophilized hydrogels, on the other hand, were mounted directly onto the sample 
holder with double-sided adhesive tape. 
Rheological measurements. Dynamic rheological measurements were 
performed on a Thermo Haake RS600 rheometer at 25 
o
C with parallel plate geometry 
(35 mm diameter) at a gap of 1 to 2 mm. Hydrogel sample that has been aged for at 
least 1 day was carefully loaded onto the measuring geometry. Precautions, which 
include gradual gap closing and careful sample trimming, were taken to minimize 
disruption to the hydrogel network and ensure optimal filling within the measuring 
geometry. Water was added around the measuring geometry to minimize the effect of 
water evaporation on the rheology data. Finally, a properly loaded sample was 
allowed to age for another 1 to 2 hours before any measurements. Oscillatory stress 
sweeps were performed by applying increasing shear stress logarithmically from 0.50 
Pa at a fix angular frequency of 1 rad/s. Upon reaching elongations of at least 4000 %, 
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the applied shear stresses were reduced to 0.30 Pa, to monitor structural recovery over 
a period of 60 minutes at the same angular frequency. Oscillatory frequency sweeps 
were done from 100 to 0.10 rad/s at a constant shear stress of either 5.0 or 0.5 Pa that 
lies within the linear viscoelastic regime of each sample. 
Morphology study of lyophilized hydrogels. Morphologies of lyophilized 
hydrogels were viewed under a scanning electron microscope (SEM, JEOL JSM-
5600). Lyophilized hydrogels were prepared by carefully spreading thin layer of 
hydrogels onto clean glass slides before subjecting them to lyophilization.  
 
3.2.4 In vitro drug release and cytotoxicity assays  
In vitro release study of 5-fluorouracil (5-FU) from hydrogel. The general 
protocol for encapsulation of 5-FU in the hydrogel samples is as follow: Into 0.927 
mL of aqueous solution containing 54 mg of guest polymer and (3 mg) of 5-FU was 
added 1.473 mL of saturated -CD solution (145 mg/mL). The mixture was sonicated 
for 10 min and distributed into three 0.6-mL vials. The vials were stored at 4 
o
C 
overnight to allow hydrogel formation. They were then have their open end covered 
with dialysis membrane with molecular weight cut-off of 50 kDa and placed in test 
tubes containing 5 mL of phosphate buffered saline (PBS) for incubation in a 37 °C 
water bath. The vials were placed inverted in the tubes while maintaining sufficient 
space below them for material transport. At predetermined intervals, the vials were 
moved to tubes containing fresh PBS. Tubes with PBS containing the released 5-FU 
were kept for further analysis. The concentrations of 5-FU released were determined 
by measuring the absorbance of PBS at 267 nm with a Shimadzu UV-2501PC 
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spectrophotometer, with reference to calibration plot obtained from 5-FU working 
standards in PBS. 
Paclitaxel (PTX) loading and in vitro release from micelles. PHB-PEG-
PHB (200 mg/mL) in DMSO 5 μL was mixed with PTX 5 μL with various 
concentrations (20, 40, 60, 80 mg/mL) in DMSO, which was then injected into 990 
μL deionized (DI) water. Free PTX with equivalent concentrations prepared by the 
same method were used as controls. The PTX-loaded micelle solutions and free PTX 
solutions were stored overnight at room temperature. After that, the solution was 
placed into a dialysis bag (MWCO 3500) and dialyzed against 4 L of distilled water 
for 12 h. The water was refreshed at appropriate time intervals to remove the DMSO. 
The aqueous solution in the dialysis bag was filtrated through 0.45 μm membrane to 
remove the free drug and obtain PTX-loaded micelles. The drug loading content was 
determined by measuring UV absorbance at 227 nm of the lyophilized PTX-loaded 
micelles in methanol (MeOH). The concentration of PTX in MeOH (c) was obtained 
based on the standard curve:  
                          c (mg/mL) = A / 38.072                                  (Eq 3.1) 
Where, A is the UV absorbance at 227 nm.  
The PTX-loaded micelle solution was distributed into three 0.6-mL vials. The 
vials were then have their open end covered with dialysis membrane with molecular 
weight cut-off of 3500 Da and placed in test tubes containing 10 mL of phosphate 
buffered saline (PBS) for incubation in a 37 °C water bath. The vials were placed 
inverted in the tubes while maintaining sufficient space below them for material 
transport. At predetermined intervals, the vials were moved to tubes containing fresh 
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PBS. Tubes with PBS containing the released PTX were freeze-dried and redissolved 
in MeOH. The concentrations of PTX released were determined by measuring the 
absorbance at 227 nm with a Shimadzu UV-2501PC spectrophotometer, with 
reference to calibration plot obtained from PTX working standards in MeOH. The 
cumulative drug release was calculated from the following relationship:  
                     Cumulative release (%) = (Mt / M0) × 100                   (Eq 3.2) 
Where, Mt is the amount of drug released from micelles at time t, and M0 is the 
amount of drug loaded into micelles. The drug release measurement was carried out in 
triplicate and the average value of three measurements was taken. 
In vitro cytotoxicity test. For each well in a 96-well plate, 100 L of Hela 
cells in DMEM, with a concentration of 1105 cells/mL, was added. The number of 
Hela cells in each well was 10000. After incubation for 24 h in incubator (37 °C, 5 % 
CO2), the culture medium was changed to 100 L of DMEM containing PTX-loaded 
micelles, blank micelles, DMSO or free PTX with various concentrations and the 
mixture was further incubated for 24 h. Then, DMEM with materials was replaced by 
fresh DMEM and 10 L of MTT solution (5 mg/mL) was added to the cells. After 
incubation for 4 h, 150 L of DMSO was added and shaken at room temperature. The 
optical density (OD) was measured at 570 nm with a microplate reader (Spectra Plus, 
TECAN). The viable rate was calculated by the following equation:  
  Viable rate = (ODtreated / ODcontrol)  100 %                        (Eq 3.3) 
Where, ODcontrol was obtained in the absence of materials and ODtreated was obtained 
in the presence of materials. 
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3.3 Results and Discussion 
3.3.1 Molecular characteristics of PHB-PEG-PHB triblock copolymers 
As shown in Scheme 3.1, the PHB-PEG-PHB triblock copolymers were 
synthesized via a controlled anionic ring-opening polymerization of (R,S)--
butyrolactone from PEG-macroinitiators. The PEG-macroinitiators were obtained 
from commercially available hydroxyl-terminated PEG through a TEMPO-mediated 
oxidation to transform the hydroxyl groups to carboxylic acid and subsequent 
neutralization with Na2CO3.  Carboxylate moieties rendered on both sides of the PEG 
chain then initiated PHB chain growth through nucleophilic attack on the methine 
carbon of -butyrolactone monomer which simultaneously generated new carboxylate 
functionality that allowed chain propagation. Upon monomer conversion of more than 
90 %, the ring-opening polymerization was quenched with 2-iodoethanol that 
concomitantly functionalized the PHB-PEG-PHB triblock copolymer with hydroxyl 
end groups.  
 
Scheme 3.1. Synthetic scheme of poly[(R,S)-3-hydroxybutyrate]-poly(ethylene glycol)-
poly[(R,S)-3-hydroxybutyrate] (PHB-PEG-PHB) triblock copolymers  from 
commercially available poly(ethylene glycol) (PEG). 
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In this study, two PHB-PEG-PHB triblock copolymers were synthesized from 
PEG-macroinitiators (Mn 3.25 kDa or 7.67 kDa) flanked with two PHB segments that 
are around 10 or 36 repeating units in length. The two triblock copolymers were 
represented by the notation H-E-H(10-74-10) or H-E-H(36-174-36), where the 
number of repeating units on each block are given in the parentheses according to the 
PHB-PEG-PHB block order. GPC measurement on the triblock copolymers revealed 
a unimodal molecular weight distribution that has Mns of 4.47 kDa and 11.0 kDa, 
respectively. In addition, 
1
H NMR spectroscopy of the triblock copolymers also 
testified to its molecular characteristics with distinctive PEG methylene proton signal 
at around  3.6 ppm as well as PHB methine, methylene and methyl protons at around 
 5.2, 2.5 and 1.3 ppm, as shown in Figure 3.1. Signals originating from the hydroxyl 
ethylene end groups can also be clearly found at  4.2 and 3.8 ppm. From the intensity 
ratio of PHB methine protons and end group protons, we estimate that the degree of 
polymerization of each PHB segment to be around 10 and 36, respectively. PHB 
content of the triblock copolymer was estimated from the intensity ratio of PHB 
methine protons and PEG methylene protons. The weight percentage of PHB in PHB-
PEG-PHB triblock copolymers were also estimated from thermal gravimetric analyses 
(TGA), as shown in Figure 3.2. The triblock copolymers exhibited a two-step 
degradation behavior in the thermal degradation profile, with the first step occurring 
between 220 °C and 330 °C followed by the second step from 340 °C to 450 °C. The 
first and second step of mass reduction can be attributed to the degradation of PHB 
and PEG, respectively. The weight percentage of PHB in PHB-PEG-PHB copolymers 
estimated from the thermal degradation profile corroborated well with those from 
1
H 
NMR estimation, as listed in Table 3.1. All of the characterizations have attested to 
the well-defined macromolecular architecture of the triblock copolymers. 





H NMR spectrum of PHB-PEG-PHB with corresponding peak assignments 
in CDCl3. PEG methylene proton signal at around  3.6 ppm as well as PHB methine, 




Figure 3.2. Thermal degradation profiles of PHB-PEG-PHB triblock copolymers. 
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Table 3.1. Molecular characteristics of PHB-PEG-PHB triblock copolymers and PEGs 

















H-E-H(36-174-36) 11.0 1.03 7.67 3.10  49.0 46.5 
H-E-H(10-74-10) 4.47 1.07 3.25 0.86  35.3 33.4 
PEG 27000 27.0 1.13 27.0 -  - - 
MPEG 5000 4.70 1.02 4.70 -  - - 
a
 Obtained from gel permeation chromatography (GPC) measurements.  
b
 Estimated from 
1
H NMR spectroscopy base on the intensity ratio of PHB methine proton ( 
5.2 ppm) and end group methylene protons ( 4.2 and 3.8 ppm).  
c
 Calculated from thermogravimetric analyses.  
d
 Calculated based on intensity ratio of PHB methine proton (δ 5.2 ppm) and PEG methylene 
proton (δ 3.6 ppm).  
 
3.3.2 Self-assembly properties of PHB-PEG-PHB triblock copolymers 
With two relatively short hydrophobic PHB chains sandwiching a hydrophilic 
PEG segment, the amphiphilic H-E-H(10-74-10) is easily dispersible in water. On 
contrary, H-E-H(36-174-36) is hard to be dispersed in water due to the long 
hydrophobic PHB chains. So we use DMSO to assist the dissolution of H-E-H(36-
174-36). Highly concentrated H-E-H(36-174-36) (200 mg/mL in DMSO) was diluted 
with a large quantity of water (H2O/DMSO 99:1 v/v) to afford micelle solutions. The 
self-assembly properties in aqueous solution was first investigated using fluorescence 
technique with pyrene probe.
22
 Excitation spectra of pyrene were used for its sensitive 
red shift in (0,0) absorption band from 333 nm to 336 nm, when it crosses from 
hydrophilic to hydrophobic environment. At the onset of micelle formation, pyrene 
preferentially enters into the hydrophobic core of micelles and results in a sudden 
change in intensity ratio at 336 nm to 333 nm (I336/I333). This provides a basis for 
determination of critical micelle concentration (CMC) and Figure 3.3(a) shows the 
intensity ratio plot as a function of the logarithm of copolymer concentrations. CMC 
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is determined graphically from the curve at the onset of large intensity ratio change, 
which occurred at 0.216 mg/mL and 0.0018 mg/mL, respectively. 
 
Figure 3.3. Self assembly of triblock copolymers in aqueous solution.  (a) Determination 
of critical micellization concentration using fluorescence probe technique.  (b) Plots of 
(F - Fmin)/(Fmax - F) vs concentration of H-E-H(36-174-36) (□) and H-E-H(10-74-10) (●). 
 
The hydrophobicity of the hydrophobic microdomain of the triblock 
copolymer micelles was estimated by calculating the partition equilibrium constant Kv 
of pyrene in the micellar solutions by the method of Wilhelm et al.
23
 It is assumed that 
pyrene binding to the micelles achieved a simple equilibrium between the micellar 
phase and the water phase. In this assumption, the ratio of pyrene in the two phases, 
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[Py]m/[Py]w (pyrene in the micellar phase to the water phase), was correlated to the 
ratio of the volume of each phase (Vm/Vw), as expressed in (Eq 3.4): 
                [Py]m/[Py]w = KvVm/Vw                                               (Eq 3.4) 
Eq 3.4 can be rewritten as 
            [Py]m/[Py]w = Kvx(c - cmc)/1000ρ                                    (Eq 3.5) 
where x is the weight fraction of hydrophobic PHB block, c is the concentration of the 
triblock copolymers, and ρ is the density of the PHB core of micelles, which is 




 In the intermediate 
range of polymer concentration with substantial increases of intensity ratios (I336/I333), 
[Py]m/[Py]w can be written as  
           [Py]m/[Py]w = (F - Fmin)/(Fmax - F)                                     (Eq 3.6) 
where Fmax and Fmin correspond to the average magnitude of the intensity ratio 
(I336/I333) in the flat region in the high and low concentration ranges in Figure 3.3(a), 
and F is the intensity ratio (I336/I333) in the intermediate concentration range of the 
PHB-PEG-PHB copolymers. Combining eqs 3.5 and 3.6, Kv values can be obtained 
by plotting a graph of (F - Fmin)/(Fmax - F) versus the concentration (c) of the PHB-
PEG-PHB polymer solutions as shown in Figure 3.3(b). The Kv values of pyrene for 
H-E-H(36-174-36) and H-E-H(10-74-10) micelles are evaluated to be 1.0105 and 
9.6103, respectively. It is worth noting that the Kv value of pyrene for H-E-H(36-
174-36) is around ten times higher than those of H-E-H(10-74-10) micelles, indicating 
a higher hydrophobicity of the H-E-H(36-174-36) microdomain, which is expected to 
load hydrophobic drugs with high encapsulation efficiency. 
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TEM and DLS were used to further verify the micelle formation. Samples 
were prepared from H-E-H(36-174-36) and H-E-H(10-74-10) copolymer solutions 
with a concentration of 1.0 mg/mL and 8.0 mg/mL, respectively, which are well 
above the triblock copolymers‟ CMCs. As shown in Figure 3.4 (a1-2) and Figure 3.4 
(b1-2), micelles of H-E-H(36-174-36) and H-E-H(10-74-10) adopted spherical 
morphology under TEM measurements with diameters of 30 nm (PDI 0.154) and 323 
nm (PDI 0.595) under DLS measurements, respectively. 
 
Figure 3.4. Self assembly of (a) H-E-H(36-174-36) and (b) H-E-H(10-74-10) in aqueous 
solution. Micelle size distribution and morphologies from DLS (a1, b1) and TEM (a2, 
b2). (a3) Schematic representation on the formation of flower-like micelles of H-E-H(36-
174-36). (b3) Schematic representation on the formation of flower-like and “bridged” 
micelles of H-E-H(10-74-10). 
 
In order for the PHB-PEG-PHB triblock copolymers to form micelles in water, 
both ends of the copolymer have to come together by looping the middle PEG block, 
forming flower-like micelles with hydrophobic core and hydrophilic corona, as 
illustrated in Figure 3.4(a3, b3). According to Balsara et al
26
 on the micellization of 
B-A-B triblock copolymers in selective solvent for A, although the looping of middle 
block carries an entropic penalty, micellization may still occur driven by favorable 
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association of the hydrophobic blocks. Thus, the micelle formation of PHB-PEG-PHB 
triblock copolymers strongly points to the highly associative behavior of the PHB 
segments in water. As also seen in Figure 3.4(b2), some of the spherical micelles 
appeared “bridged” to one another. The “bridging” of these micelles is another 
manifestation of the strongly associative behavior of the hydrophobic PHB segments, 
where the telechelic PHB segments of a single triblock copolymer are trapped in the 
cores of different micelles with middle PEG chain buried inside the hydrophilic 
coronas.
27
 Compared to H-E-H(10-74-10), H-E-H(36-174-36) have longer PEG 
chains and more hydrophobic microdomain, which leads to more compact 
hydrophobic core and stretched hydrophilic coronas that decrease the chance of 
forming “bridged” micelles.   
 
3.3.3 Preparation and formation of supramolecular hydrogels 
While amphiphilic block copolymers are widely known to form hydrogel after 
a critical concentration, H-E-H(10-74-10) solutions remained in sol state at 45 mg/mL, 
the most concentrated copolymer solution used appeared watery and slightly turbid, as 
shown in Figure 3.5(a).   
 
Figure 3.5. Photographs of (a) aqueous solution of H-E-H(10-74-10) at 45 mg/mL, (b) 
GEL-HEH-1and (c) GEL-HEH-2. 
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The ability of the relatively low molecular weight (Mn < 5000 Da) PHB-PEG-
PHB triblock copolymer to form strong hydrogel was first observed in the course of 
our investigation for block-selected polypseudorotaxane of similar PHB-PEG-PHBs 
at low -CD coverage.19 In current study, to find out the reason behind this interesting 
rheological property, we examine the hydrogel formation of H-E-H(10-74-10) with -
CD at two polymer to -CD feed ratios and also compare them with similar hydrogels 
prepared from high molecular weight PEG with Mn of 27.0 kDa as well as MPEG 
with similar molecular weight to H-E-H(10-74-10).  The hydrogel formulations are 
listed in Table 3.2 and each formulation is represented by the notation GEL-(polymer 
abbreviation)-x, where x distinguishes different formulations within a polymer series.   
 














 (min) Polymer -CD 
GEL-HEH-1 H-E-H(10-74-10) 0.146 0.579 2.3 8.9 7 
GEL-HEH-2 H-E-H(10-74-10) 0.293 0.432 4.5 6.7 225 
GEL-PEG-1 PEG 27000 0.146 0.579 2.3 8.9 60 
GEL-PEG-2 PEG 27000 0.293 0.432 4.5 6.7 250 
GEL-MPEG-1 MPEG 5000 0.146 0.579 2.3 8.9 1 
GEL-MPEG-2 MPEG 5000 0.293 0.432 4.5 6.7 6 
a 
Hydrogel formulations are notated as GEL-(polymer abbreviation)-x, where HEH represents 
H-E-H(10-74-10); PEG represents high molecular weight PEG with Mn 27.0 kDa; MPEG 
represents methoxy-PEG with Mn 4.70 kDa and x distinguishes the different formulations 
within a polymer series.  
b
 Estimated from vial-tiling technique.  
 
Hydrogel formation from α-CD and hydrophilic or amphiphilic polymers is a 
result of hierarchical molecular self-assembly that involves an initial threading of α-
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CD molecules onto the polymer chains to form stable polymeric inclusion complexes 
known as polypseudorotaxanes and subsequent aggregation of the resultant 
polypseudorotaxanes, similar to the process of precipitate formation.
28, 29
 The 
aggregation of polypseudorotaxanes through association of columnar α-CD in 
different polypseudorotaxanes serves as physical crosslinks for the hydrogel while 
remaining uncovered hydrophilic chains function as water absorbing segments. α-CD 
coverage on the polymer chains is thus a vital design parameter that affects 
crosslinking density and water retaining capability. In the present study, α-CD 
coverage is modulated by polymer to α-CD feed ratio. The two polymer to -CD feed 
ratios explored are 2.3 to 8.9 % and 4.5 to 6.7 %, each corresponding to 
approximately 32.3 and 11.8 % of -CD chain coverage, respectively for H-E-H(10-
74-10). The -CD chain coverage is calculated first by determining the hypothetical 
amount of -CD for complete chain coverage at certain polymer loading, in moles, 
and use this value to divide the number of moles of -CD used. The estimation on the 
amount of -CD required for complete chain coverage is based on the assumption that 
each -CD molecule can include two ethylene oxide monomers or one 
hydroxybutyrate monomer.
30, 31
 For high molecular weight PEG and MPEG controls, 
their chain coverage values are 36.1 % at high -CD loading and 13.2 % at low -CD 
loading. While changing the polymer to -CD feed ratios, we deliberately fix the total 
solid content at 11.2 % of the formulation. This is to eliminate the effect of solid 
content on subsequent gelation time and rheological measurements. It is also an 
attempt to push the formulation limit towards lower solid loading in this type of 
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When -CD solution was mixed with the aqueous solutions of H-E-H(10-74-
10) and sonicated for 10 minutes, the solutions appeared only slightly more turbid as 
before without appreciable viscosity build up. The mixtures were then stored at 4 
o
C 
and their viscosity gradually increased with simultaneous increase in turbidity.  
Finally, the opaque solutions became non-flowing, yielding the required hydrogels as 
shown in Figure 3.5 (b, c). Similarly, formulations constituting high molecular weight 
PEG only showed drastic changes in viscosity and turbidity after storage at 4
o
C. On 
the other hand, formulations with MPEG became very turbid upon mixing the 
polymer solutions with -CD solution, even before sonication. Their viscosity built 
up during the sonication step and gave non-flowing mass soon after the sonication.  
The gelation times for all the hydrogel formulations were estimated by simple vial-
tilting technique and listed in Table 3.2. The timing for each formulation was started 
immediately after the sonication step until no flow was observed for at least 30 
seconds when vial containing the hydrogel formulation was tilted. One should bear in 
mind that the gelation time obtained by this technique is the time required for a 
hydrogel formulation to form network structure that is strong enough to support its 
own weight under gravity.
21
 Thus, network structure may have been formed well 
before the observed gelation time. Nevertheless, the data may still be used to 
understand factors affecting the kinetics of hydrogel formation.    
The effect of polymer to -CD ratio on gelation time can be clearly seen from 
all three polymers used. At higher -CD ratio, GEL-HEH-1, GEL-PEG-1 and GEL-
MPEG-1 all gelled faster than their lower -CD ratio counterparts. As the gelation of 
these physical hydrogels relies on the threading of sufficient -CD molecules onto 
polymer chain to form polypseudorotaxanes that subsequently aggregate to give 
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crystalline physical crosslinks, a higher -CD ratio will definitely tilt the equilibrium 
towards polypseudorotaxane formation and hence leading to shorter gelation time.  
Besides polymer to -CD ratio, macromolecular architecture and molecular 
weight of polymer used also have significant effect on the gelation time of the 
hydrogel formulations. At high -CD ratio, GEL-MPEG-1 gelled almost immediately 
after 10 minutes of sonication, followed by GEL-HEH-1 and GEL-PEG-1. Both H-E-
H(10-74-10) and MPEG have very similar molecular weight of around 4.5 to 4.7 kDa 
but H-E-H(10-74-10) has atactic PHB segments on both ends of its polymer chain. 
According to our previous study, -CD molecules can only form stable 
polypseudorotaxane when they thread pass atactic PHB segments and settle on middle 
PEG block of PHB-PEG-PHB triblock copolymers due to a mismatch in atactic PHB 
chain cross-sectional area and -CD cavity size.19 Hence, in the case of GEL-HEH-1, 
-CD threading is retarded by the bulky telechelic atactic PHB segments and this 
further leads to a slower gelation process as compared to GEL-MPEG-1. MPEG, on 
the other hand, is highly accessible to -CD macrocycles. This leads to very fast 
hydrogel formation even at lower -CD ratio, i.e. GEL-MPEG-2. Although the chain 
ends of high molecular weight PEG are also freely accessible to -CD molecules, its 
much lower chain end concentration of 1.67 mM for GEL-PEG-1 as compared to 
those of GEL-HEH-1 and GEL-MPEG-1 at 10.1 and 9.56 mM, respectively, lead to a 
much longer gelation time of 60 minutes. For hydrogels with lower α-CD feed ratio, 
the impact of telechelic PHB segments on gelation time becomes more obvious.  
Gelation time was delayed to 225 minutes for GEL-HEH-2 from 7 minutes for GEL-
HEH-1 whereas for MPEG hydrogels the gelation times were only a few minutes 
apart.   
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The formation of crystalline physical crosslinks in all the hydrogels is 
substantiated by X-ray diffraction (XRD) characterizations of the hydrogels (Figure 
3.6) and their lyophilized samples (Figure 3.7). XRD traces of all the hydrogels 
shown in Figure 3.6 have been normalized against their amorphous background and 
even with around 90 % of water, the diffraction peak originating from (210) plane of 
crystalline columnar -CD in the hydrogels can still be identified at around 2  = 19.8 
, along with a weaker diffraction from (300) plane at around 2  = 22.6 .33-35 Except 
for hydrogels based on high molecular weight PEG, among the other four hydrogels 
studied, those formulated from high -CD ratio generally gave stronger diffraction 
peaks than their low -CD ratio counterparts. The results can be recognized as a 
consequence of high -CD concentration that favors columnar -CD formation and 
its subsequent crystallization. The little difference between GEL-PEG-1 and GEL-
PEG-2 is probably due to their very low polymer chain end concentration to the extent 
that the polymer chain end concentration becomes the limiting factor towards the 
formation of crystalline columnar -CD domains. Comparing the hydrogels based on 
their guest polymers, GEL-MPEGs consistently gave stronger columnar -CD 
diffraction patterns. This suggests that the crystallization of columnar -CD is highly 
favorable in MPEG hydrogels and this in turn can be attributed to the highly 
accessible MPEG chain ends towards -CD threading. GEL-HEH-1 has only 
comparable columnar -CD diffraction intensity as GEL-PEG-1 even though its 
polymer chain end concentration is much higher than that of the latter; while GEL-
HEH-2 has the weakest intensity among all the hydrogels. These observations allude 
to the interference of bulky PHB chain ends towards columnar -CD crystallization. 
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Figure 3.6. X-ray diffraction traces of (a) GEL-HEH-1, (b) GEL-HEH-2, (c) GEL-PEG-
1, (d) GEL-PEG-2, (e) GEL-MPEG-1 and (f) GEL-MPEG-2.  The characteristic X-ray 
diffraction peaks of crystalline columnar α-CD at around 2 = 19.8 and 22.6  are 
labeled with * and , respectively. 
 
On drying, the XRD traces of the lyophilized hydrogel samples gave clearer 
columnar -CD crystalline diffraction peaks at 2  = 19.8 and 22.6 , as shown in 
Figure 3.7. GEL-PEG-2 and GEL-MPEG-2 have additional diffraction peaks at 
around 2  = 19.3 and 23.5  that can be ascribed to crystalline PEG. The appearance 
of the additional PEG peaks in these two samples can be explained by the lower -CD 
chain coverage at around 13.2 %, that allows most of the uncovered PEG segments to 
form crystalline phase. The same phenomenon is not seen in GEL-HEH-2 as a result 
of preferential coverage of -CD on PEG segment over PHB chains and also possibly 
the due to the shorter PEG segment as compared to MPEG and high molecular weight 
PEG. The stronger PEG peaks in GEL-PEG-2 than that in GEL-MPEG-2 again 
reflects that although with same -CD loading ratio, -CD threading on high 
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molecular weight PEG is much lesser than in MPEG. On another note, hydrogels 
formulated from H-E-H(10-74-10) generally exhibit broadened columnar -CD 
diffraction peak as compared to others, reflecting smaller columnar -CD crystallite 
thickness possibly due to atactic PHB present.   
 
Figure 3.7. Powder X-ray diffractions of (a) pristine α-CD, (h) MPEG (Mn 4.70 kDa) and 
(i) H-E-H(10-74-10) as well as lyophilized samples of (b) GEL-HEH-1, (c) GEL-HEH-2, 
(d) GEL-PEG-1, (e) GEL-PEG-2, (f) GEL-MPEG-1 and (g) GEL-MPEG-2.  The 
characteristic X-ray diffraction peaks of crystalline columnar α-CD at around 2 = 19.8 




3.3.4 Rheological properties of supramolecular hydrogels 
Although gelation time and XRD measurements reveal that PHB-PEG-PHB 
hydrogels take longer time to form hydrogel and have lesser crystalline columnar -
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CD as compared to MPEG hydrogels, their rheological properties surprisingly surpass 
those of MPEG hydrogels. As shown in Figure 3.8(a), an oscillatory stress sweep 
measurement on GEL-HEH-1 shows that the hydrogel, within its linear viscoelastic 
range of up to almost 100 Pa in terms of shear stress, has elastic modulus (G’) 
dominates over its viscous modulus (G”) with a magnitude in the order of 105 Pa; 
while in Figure 3.8(c), we see that the G’ of GEL-MPEG-1 is one order magnitude 
lower as compared to GEL-HEH-1 and with a relatively narrow linear viscoelastic 
range of up to only a shear stress of around 1 Pa. In addition, a shear stress of around 
400 Pa is required to destroy the network structure of GEL-HEH-1 that is manifested 
by a G’/G” crossover into liquid-like phase.36 This is in contrast to GEL-MPEG-1 that 
yields at around shear stress of only 9 Pa. When the destroyed hydrogels were 
monitored of their G’, G” evolution immediately after deformation of at least 4000 %, 
GEL-HEH-1 shows an almost instantaneous structural recovery with G’ dominating 
over G” soon after removal of high shear stress (Figure 3.8(b)); but GEL-MPEG-1 
only shows a G”/G’ crossover approximately 30 minutes after removal of high shear 
stress (Figure 3.8(c)). The marked improvement in hydrogel rheology of GEL-HEH-1 
over GEL-MPEG-1 is also manifested in the frequency sweep measurements, as 
shown in Figure 3.9 (a). GEL-HEH-1 has its G’ dominating over G” over the whole 
frequency range. While GEL-MPEG-1 similarly has its G’ always greater than G” but 
they almost came together towards the low frequency end. 
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Figure 3.8. (a) Oscillatory stress sweep measurements of GEL-HEH-1 at 25 
o
C and 
constant  = 1 rad/s.  Inset is an expansion on the region where G’/G” crossover 
occurred and the applied shear stress at this point is defined as yield stress, y. (b) 
Oscillatory time sweep measurements of GEL-HEH-1 at 25 
o
C  and constant  = 0.3 Pa 
soon after the hydrogel was deformed to at least 4000 %.  (c) and (d) are oscillatory 
stress and time sweep measurements of GEL-MPEG-1, respectively, performed under 
identical condition as for GEL-HEH-1.  G’ and G” are represented by closed and open 
symbols, respectively. 
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Figure 3.9. (a) Oscillatory frequency sweep measurements of GEL-HEH-1( , ), GEL-
PEG-1( , ) and GEL-MPEG-1( , ).  (b) Oscillatory frequency sweep measurements 
of GEL-HEH-2( , ), GEL-PEG-2( , ) and GEL-MPEG-2( , ).  G’ and G” are 
represented by closed and open symbols, respectively. 
 
The complete list of rheological data obtained from oscillatory stress sweep 
measurements for all six hydrogels is presented in Table 3.3. From the list we can see 
that hydrogels formulated from H-E-H(10-74-10) are much stiffer (higher G’ values) 
and yield at higher shear stress values as compared to MPEG hydrogels. The triblock 
copolymer hydrogels also have lower phase angle () than their MPEG counterparts.  
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This means that they are more solid-like than the MPEG hydrogels.
37
 Comparing with 
high molecular weight PEG, on the other hand, the triblock copolymer hydrogels 
appear softer (lower G’ values) with similar or better yield stress value. When the 
hydrogels were subjected to oscillatory frequency sweep measurements, hydrogels 
formulated from H-E-H(10-74-10) and high molecular weight PEG all showed very 
little changes in their G’ values, which are always larger than G” over the entire 
experimental frequency range. This confirms their gel states. Hydrogels obtained from 
MPEG, however, demonstrated greater frequency dependency in their G’ values. As 
shown in Figure 3.9, the G‟ and G” curves of GEL-MPEG-1 almost come together at 
the low frequency end while GEL-MPEG-2 exhibited a G’/G” crossover at around 
0.25 rad/s. From here, we see that the MPEG hydrogels are less gel-like than the other 
hydrogels. 
 
Table 3.3. Rheological data of hydrogels obtained from oscillatory stress sweep 
measurements at 25 
o




  G’ b (kPa) G” c (kPa)  d () y
e
 (Pa) 
GEL-HEH-1 131.3  8.9 15.6  2.1 6.75  0.45 413.4  4.5 
GEL-HEH-2 41.9  0.1 10.1  0.1 13.74  0.26 100.7  40.0 
GEL-PEG-1 262.5  7.4 31.9  0.6 6.93  0.33 298.9  4.3 
GEL-PEG-2 69.9  11.1 10.5  0.8 8.65  0.75 100.9  14.8 
GEL-MPEG-1 10.1  0.1 3.2  0.1 17.21  3.12 9.41  0.04 
GEL-MPEG-2 8.1  0.2 2.1  0.1 14.33  0.12 7.43  0.68 
a 
Hydrogel formulations are notated as GEL-(polymer abbreviation)-x, where HEH represents 
H-E-H(10-74-10); PEG represents high molecular weight PEG with Mn 27.0 kDa; MPEG 
represents methoxy-PEG with Mn 4.70 kDa and x distinguishes the different formulations 
within a polymer series.  
b
 Elastic modulus in the linear viscoelastic region.  
c
 Viscous modulus in the linear viscoelastic region.  
d 
Phase angle in the linear viscoelastic region.  
e 
Yield stress, defined as the applied shear stress value at the G’/G” crossover.  
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The effect of -CD feed ratio on hydrogel stiffness and hydrogel strength can 
be seen in Table 3.3 as well as on Figure 3.9. For all of the three guest polymers used, 
high -CD feed ratio invariably leads to higher G’ and larger y values that can be 
interpreted as higher stiffness and greater hydrogel strength, respectively, as 
compared to the low -CD feed ratios ones. Moreover, high -CD feed ratio also 
causes the hydrogels to have lower  values, which implies more solid-like character 
in them. All these properties can be attributed to the higher crosslinking density in the 
high -CD loading hydrogels, as proven by XRD characterizations.  
Comparing the rheological properties MPEG/-CD and high molecular weight 
PEG/-CD hydrogels, one can infer that while crystalline columnar -CD contributes 
greatly towards network formation in these supramolecular hydrogels, a molecular 
weight of around 4.70 kDa for MPEG does not seem sufficient for formation of 
extensive and strong hydrogel network. On the other hand, with its long polymer 
chain, high molecular weight PEG chains could entangle with one another and form 
much stronger and stiffer hydrogels although with lesser crystalline columnar α-CD.  
For hydrogels formulated from H-E-H(10-74-10), their rheological properties are 
comparable to those obtained from high molecular weight PEG. Similar to PEG/-CD 
hydrogels, XRD characterizations also indicated that the triblock copolymer 
hydrogels have less crystalline columnar α-CD content as compared to MPEG/-CD 
hydrogels. We have demonstrated earlier that with the formation of flower-like and 
“bridged” micelles, H-E-H(10-74-10) has strong associative behavior in aqueous 
environment due to its hydrophobic telechelic PHB segments. The superior 
rheological properties of its -CD hydrogels can thus be attributed to the hydrophobic 
interaction of PHB segments that complements its low molecular weight to build an 
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extensive and strong hydrogel network. In this respect, the molecular recognition of 
α-CD hosts in favor of middle PEG block from the outer PHB segments has been 
instrumental for formation of crystalline columnar α-CD yet availing the PHB 
segments for hydrophobic interaction. The three different hydrogel network models 
based on the three different guest polymers can be visualized from Figure 3.10.  
Alongside with the different network models are SEM images of lyophilized 
hydrogels obtained from high α-CD feed ratio. By visual inspection, GEL-PEG-1 is 
the least porous, followed by GEL-HEH-1 and GEL-MPEG-1. The order is in line 
with the order of hydrogels‟ stiffness of GEL-PEG-1 > GEL-HEH-1 > GEL-MPEG-1, 
as reflected by their G’ values. The hydrogel morphologies show that H-E-H(10-74-
10), with its associative behavior, and high molecular weight PEG, with its long 
polymer chain, have been able to form more extensive network structure than MPEG 
and hence give better rheological performance. The better yield stress demonstrated 
by GEL-HEH-1 than GEL-PEG-1, however, cannot be explained totally by the 
compactness of their hydrogel network. When a physical hydrogel is sheared towards 
its yield point, a competition between structural destruction and reformation takes 
place at microscopic level.
38
 Hence, the higher yield stress of GEL-HEH-1is due to 
the requirement of more energy to destroy its hydrogel network as a result of the 
greater inclination of its guest polymer, i.e. H-E-H(10-74-10), to form associative 
network.  
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Figure 3.10. Schematic representations of different polymer/-CD hydrogel networks 
based on low molecular weight but hydrophobically associative H-E-H(10-74-10), high 
molecular weight PEG or MPEG along with corresponding lyophilized hydrogel 
morphologies obtained from scanning electron microscopy. 
 
Since we are interested in developing injectable hydrogels for drug delivery 
purposes, a good recovery of hydrogel network after structural destruction as a result 
of high shear stresses during injection is important to ensure successful application.  
In particular, the hydrogel network should recover as fast as possible to be able to 
withstand mechanical stresses caused by surrounding tissues and body fluids after 
injection. In this study, the rheometer is used to simulate the injection process by 
subjecting the hydrogels to high shear stresses until their hydrogel network collapse 
and then, by applying a lowest possible shear stress, have their structural recovery 
monitored from G’ and G” evolution, as shown in Figure 3.8(b) and Figure 3.8(d).  
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As all of the hydrogels come in various stiffness and yield stress, we subjected all of 
them to stresses corresponding to deformation of at least 4000 % to ensure fair 
comparison. Both MPEG/-CD hydrogels took 20 to 30 minutes before their G’ 
dominates over G”. For H-E-H(10-74-10)/-CD and high molecular weight PEG/-
CD hydrogels, all of them demonstrated solid-like behavior with G’ dominating over 
G” soon after removal of high shear stress. Figure 3.11 shows the hydrogels‟ moduli 
soon after network destruction and also after 60 minutes of aging. The percentages of 
moduli recovery after 60 minutes with respect to pre-shear values are also presented.  
Generally, the moduli of H-E-H(10-74-10) and PEG hydrogels dropped 2 order of 
magnitude after deformation of at least 4000 % while MPEG hydrogels decreased by 
4 order of magnitude. After 60 minutes of aging, both G’ and G” values increased for 
all hydrogels. This means that all of the hydrogels are thixotropic in nature, exhibiting 
time dependant viscoelastic behavior as a result of gradual structural recovery.
39
  
Among the six hydrogels, those with higher polymer feed ratio were found to have 
better G’ recovery than their high α-CD feed ratio counterparts. Of the three guest 
polymers used, those formulated from H-E-H(10-74-10) show better recovery than 
the rest. Notably, GEL-HEH-2 has the highest G’ recovery of up to 79 % of pre-shear 
value within 1 hour. The results highlight the dominant role of guest polymer on the 
hydrogel recovery.  
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Figure 3.11. Elasitc (G’) and viscous (G”) moduli of hydrogels immediately and 60 
minutes after at least 4000 % of deformation.  Percentage recovery of G’ and G” are 
calculated with reference to pre-shear values.  Hydrogels based on H-E-H(10-74-10), 
PEG and MPEG are represented by purple, orange and green bars, respectively.  
Among the hydrogels with same guest polymer, solid bar represents hydrogel with high 
-CD feed ratio.  E.g. Solid purple bar represents GEL-HEH-1. 
 
While providing us with insights on ways to modulate rheological properties 
of supramolecular hydrogels based on polymer/α-CD polypseudorotaxanes through 
proper selection of guest polymer and controlling their feed ratio with respect to α-CD, 
the dynamic rheological characterizations carried out have also helped us to answer 
several questions pertaining to the suitability of these hydrogels for injectable 
biomedical applications. Firstly, oscillatory frequency sweep measurements showed 
that hydrogels based on H-E-H(10-74-10) and high molecular weight PEG are 
essentially elastic in response to small stresses over a frequency range that covers 
everyday activities such as walking and running.
40
 Secondly, oscillatory stress sweep 
measurements revealed that, with stiffness in the range of tens to hundreds of kPa, 
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hydrogels formulated from H-E-H(10-74-10) as well as those from high molecular 
weight PEG are generally stiffer than normal block copolymer hydrogels
41-44
 and have 
closer match to G’ values of some natural tissues.41 Furthermore, they only yield at 
sufficiently high shear stress above 100 Pa and started to restore its network structure 
immediately after removal of high shear stress. Noted that further improvements on 
their structural recovery rate and yield stress can still be made, all these results 
nevertheless show that both H-E-H(10-74-10)/-CD and high molecular weight 
PEG/-CD hydrogels have the necessary mechanical properties as injectable 
hydrogels for biomedical applications. But H-E-H(10-74-10)/-CD hydrogels may be 
more preferred for injectable applications due to their better structural recovery and 
their guest polymer‟s biodegradability and easy elimination by renal filtration. 
 
3.3.5 Supramolecular hydrogels for hydrophilic drug (5-FU) delivery 
Based on their more superior rheological properties, GEL-HEH-1 along with 
GEL-PEG-1 were further examined for their sustained drug release properties. 5-
fluorouracil (5-FU), a water soluble anti-cancer drug,
45
 was used as a model drug and 
its sustained release from the two hydrogels are shown in Figure 3.12. As 5-FU is 
water soluble, it can be completely encapsulated into the hydrogel matrix by first 
dissolving it in the polymer/α-CD solution before hydrogel formation. The complete 
encapsulation of 5-FU is verified from the drug release profile of both GEL-HEH-1 
and GEL-PEG-1, where the final cumulative release of 5-FU are around 100 % of the 
amount of drug loaded during hydrogel formation. As the hydrogel formation only 
involves mixing, sonication and aging at 4 
oC, the polymer/α-CD supramolecular 
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hydrogel system presents an efficient and simple way for complete encapsulation of 
drug into drug release depot. This is a highly desirable feature that reduces wastage of 
expensive therapeutic agents and at the same time provides good control over drug 
loading capacity. 
 
Figure 3.12. Cumulative release profile of 5-fluorouracil from GEL-HEH-1 ( ) and 
GEL-PEG-1 ( ).  Inset shows the cumulative release profiles for the first day. 
 
At solid content of around 11.2 % of total formulation, both GEL-HEH-1 and 
GEL-PEG-1 are able to provide sustained release of 5-FU over a period of 6 and 9 
days, respectively. Although the sustained release data of only a few days come short 
as compared to our previous study with PEG-PHB-PEG/α-CD hydrogels that went 
over 30 days,
13
 one should bear in mind of the relatively low solid content of 
hydrogels in this study. The release of 5-FU from GEL-HEH-1 is faster than that from 
GEL-PEG-1. For instance, after incubated for 1 day, 45 % of encapsulated 5-FU was 
released from GEL-HEH-1 as compared to 35 % for GEL-PEG-1. As both of the 
hydrogels eroded gradually from the media-hydrogel interface throughout the course 
of drug release and finally disappeared upon 100 % of drug release, the main 
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mechanism for drug release is thus believed to be via surface erosion of hydrogel 
along with molecular diffusion of drug. The faster drug release demonstrated by GEL-
HEH-1 could thus be due to its looser hydrogel network, as evidenced by SEM image 
in Figure 3.10, that encourages both surface erosion of hydrogel matrix as well as 
diffusion of encapsulated 5-FU.   
Based on these observations, one could potentially modulate the drug release 
behavior from these polymer/α-CD supramolecular hydrogels by tuning the 
compactness of their hydrogel network. The endeavor could be accomplished by 
either changing the choice of guest polymer or by adjusting polymer/α-CD feed ratios 
to control crosslinking density or by varying the overall solid content. For hydrogels 
formulated from PHB-PEG-PHB triblock copolymer, increasing the PHB chain length 
to an optimum value may slow down hydrogel erosion due to higher hydrophobicity 
and sustain drug release for longer period. 
 
3.3.6 Polymeric micelles for hydrophobic drug (PTX) delivery  
To evaluate the loading capacity of H-E-H(36-174-36) polymeric micelles, 
copolymers (200 mg/mL) in DMSO 5 μL was mixed with PTX 5 μL with various 
concentrations (20, 40, 60, 80 mg/mL) in DMSO, which was then injected into 990 
μL DI water. The final concentration of H-E-H(36-174-36) was fixed to be 1 mg/mL 
and the feeding weight ratios of H-E-H(36-174-36) to PTX were 10, 5, 3.3 and 2.5, 
respectively. Free PTX with equivalent concentrations prepared by the same method 
were used as controls. The sample solutions were stored overnight at room 
temperature. It was found that all the free PTX samples precipitated after overnight 
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storage, while H-E-H(36-174-36)/PTX samples at ratio 10 and 5 kept clear. The H-E-
H(36-174-36)/PTX samples at ratio 3.3 or higher appeared turbid. After that, the H-E-
H(36-174-36)/PTX (ratio 5) solution was dialyzed against distilled water to remove 
DMSO. The aqueous solution in the dialysis bag was filtrated through 0.45 μm 
membrane to remove the free drug and obtain PTX-loaded micelles.  
The PTX-loaded micelles were freeze-dried and re-dissolved in MeOH for UV 
measurement, the loading capacity of H-E-H(36-174-36) was estimated to be 0.139 
mg PTX per 1 mg polymer and the loading efficiency of PTX was around 69.7 %. 
The high efficiency of drug encapsulation can reduce wastage of expensive 
therapeutic agents. The cumulative release profile of PTX from H-E-H(36-174-36) 
triblock copolymer micelles was shown in Figure 3.13. From the profile, low initial 
burst release was found in this system, indicating that the overwhelming majority of 
the encapsulated drug was located in the hydrophobic core. Burst release effect is not 
favorable for controlled drug delivery, but this effect was frequently observed in the 
previous reported PTX-loaded drug delivery systems.
46-48
 The triblock copolymer 
micelles provided smooth and sustained release of PTX over half a month.  
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Figure 3.13. Cumulative release profile of paclitaxel from H-E-H(36-174-36) triblock 
copolymer micelles. 
 
To estimate the antitumor activity of the PTX-loaded H-E-H(36-174-36) 
triblock copolymer micelles, MTT assay with Hela cells was performed. The H-E-
H(36-174-36)/PTX (ratio 5) micellar solution before dialysis was chosen to carry out 
the cytotoxicity test. Blank micelles, DMSO and free PTX with equivalent 
concentrations were tested as controls. It should be noted that the free PTX sample 
precipitated while PTX-loaded micellar solution kept clear after overnight storage, as 
described in the beginning of this section. The free PTX control sample was re-
dispersed by sonication before feeding to the cells. The blank H-E-H(36-174-36) 
triblock copolymer micelles and DMSO showed no cytotoxicity within the test 
concentration, as shown in Figure 3.14. The light microscopic images of cells also 
indicated that the cells were healthy. 
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Figure 3.14. Cytotoxicity of PHB-PEG-PHB blank micelles (a1) and DMSO (b1) on Hela 
cells. The light microscopic images of cells showed the cell state after treated with H-E-
H(36-174-36) at concentration 320 mg/L (a2) and 0.2 v/v % DMSO (b2). 
 
Figure 3.15 showed the cytotoxicity of PTX-loaded H-E-H(36-174-36) 
triblock copolymer micelles on Hela cells, which exhibited enhanced antitumor 
activity compared to free PTX with equivalent concentrations. The inset light 
microscopic images of cells showed that the state of Hela cells after treated with PTX-
loaded micelles was obviously worse than that with free PTX, especially at lower 
concentrations. The reason that micelles enhanced the cytotoxicity can be attributed to 
the increase of cellular uptake. As an extremely hydrophobic drug, PTX is poorly 
absorbed because they can not gain access to the cell membrane due to the insolubility 
in aqueous fluids. 
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Figure 3.15. Cytotoxicity of PTX-loaded H-E-H(36-174-36) triblock copolymer micelles 
(a) and free PTX with equivalent concentrations (b) on Hela cells. The inset light 
microscopic images of cells showed the cell state after treated with PTX-loaded micelles 
and free PTX at corresponding concentrations. 
 
To exclude the influence of undissolved PTX, both PTX-loaded H-E-H(36-
174-36) micelles and free PTX were filtered through 0.45 μm membrane to remove 
undissolved PTX. From Figure 3.16, we can see that the cytotoxicity of filtered PTX-
loaded micelles did not change a lot compared with the un-filtered PTX-loaded 
micelles, indicating that the overwhelming majority of PTX was encapsulated into the 
micelles. In contrast, the cytotoxicity of filtered free PTX was low since most of PTX 
was removed by filtration. 
 
Figure 3.16. Cytotoxicity of filtered PTX-loaded H-E-H(36-174-36) triblock copolymer 
micelles (a) and filtered free PTX (b) on Hela cells. The concentrations are initial feeding 
PTX concentrations before filtration. The inset light microscopic images of cells showed 
the cell state after treated with filtered PTX-loaded micelles and filtered free PTX at 
corresponding concentrations. 
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3.4 Conclusions 
Hydrogels based on inclusion complexation of PHB-PEG-PHB triblock 
copolymer and -CD were prepared. The PHB-PEG-PHB triblock copolymer was 
carefully synthesized and characterized to ensure well-defined macromolecular 
architecture that favor formation of block-selected polypseudorotaxanes with α-CD 
molecules preferentially cover middle PEG block. Although the PHB-PEG-PHB used 
has Mn of less than 5000 Da and XRD measurements indicated that the hydrogels 
based on PHB-PEG-PHB have less crystalline columnar α-CD that leads to physical 
crosslinking, the hydrogels still demonstrate better elastic response over the 
investigated frequency range than hydrogels obtained from MPEG of similar 
molecular weight. The good rheological properties are believed to be due to the 
strongly hydrophobically associative behavior of PHB-PEG-PHB, as evidenced by 
TEM, CMC and DLS measurement that confirm the micellization behavior of PHB-
PEG-PHB. 
The hydrophobic interaction leads to the formation of extensive and strong 
hydrogel network, similar to hydrogels formulated with high molecular weight PEG. 
 hile higher α-CD feed ratio in the hydrogels leads to greater stiffness and yield 
strength, the associative properties of PHB-PEG-PHB is responsible to faster 
structural recovery of the hydrogels after shear-induced structural destruction. The 
PHB-PEG-PHB/α-CD hydrogel exhibited sustained release of 5-FU over a 6 day 
period. The more hydrophobic PHB-PEG-PHB formed nano-sized micelles (~30 nm) 
which exhibited high PTX encapsulation and sustained release of PTX over half a 
month. 
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CHAPTER 4 AMPHIPHILIC POLY[(R,S)-3-
HYDROXYBUTYRATE]-BASED STAR-BLOCK 
COPOLYMERS AND SUPRAMOLECULAR 
TRANSFORMATION OF NANOGEL-LIKE MICELLES 
TO VESICLES 
4.1 Introduction  
Nanostructures self-assembled from amphiphilic block copolymers have 
attracted interests from areas ranging from nanofabrication, catalysis to biomedicine 
due to their unique properties and immense application potentials.
1-9
 To date, a variety 
of nanostructures ranging from micelles to vesicles of various shapes and intricacies 
have been reported.
10-14
 These advancements were built upon a solid understanding on 
the interactions amongst various segments in block copolymer and surrounding 
environment as well as the influence of these interactions on nanostructure 
morphology.
15, 16
 In addition, the ability to create block copolymers with ever 
increasing complexity and functionality, as empowered by an extensive array of 
controlled/living polymerization techniques and efficient coupling strategies, has also 
contributed to the developments.
17-19
 However, the relationship between polymer 
architecture and resultant self-assembled nanostructure is often not straightforward, 
 Chapter 4 
103 
more so with complex polymer architecture.
20, 21
 Moreover, being a supramolecular 
event, the course of block copolymer self-assembly could be altered in the presence of 
other supramolecular interactions.
22
 Further understanding on these issues may open 
new opportunities into customized amphiphilic block copolymer nanostructures with 
well controlled morphologies. 
With a keen interest in biomedical application, our attention was drawn to 
amphiphilic block copolymers containing PHB due to its inherent biodegradability 
and biocompatibility.
23-26
 Much of recent efforts have been devoted to the synthesis of 
linear PHB block copolymers via chemical modification of bacterial PHB or 
chemosynthesis from -butyrolactone monomer for tissue engineering and other 
biomedical applications.
27-32
 It was reported that nanoparticles self-assembled from 
amphiphilic PHB block copolymers exhibited very low critical micelle concentration 
(CMC) due to the highly hydrophobic nature of PHB and hence have great potentials 
in drug delivery application because of the bestowed micelle stability.
33-35
 To our 
knowledge, report on star-block copolymer of PHB is rare,
36-39
 not to mention any 
examples on self-assembly behavior. The compact architecture of a star polymer with 
multiple polymer chains (arms) connected to a central core generally leads to smaller 
hydrodynamic size and more end-group funtionality than its linear counterpart.
37
 In 
addition, due to the star architecture, the movement of each polymer chain during a 
self-assembly process is expected to be restricted and affected by other parts of the 
star polymer. This may potentially lead to self-assembled structure and properties not 
accessible by a linear counterpart.  
In chapter 3, we proposed that triblock PHB-PEG-PHB copolymers form 
“flower-like” or “bridged” micelles. We are curious how the restricted polymer chain 
movement resulted from star architecture would affect the self-assembly behavior. 
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Herein, we present a facile synthesis of a series of PHB-based amphiphilic star-block 
copolymers through a “coupling onto” method, as shown in Scheme 4.1. Interestingly, 
the copolymers self-assembled into nanogels-like large compound micelles (LCMs) in 
aqueous medium. With the adamantyl ends of the star-block copolymers, the self-
assembly behaviors were modulated by heptakis(2,6-di-O-methyl)-β-cyclodextrin 
(DM-β-CD). Both the star architecture and the DM-β-CD binding have led to unique 
self-assembled vesicular structures, otherwise not seen in systems void of any of the 
two structural elements. 
 
4.2 Experimental Section  
4.2.1 Materials  
(a) Chemicals 
Hydroxyl-terminated eight-arm star poly (ethylene glycol) (sPEG) with Mn of 
ca. 9.50 and 19.9 kDa were obtained from NOF Corp. (Tokyo, Japan), and dried 
under high vacuum at 60 °C for 24 h before use. Poly(ethylene glycol) methyl ether 
(MPEG) with Mn of ca. 2000 Da was obtained from Aldrich, and dried under high 
vacuum at 60 °C for 24 h before use. (R,S)-β-butyrolactone (> 95 %, Tokyo Kasei Inc) 
was dried over and vacuum distilled from CaH2 twice before use. Thionyl chloride 
(SOCl2, ≥ 99 %, Sigma-Aldrich), sodium azide (NaN3, ≥ 99.5 %, Sigma-Aldrich), 1-
adamantaneacetic acid (98 %, Aldrich), propargyl bromide solution (80 wt.% in 
toluene, Aldrich), copper sulfate pentahydrate (CuSO4·5H2O, 98 %, Sigma-Aldrich), 
sodium ascorbate (≥ 99 %, Aldrich), heptakis(2,6-di-O-methyl)-β-cyclodextrin (DM-
β-CD, ≥ 98.0 %, Aldrich), dimethylsulfoxide (DMSO, anhydrous, ≥ 99.9 %, Aldrich), 
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toluene (99 %, Tedia), chloroform (99.8 %, Tedia), tetrahydrofuran (THF, > 99 %, 
Tedia), diethyl ether (Et2O, 99 %, Tedia) and n-hexane (95 %, Tedia) were used as 
received. 
(b) Cells 
Human cervical cancer cell line HeLa was purchased from ATCC (Rockville, 
MD) and maintained in Dulbecco‟s Modified Eagle‟s Medium (DMEM) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 100 units/mg 
penicillin, 100 g/mL streptomycin at 37 C and 5 % CO2.  
 
4.2.2 Synthesis Methods  
Synthesis of -Adamantyl--alkynyl-poly(3-hydroxybutyrate) (PHB). The 
heterofunctionalised PHB was synthesized via anionic ring-opening polymerization of 
(R,S)--butyrolactone in DMSO at room temperature under dry N2 atmosphere, 
similar to the method reported previously.
40
 The initiator sodium adamantaneacetate 
(Ada-CH2CO2Na) was obtained from the neutralization of commercially available 
adamantaneacetic acid with sodium hydroxide in methanol. In a typical example, the 
ring opening polymerization was initiated by reacting 0.314 g of dried Ada-
CH2CO2Na (1.45 mmol) with 1.98 mL of -butyrolactone monomer (25 mmol) in 80 
mL of anhydrous DMSO at room temperature. With the aid of 
1
H NMR monitoring, 
the polymerization was quenched by adding an excess of propargyl bromide upon 
reaching a monomer conversion of >90 %. Solvent DMSO was then removed by 
rotary evaporation and the crude polymer sample was re-dissolved in chloroform, 
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filtered and precipitated into n-hexane to afford the purified polymer. Yield: 2.05 g 
(88.3 %, based on theoretical yield computed using actual monomer conversion). 
GPC (THF): Mn = 1.60 kDa, PDI = 1.10. 
1
H NMR (400 MHz, CDCl3):  1.26 – 1.31 
(m, -OCH(CH3)CH2CO2- of PHB), 1.59 – 1.71 (m, methylene protons of adamantyl 
end group), 1.95 (br, methine protons of adamantyl end group), 2.02 (s, -OCCH2-Ada) 
2.43 – 2.62 (m, -OCH(CH3)CH2CO2- of PHB and –OCH2CCH of alkynyl end 
group), 4.68 (s, -OCH2CCH), 5.23 – 5.32 ppm (m, -OCH(CH3)CH2CO2- of PHB). 
13
C NMR (100 MHz, CDCl3): 169.58 – 172.18 (-CO- of PHB and -COCH2-Ada), 
75.53 (alkynyl group), 67.94 (-CH- of PHB), 52.42 (-CH2-alkynyl), 49.31 (-CH2-
adamantyl), 41.12 (-CH2- of PHB), 42.67, 37.04, 33.10, 28.90 (adamantyl group), 
20.07 ppm (-CH3 of PHB). 
Synthesis of azide-functionalized 8-arm sPEG (sPEG-N3). sPEG-N3 was 
prepared from commercially available hydroxyl-terminated 8-arm PEG via 
substitution reaction. The 8-arm PEG contains a hexaglycerol core. Typically, 4.75 g 
of sPEG (Mn 9.50 kDa, 0.5 mmol) and 0.73 mL of SOCl2 (10 mmol) were dissolved 
in 15 mL of toluene and refluxed overnight under N2. Toluene was then removed by 
distillation. After cooling to room temperature, 1.30 g of NaN3 (20 mmol) dispersed 
in 15 mL of DMSO was added to the reaction vessel. The reaction was allowed to stir 
at 90 °C under N2 overnight. The reaction mixture was then partitioned between 
deionised water and chloroform. The aqueous layer was further extracted with 
chloroform for at least three times and the combined organic fraction was dried over 
anhydrous magnesium sulphate. After evaporation of solvent, the remaining product 
was dried under vacuum overnight. Yield: 3.60 g (74.5 %, assuming complete azide 
substitution). 
1
H NMR (400 MHz, CDCl3):  3.30 – 3.41 (m, -CH2-N3), 3.41 – 3.88 
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ppm (m, sPEG backbone). 
13
C NMR (100 MHz, CDCl3): 74.32 – 68.79 (sPEG 
backbone), 51.08 ppm (-CH2-N3). 
Synthesis of sPEG-PHB via alkyne-azide coupling. Four sPEG-PHB star-
block copolymers were synthesized via alkyne-azide coupling in DMSO/H2O system. 
In a typical example, a bottle with an N2 inlet was charged with 0.96 g of PHB (Mn 
1.60 kDa, 0.6 mmol), 0.47 g of sPEG-N3 (Mn 9.50 kDa, 0.05 mmol) and 4 mL DMSO. 
A freshly prepared 23 wt% aqueous solution of CuSO4·5H2O (0.18 mmol) and 33 
wt% aqueous solution of sodium ascorbate (0.38 mmol) were then added sequentially. 
The reaction was allowed to stir at room temperature under N2 atmosphere for 48 h. 
The reaction mixture was diluted with THF and passed through alumina column to 
remove copper residue. Then, the polymer solution was precipitated into Et2O. The 
product was collected by filtration and purified twice by dissolution / precipitation 
with THF / Et2O, and dried under vacuum overnight. Yield: 0.82 g (73.6 %, assuming 
all 8 arms of sPEG are conjugated with PHB). 
1
H NMR (400 MHz, CDCl3):  1.14 – 
1.36 (m, -OCH(CH3)CH2CO2- of PHB), 1.52 – 1.78 (m, methylene protons of 
adamantyl end group), 1.96 (br, methine protons of adamantyl end group), 2.02 (s, -
OCCH2-Ada), 2.33 – 2.79 (m, -OCH(CH3)CH2CO2- of PHB), 3.41 – 3.95 (m, sPEG 
backbone), 4.50 – 4.62 (m, -CH2-triazole N), 5.12 – 5.36 (m, -OCH(CH3)CH2CO2- of 
PHB and -CH2-triazole C), 7.79 ppm (s, -C=CH-N- of triazole). 
13
C NMR (100 MHz, 
CDCl3): 168.83 – 171.72 (-CO- of PHB and -COCH2-Ada), 142.65 (-CH=C- of 
triazole), 125.37 (-CH=C- of triazole), 73.26 – 68.98 (sPEG backbone), 67.99 (-CH- 
of PHB), 58.19 (-CH2-triazole C), 50.67 (-CH2-triazole N), 49.37 (-CH2-adamantyl), 
41.18 (-CH2- of PHB), 42.73, 37.10, 33.16, 28.96 (adamantyl group), 20.16 ppm (-
CH3 of PHB). 
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Synthesis of MPEG-PHB via alkyne-azide coupling. Two MPEG-PHB 
linear copolymers were synthesized using the same route as that for sPEG-PHB star-
block copolymers. First, MPEG-N3 (2.18 kDa) was prepared from commercially 
available hydroxyl-terminated MPEG via substitution reaction. Then PHBs (Mn 1.60 
kDa and 3.07 kDa) were reacted with MPEG-N3 via alkyne-azide coupling in 
DMSO/H2O system. Yield: 75.2 % and 79.5 %, respectively. 
1
H NMR (400 MHz, 
CDCl3):  1.16 – 1.37 (m, -OCH(CH3)CH2CO2- of PHB), 1.47 – 1.81 (m, methylene 
protons of adamantyl end group), 1.96 (br, methine protons of adamantyl end group), 
2.02 (s, -OCCH2-Ada), 2.32 – 2.72 (m, -OCH(CH3)CH2CO2- of PHB), 3.38 (s, methyl 
ether end group), 3.41 – 3.96 (m, MPEG backbone), 4.47 – 4.62 (m, -CH2-triazole N), 
5.12 – 5.35 (m, -OCH(CH3)CH2CO2- of PHB and -CH2-triazole C), 7.79 ppm (s, -
C=CH-N- of triazole). 
Preparation of polymeric micelles and inclusion complexes. Dialysis 
method was used to prepare sPEG-PHB polymeric micelles and their inclusion 
complexes with DM-β-CD. For micelles preparation, the sPEG-PHB polymers were 
dissolved in DMSO at concentration of 0.05 mg/mL, and then dialyzed against 
distilled water for 48 h using a dialysis membrane (MWCO 1000). The concentration 
of the micelles obtained from dialysis was determined to be around 0.02 mg/mL. For 
inclusion complexes preparation, DM-β-CD and sPEG-PHB polymers were mixed 
and dissolved in DMSO, then dialyzed against distilled water for 48 h using a dialysis 
membrane (MWCO 1000). The initial concentration (before dialysis) of sPEG-PHB is 
0.05 mg/mL
 
and the weight ratio of DM-β-CD to sPEG-PHB is fixed at 20. 
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4.2.3 Characterization Methods 
Molecular characterizations. Gel permeation chromatography (GPC) 
measurements were done at 40 
o
C on a Shimadzu SIL-10A and LC-20AD system 
equipped with two Phenogel 5 100 and 104 Å columns (size: 300 × 4.6 mm) 
connected in series and a Shimadzu RID-10A refractive index detector. THF was used 
as the mobile phase at a flow rate of 0.3 mL/min. Monodispersed PEG standards were 
used to calibrate the system. The absolute weight-averaged molecular weight (Mw) of 
sPEG-PHB copolymers was determined by Gel permeation chromatography/Light 
Scattering (GPC/LS) analysis. GPC was performed using two 10-m PLgel MIXED-
B columns (size: 300 × 7.5 mm) in series with a THF flow rate of 1 mL/min. Light 
scattering and refractive index measurements were acquired using an Alliance Waters 
2690 separation module equipped with a Waters 410 differential refractometer and a 
Wyatt MiniDAWN light scattering detector. The LS detection measures the light-
scattering intensity at 90° and the RI detection measures the concentration of the 





spectra were obtained at room temperature on a Bruker Avance DRX 400 MHz NMR 
spectrometer operating at 400 and 100 MHz, respectively. Chemical shifts are 
reported in ppm with reference to solvent peak (CHCl3: δ 7.26 ppm for 
1
H NMR and 
 77.2 ppm for 13C NMR). Fourier transform infrared (FTIR) spectra of polymers in 




Thermal analysis. Thermogravimetric analyses (TGA) were done on a TA 
Instruments Q500, by heating polymer samples at a rate of 20 °C min
-1
 from room 
temperature to 800 °C in a dynamic nitrogen atmosphere (flow rate = 60 mL/min). 
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 Differential scanning calorimetry (DSC) measurements were performed on a 
TA Instruments Q100 differential scanning calorimeter equipped with an auto-cool 
accessory and calibrated using indium. The following protocol was used for each 
sample: heating from room temperature to 150 °C at a heating rate of 5 °C min
-1
, 
holding at 150 °C for 3 min, cooling from 150 to -80
 





°C for 3 min and finally reheating from -80
 
to 150 °C at a heating 
rate of 5 °C min
-1
. Data collected from both first cooling and second heating runs 
were analyzed and peak maxima were taken as transition temperatures.  
Laser light scattering. Dynamic light scattering (DLS) measurements on 
polymer and inclusion complex particles were carried out on a Malvern Instrument 
Zetasizer Nano ZS, with a laser light wavelength of 633 nm at a 173 scattering angle 
at 25 C. Z-average hydrodynamic radii (Rh) of the particles were reported. Static 
light scattering (SLS) was used to study the aggregation behavior of the polymers in 
aqueous solution. Information on weight-averaged molecular weight (Mw,agg), z-
average radius of gyration (Rg) and second virial coefficient (A2) of micelles were 












where K is the optical constant, which depends on the refractive index increment 
(dn/dc) of the polymer solution (K = 4π2n2(dn/dc)2/NAλ
4
, where NA is Avogadro‟s 
number, n is the refractive index of the liquid medium, and λ is the wavelength of the 
laser). ∆Rθ is the excess Rayleigh ratio, and q is the scattering vector determined by 
the scattering angle θ (q = 4πn/λsin(θ/2), where n is the refractive index of the liquid 
medium, and λ is the wavelength of the laser). Mw,agg was estimated from the 
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extrapolation of Kc/ΔRθ to zero angle (θ) and zero concentration (c) while Rg and A2 
were estimated from the slope of the angular and concentration dependence of the 
Zimm plots, respectively. All SLS measurements were carried out at 25 C within the 
angular range of 50° to 120° with 5° increments. The refractive index increment 
(dn/dc) of sPEG-PHB polymers in aqueous solution was measured using a BI-DNDC 
differential refractometer at a wavelength of 620 nm. The instrument was calibrated 
with potassium chloride (KCl) in aqueous solution. The dn/dc values of the block 
copolymers are listed below. 








Microscopy. Transmission electron microscopy (TEM) images were taken on 
a JEOL JEM-3010 FasTEM field emission transmission electron microscope, 
operated at 300 kV. TEM sample was prepared by directly depositing a drop of 
sample solution containing 0.05 wt% of phosphotungstic acid (PTA) onto a 200 mesh 
carbon coated copper grid. The sample was kept in a dry box for 48 h at room 
temperature before TEM imaging. Analyses on TEM images were done using ImageJ 
software. Scanning electron microscopy (SEM) images were obtained at acceleration 
voltage of 5 kV on a JEOL JSM-6700F microscope. The samples were prepared by 
casting a drop of sample solution on glass substrate and dried at room temperature for 
48 h in a dry box. The samples were sputter-coated with a thin layer of gold for 15 s 
to make the samples conductive before testing. 
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4.2.4 Drug loading and in vitro cytotoxicity assays  
Paclitaxel (PTX) loading. Dialysis method was used to prepare PTX-loaded 
sPEG-PHB(10-3.1) micelles. sPEG-PHB(10-3.1) (0.1 mg/mL) in DMSO 1 mL was 
mixed with PTX 1 mL with various concentrations (0.02, 0.06, 0.1, 0.15, 0.2 mg/mL) 
in DMSO, which was then transferred to a dialysis tube (MWCO 1000) and dialyzed 
against water for 24h. The water was refreshed at appropriate time intervals to remove 
the DMSO. The aqueous solution in the dialysis tube was filtrated through 0.45 μm 
membrane to remove the free drug and obtain PTX-loaded micelles. The drug loading 
efficiency was determined by measuring UV absorbance at 227 nm of the lyophilized 
PTX-loaded micelles in methanol (MeOH). 
In vitro cytotoxicity test. For each well in a 96-well plate, 100 L of Hela 
cells in DMEM, with a concentration of 1105 cells/mL, was added. The number of 
Hela cells in each well was 10000. After incubation for 24 h in incubator (37 °C, 5 % 
CO2), the culture medium was changed to 100 L of DMEM containing PTX-loaded 
micelles, blank micelles or free PTX with various concentrations and the mixture was 
further incubated for 24 h. Then, DMEM with materials was replaced by fresh 
DMEM and 10 L of MTT solution (5 mg/mL) was added to the cells. After 
incubation for 4 h, 150 L of DMSO was added and shaken at room temperature. The 
optical density (OD) was measured at 570 nm with a microplate reader (Spectra Plus, 
TECAN). The viable rate was calculated by the following equation:  
  Viable rate = (ODtreated / ODcontrol)  100 %                        (Eq 4.1) 
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Where, ODcontrol was obtained in the absence of polymers and ODtreated was obtained 
in the presence of polymers. 
4.3 Results and Discussion 
4.3.1 Facile synthesis and characterizations of sPEG-PHBs 
Heterofunctionalized PHB, with telechelic adamantyl moiety and alkynyl 
functionality, was first synthesized in a one pot fashion by anionic ring opening 
polymerization (ROP) of racemic -butyrolactone. The ROP procedure proceeded 
with excellent control over the molecular weight, molecular weight distribution and 
end-group fidelity (Figure 4.1). This has allowed facile incorporation of 
heterofunctionality, through a judicious selection of anionic initiator and nucleophilic 
capping agent, onto a PHB precursor with desired molecular weight. 
Adamantaneacetate and propargyl bromide were chosen as the initiator and capping 
agent, respectively, to produce PHB that is able to participate in CD-binding as well 
as alkyne-azide conjugation.  





H NMR spectrum of heterofunctionalized PHB with corresponding peak 
assignments in CDCl3. Alkynyl and adamantyl end groups can be clearly seen in the 
spectrum.  
Two PHB polymers with different molecular weight have been synthesized 
through adjusting the -butyrolactone monomer to adamantaneacetate initiator ratio. 
The degree of polymerization (DP) and Mn of PHB polymers were evaluated from 
1
H 
NMR spectra (Figure 4.1) based on the intensity ratio of PHB methine proton at 
around δ 5.2 ppm to alkynyl end group protons at around δ 4.7 ppm. DPs for the two 
polymers were estimated to be 17 and 35, and each corresponds to Mn of 1.69 kDa 
and 3.24 kDa, respectively. The Mn values are in good agreement with GPC 
measurements (1.60 and 3.07 kDa). In addition, both alkynyl and adamantyl end 
groups of the PHB polymers are clearly identified from 
1
H NMR spectra. Together 
with the relatively narrow PDI as determined from GPC, all of the above 
characterization data attest to the well-defined nature of the two PHB polymers. The 
PHB polymer precursors were then coupled to star poly(ethylene glycol) (sPEG) 
cores with Mn of 9.50 and 19.9 kDa, respectively, through alkyne-azide coupling 
(Scheme 4.1). The resultant four sPEG-PHB star block copolymers are represented by 
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the notation sPEG-PHB(x-y), where x and y denote the approximate Mn of constituting 
sPEG and PHB, in kDa, respectively (Table 4.1). 
 
Scheme 4.1. Synthetic route of star PEG-PHB block copolymer (sPEG-PHB) with 
peripheral adamantly moiety. 
 

























10-3.1 27.6 29.6 1.41 63.8 62.6  6 6 
20-3.1 36.8 43.6 1.39 45.7 46.0  6 6 
10-1.6 20.6 23.3 1.30 51.4 51.3  7 7 




H NMR spectroscopy. 
b 
Determined by GPC-LS.  
c 
Determined by conventional GPC installed with refractive index detector. 
d 
Calculated from TGA. 
 
The successful syntheses of the sPEG-PHB block copolymers were first 
evidenced by gel permeation chromatography (GPC) analyses. As a typical example, 
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the molecular weight of sPEG-PHB(20-1.6) shifted to higher molecular weight region 
as compared to both its precursors (Figure 4.2(a)). Molecular weight distributions of 
all the star-block copolymers remain in the moderately narrow range of 1.3 – 1.4, 
implying an efficient and uniform PHB conjugation onto the sPEG cores.  
 
Figure 4.2. (a) GPC traces of sPEG-PHB(20-1.6) and its precursors; (b) FTIR spectra of 
PHB(Mn 1.60 kDa), sPEG-N3(Mn 19.9 kDa) and sPEG-PHB(20-1.6) in the form of KBr 
discs; (c) 
1
H NMR spectrum of sPEG-PHB with corresponding peak assignments in 
CDCl3. Triazole linking group and adamantyl end group can be clearly seen in the 
spectrum. 
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The chemical structure of the obtained sPEG-PHB star-block copolymers was 
elucidated by 
1
H NMR. A typical 
1
H NMR spectrum of sPEG-PHB is shown in 
Figure 4.2(c). All signals in the spectrum can be ascribed to protons belonging to 
either PHB, PEG, linkage segment or adamantyl end group. In particular, the 
appearance of triazole proton at δ 7.8 ppm (and the disappearance of azide 
functioanlity as evidanced by FTIR in Figure 4.2(b)) further attested to the successful 
PHB conjugation onto sPEG core. The intensity ratio between the PHB‟s methylene 
proton at δ 2.3 – 2.8 ppm and PEG‟s methylene proton at δ 3.4 – 3.9 ppm were used 
to estimate PHB content in the sPEG-PHB star-block copolymers. The weight 
percentage values were further used to calculate the number of PHB arm on each 
sPEG core and the Mn of the final sPEG-PHB star-block copolymers, as listed in 
Table 4.1. The Mn values derived from 
1
H NMR estimation were further compared 
with data obtained from online GPC light scattering (GPC-LS) measurements and 
close agreement were observed in all the star-block copolymers. The successful 
syntheses of all the macromolecules were confirmed by 
13
C NMR as shown in Figure 
4.3. 





C NMR spectra of (a) sPEG-N3, (b) PHB, and (c) sPEG-PHB with 
corresponding peak assignments in CDCl3.  
 
4.3.2 Synthesis and characterization of linear MPEG-PHBs 
Two linear analogues of sPEG-PHB star-block copolymers, methoxy 
poly(ethylene glycol)-block-poly(3-hydroxybutyrate) (MPEG-PHB), were also 
synthesized as a control. They were obtained by coupling MPEG-N3 (Mn 2.18 kDa) 
with the same PHB precursors used for star-block copolymer syntheses. The resultant 
two MPEG-PHB linear block copolymers are represented by the notation MPEG-
PHB(x-y), where x and y denote the approximate Mn of constituting MPEG and PHB, 
in kDa, respectively. Figure 4.4 showed the 
1
H NMR spectrum of MPEG-PHB(2.2-
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1.6), which is typical of all the linear MPEG-PHB copolymers. All signals in the 
spectrum can be ascribed to protons belonging to either PHB, MPEG, linkage group 
or end group. Methylene protons of MPEG contribute to the signals at around  3.41 – 
3.96 (m, MPEG backbone). A peak at  3.38 ppm was attributed to the methyl ether 
end group of MPEG, which is absent in the spectra of star sPEG-PHB copolymers. 
Signals of PHB protons and linking triazole group can be found at  1.16 – 1.37 (m, -
OCH(CH3)CH2CO2- of PHB), 2.32 – 2.72 (m, -OCH(CH3)CH2CO2- of PHB), 4.47 – 
4.62 (m, -CH2-triazole N), 5.12 – 5.35 (m, -OCH(CH3)CH2CO2- of PHB and -CH2-
triazole C), 7.79 (s, -C=CH-N- of triazole). The adamantane end group protons can be 
seen at  1.47 – 1.81 (m, methylene protons of adamantyl end group), 1.96 (br, 
methine protons of adamantyl end group), 2.02 (s, -OCCH2-Ada). Conventional GPC 
measurements on the linear copolymers gave narrow PDIs.  
 





H NMR spectrum of MPEG-PHB with corresponding peak assignments in 
CDCl3. Triazole linking group and adamantyl end group can be clearly seen in the 
spectrum. A peak at  3.38 ppm was attributed to the methyl ether end group of MPEG, 
which is absent in the spectra of star sPEG-PHB copolymers. 
 
4.3.3 Thermal properties of sPEG-PHBs 
The thermal degradation profiles of sPEG-PHB star-block copolymers were 
studied by TGA, as shown in Figure 4.5. The sPEG-PHB copolymers exhibited a two-
step degradation behavior in the thermal degradation profile, with the first step 
occurring between 220 °C and 340 °C followed by the second step from 340 °C to 
450 °C. The first and second step of mass reduction can be attributed to the 
degradation of PHB and sPEG, respectively. The weight percentage of PHB in sPEG-
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PHB star-block copolymers can be estimated from the thermal degradation profile, 
and the values were further used to calculate the PHB arm numbers of each sPEG 
core as listed in Table 4.1. The results evaluated from TGA corroborated well with 
those from 
1
H NMR estimation. 
 
Figure 4.5. Thermal degradation profiles of sPEG-PHB copolymers i: sPEG-PHB(20-
1.6), ii: sPEG-PHB(20-3.1), iii: sPEG-PHB(10-1.6), iv:sPEG-PHB(10-3.1). 
 
DSC was carried out to study the thermal properties of sPEG-PHB copolymers, 
the first cooling curves and second heating curves were shown in Figure 4.6. In our 
previous work,
41, 42
 the crystallinity of triblock copolymer PHB-PEG-PHB was found 
to depend on the molecular weight of PEG segment and the PHB chain length. In this 
study, the same method was employed to prepare amorphous PHB, and the resulting 
sPEG-PHB polymers were found to behave similarly. The crystallization of sPEG was 
hindered by PHB chain and the inhibition becomes more pronounced with higher 
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PHB content and thus no PEG crystallization was observed in sPEG-PHB(10-3.1) and 
sPEG-PHB(10-1.6). The completely amorphous sPEG-PHB(10-3.1) and sPEG-
PHB(10-1.6) can be explained by the existence of the lower molecular weight of PEG 
segment and the amorphous PHB segment of comparable length. Single glass 
transitions from the miscible amorphous sPEG and PHB segments at around -32 °C 
and -37 °C were observed for sPEG-PHB(10-3.1) and sPEG-PHB(10-1.6), 
respectively. Compare to the polymers containing sPEG10k, sPEG-PHB(20-1.6) and 
sPEG-PHB(20-3.1) were found to exhibit melting endotherms. The sPEG-PHB(20-
1.6) which had the lowest PHB content exhibited a melting endotherm at around 
40 °C and only a weak glass transition. It is interesting to see both the crystallization 
exotherm and melting endotherm in the second heating run of sPEG-PHB(20-3.1), 
which is an reflection of the sPEG crystallization hindrance. The sPEG crystallization 
was suppressed by PHB during the first cooling run, but the polymer got another 
chance to crystalline after heating above Tg with sufficient chain mobility in the 
second heating run.  
 
Figure 4.6. DSC first cooling (a) and second heating (b) curves of sPEG-PHB 
copolymers i: sPEG-PHB(10-3.1), ii: sPEG-PHB(20-3.1), iii: sPEG-PHB(10-1.6), iv: 
sPEG-PHB(20-1.6). 
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4.3.4 Self-assembly into nanogel-like large compound micelles   
Being amphiphilic in nature, all of the synthesized sPEG-PHB star-block 
copolymers self-assembled into micelles under aqueous condition, as shown by a 
typical transmission electron microscopy (TEM) image in Figure 4.7 and Figure 
4.8(a). The sPEG-PHB polymeric micelles were prepared using dialysis method and 
their hydrodynamic radii (Rh) were accessed using dynamic light scattering (DLS). 
The Rh are found to be inversely proportional to PHB content of the star copolymer 
(Table 4.2). However, once formed, the micelles are very stable against dilution, as 
shown by the stable micelle Rh values under stepwise dilution from a polymer 
concentration of 20 down to 1.0 mg/L in Figure 4.8(b). The excellent micelle stability 
demonstrated here could be due to the very hydrophobic nature of PHB chain and 
adamantane end group. 
 
Figure 4.7. TEM images of (a) sPEG-PHB(20-1.6) micelles, (b) sPEG-PHB(10-1.6) 
micelles, (c) sPEG-PHB(20-3.1) micelles. 
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Figure 4.8. (a) TEM of sPEG-PHB(10-3.1) micelles (Scale bar = 100 nm); (b) Rh (z-
average) stability of sPEG-PHB micelles in aqueous solution against dilution. 
 
Table 4.2. Micellar properties of sPEG-PHB copolymers in aqueous solution 
 
a 
Determined by DLS.  
b 
Determined by SLS.  
c 
Ratio of Rg/Rh.  
d 
Aggregation number Nagg = Mw,agg/Mw, Mw as determined from GPC-LS.  
e 
Average particle density ρp = 3Mw, agg<Rh
-1
>
3/4πNA, NA is Avogadro constant. 
  
To gain better insights on the aggregation behaviors within this concentration 
range, static light scattering (SLS) measurements were employed. The radius of 
gyration (Rg), molecular weight of micellar aggregates (Mw,agg) and second virial 
coefficient (A2) were extracted from respective Zimm plots (Figure 4.9) and are partly 
listed in Table 4.2. The ratios of Rg to Rh (ρ) of the sPEG-PHB polymeric micelles are 





























10-3.1 77 81 1.05 30.5 1030 0.026 - 2.82 
20-3.1 100 119 1.19 61.5 1411 0.024 - 2.64 
10-1.6 109 142 1.30 56.2 2412 0.017 - 5.74 
20-1.6 132 223 1.69 185 6314 0.032 - 1.28 
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sphere micelle at 0.78 but less than that of random coil at 1.78,
43, 44
 suggesting that the 
sPEG-PHB polymers form aggregates with higher penetrability than non-draining 
hard-sphere micelles.  
 
Figure 4.9. Zimm plot of sPEG-PHB(20-1.6) micelles in aqueous solution at 25 °C, where 
c changes from 0.02 to 0.00125 mg/mL. The lines are drawn to visualize the data points. 
 
On account of the  values and very large Nagg, the self-assembly of sPEG-
PHB is thought to occur through the formation of nanogel-like large compound 
micelle (LCM).
15, 45
 During LCM formation, the entropic penalty associated with 
intramolecular PHB sequestration via chain looping
46
 could be reduced by the more 
favorable intermolecular PHB aggregation, forming many hydrophobic PHB pockets 
that are interconnected by loose PEG chains within each LCM (Scheme 4.2(a)). Such 
morphology allows deep penetration of water into the particles, akin to nanogel. 
Indeed, the large amount of water contained in the LCM can be inferred from the 
much smaller particle sizes as measured from TEM than DLS (refer to Table 4.3), 
where the previous method estimates particle in dried and compact state while the 
latter reflect particle size in hydrated state. In addition, further assessment on the 
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average particle density (ρp) of the LCMs in aqueous state revealed low particle 
density of 0.017 – 0.032 gcm-3, far lower than bulk polymer density (~1 gcm-3).47 This 
again points to a loosely packed morphology of sPEG-PHB LCMs. Previous studies 
on LCM formed by linear block copolymers showed that Nagg increased sharply as the 
molecular weight of hydrophobic block increased.
48
 However, our LCMs displayed a 
different trend. For a fixed sPEG core, Nagg decreased with increased PHB length, 
while Nagg increased with larger sPEG core. The trend suggests an interplay of effects 
arising from sPEG size, which restricts PHB aggregation because of its star 
architecture, and PHB chain length on LCM formation. Larger sPEG being more 
flexible also provides more room for sPEG-PHB micellization, as evidenced by DLS 
measurements. In any case, the restrictive movement of sPEG resulted in an 
incomplete packing of PHB into LCM interior, causing the LCM surface to be slightly 





Scheme 4.2. Schematic representation on the self-assembly of sPEG-PHB (a) and sPEG-
PHB/DM-β-CD complexes (b) in aqueous solution. 
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Table 4.3. Particle Sizes of sPEG-PHB micelles as determined from DLS at a 
concentration of 20 mg/Land TEM.  
 
sPEG-PHB micelles 
Particle radius [nm] 
DLS  TEM 
sPEG-PHB(10-3.1) 77  1 13  3 
sPEG-PHB(20-3.1) 100  1 16  3  
sPEG-PHB(10-1.6) 109  2 22  5 
sPEG-PHB(20-1.6) 132  2 18  7 
 
4.3.5 Cyclodextrin-directed vesicle formation. 
Interestingly, when sPEG-PHB star-block copolymers were self-assembled in 
the presence of DM-β-CD, they formed vesicles rather than LCMs, as visualized from 
TEM images shown in Figure 4.10 and Figure 4.11. DM-β-CD is a highly hydrophilic 
derivative of β-CD. Its donut-shaped molecular structure has a hydrophobic cavity 
that binds strongly to adamantane (Ada) via host-guest interaction.
50
 Hence, the 
vesicle formation observed here could be a manifestation of CD-binding onto the 
Ada-functionalized sPEG-PHB star-block copolymers, where such binding is 
expected to shift the hydrophilic/hydrophobic balance of the amphiphilic star 
polymers and hinder hydrophobic interaction between PHB chains.  
 
Figure 4.10. TEM image (a) and SEM image (b) of sPEG-PHB(10-3.1)/DM-β-CD 
aggregates. 




Figure 4.11. TEM images of (a) sPEG-PHB(10-1.6)/DM-β-CD aggregates, (b) sPEG-
PHB(20-3.1)/DM-β-CD aggregates, (c) sPEG-PHB(20-1.6)/DM-β-CD aggregates. The 
scale bar represent 200 nm. 
 
It has been reported that linear diblock copolymers self-assemble into vesicles 
only when the hydrophilic block fraction (fhydrophilic) is around 35±10 %, while micelle 
is formed when fhydrophilic > 45 %.
12
 However, the sPEG-PHB/DM-β-CD complexes 
formed vesicles even when the fhydrophilic exceeds 45 %. Particularly, fhydrophilic is 
beyond 64 % for sPEG-PHB(20-1.6)/DM-β-CD complex. The star architecture of 
sPEG-PHB star-block copolymer which restricts chain movements is critical to such 
unique self-assembly behavior. This is further demonstrated by the self-assembly of 
the linear analogues of sPEG-PHB star-block copolymers, methoxy poly(ethylene 
glycol)-block-poly(3-hydroxybutyrate) (MPEG-PHB), which were obtained by 
coupling MPEG-N3 (Mn 2.18 kDa) with the same PHB precursors used for star-block 
copolymer syntheses. The MPEG-PHB/DM-β-CD complexes only self-assembled 
into spherical micelles (Figure 4.12). 
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Figure 4.12. TEM images of (a) MPEG-PHB(2.2-1.6)/DM-β-CD aggregates, (b) MPEG-
PHB(2.2-3.1)/DM-β-CD aggregates. 
 
The size and wall thickness of the sPEG-PHB/DM-β-CD vesicles were 
estimated from TEM images and summarized in Table 4.4. The vesicle diameters are 
in the range of 200 – 500 nm and are much larger than the corresponding sPEG-PHBs 
LCMs. sPEG-PHB with longer PHB generally gives thicker vesicle wall. It should, 
however, be noted that the thickness of the vesicle wall ranged between 45 – 155 nm 
which is much larger than the length of one PHB chain. 
 











10-3.1 514  54 155  28 
20-3.1 339  15 106  14 
10-1.6 480  68 57  9 
20-1.6 234  57 46  12 
a
 Determined by TEM. Analyses on TEM images were done using ImageJ software. 
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Considering both the restrictive nature of star architecture and the hydrophobic 
properties of PHB, we propose a possible model for the supramolecular self-assembly 
of sPEG-PHB/DM-β-CD complexes, as illustrated in Scheme 4.2(b). The vesicle wall 
is formed by PHB aggregation with the possibility of embedded sPEG segments and 
DM--CD while its exterior and interior surfaces are covered with hydrophilic sPEG 
and DM-β-CD. The vesicular structure was further confirmed by SEM, as shown in 
Figure 4.10(b). 
 
4.3.6 Large compound micelles (LCMs) for drug delivery 
To evaluate the loading capacity of sPEG-PHB(10-3.1) large compound 
micelles (LCMs) in dilute aqueous solution, sPEG-PHB(10-3.1) and PTX with 
various concentrations were mixed in DMSO. The final concentration of sPEG-
PHB(10-3.1) in DMSO was fixed to be 0.05 mg/mL and the feeding weight ratios of 
PTX to polymer were 0.2, 0.6, 1.0, 1.5 and 2, respectively. The solution was dialyzed 
against water to remove DMSO and the aqueous solution in the dialysis bag was 
filtrated through 0.45 μm membrane to remove the free drug and obtain PTX-loaded 
micelles. Figure 4.13 showed that hydrodynamic radius (Rh) of PTX-loaded LCMs 
increases as the weight ratio increases from 0.2 to 2, as determined by DLS 
measurement. The very hydrophobic PTX participated in the self-assembly process 
and the particle size was increased by entering the PHB pocket of the LCMs. Both the 
Rh and polydispersity index (PDI) increased abruptly at weight ratio 2, indicating the 
overload of PTX. The PTX-loaded LCMs with weight ratio 1.5 were chosen to carry 
out further tests due to their narrow PDI and acceptable particle size. The PTX-loaded 
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LCMs (feed weight ratio 1.5) were then freeze-dried and re-dissolved in MeOH for 
UV measurement, the loading efficiency of PTX was estimated to be 11.1 %. 
 
Figure 4.13. Rh (z-average) and PDI of PTX-loaded LCMs as a function of composition 
(weight ratio of PTX to sPEG-PHB(10-3.1)).  
 
To estimate the antitumor activity of the PTX-loaded LCMs (feed weight ratio 
1.5), MTT assay with Hela cells was performed. Blank micelles and free PTX with 
equivalent concentrations were tested as controls. The free PTX control sample was 
prepared by diluting concentrated PTX DMSO solution with cell culture medium, the 
final DMSO content was 0.2 v/v %.  
Figure 4.14(a) showed the cytotoxicity of PTX-loaded LCMs on Hela cells, 
which exhibited enhanced antitumor activity compared to free PTX with equivalent 
concentrations. The blank micelles showed no cytotoxicity within the test 
concentration, as shown in Figure 4.14(b). The light microscopic images of cells 
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showed that the state of Hela cells after treated with PTX-loaded micelles was worse 
than that with free PTX at 2 μg/mL, as shown in Figure 4.15. The light microscopic 
image of cells treated with blank micelles indicated that the cells were healthy. The 
reason that micelles enhanced the cytotoxicity of PTX can be attributed to the 
increase of cellular uptake. As an extremely hydrophobic drug, PTX is poorly 
absorbed because they can not gain access to the cell membrane due to the insolubility 
in aqueous fluids. 
 
Figure 4.14. Cytotoxicity of PTX-loaded sPEG-PHB(10-3.1) LCMs and free PTX with 




Figure 4.15. Light microscopic images of Hela cells treated with (a) PTX-loaded LCMs 
(PTX 2 μg/mL), (b) free PTX with equivalent concentration (2 μg/mL), and (c) blank 
sPEG-PHB(10-3.1) LCMs (20 μg/mL). 
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5.4 Conclusions 
In summary, we present here the synthesis of novel amphiphilic PHB-based 
star-block copolymers with sPEG cores and PHB-adamantyl peripheries, and their 
unique self-assembly behaviors forming nanogel-like LCMs and the supramolecular 
transformation to nano-sized vesicles. The design of heterofunctionalized PHB 
precursors via well-controlled ROP of -butyrolactone is key to the facile synthesis of 
the star-block copolymers. The amphiphilic star-block copolymers were found to self-
assemble into very stable nanogel-like LCMs in aqueous medium. On the other hand, 
more remarkably, in the presence of DM--CD, the self-assembled particles took the 
form of vesicles. The favorable adamantane-CD host-guest interaction and the star 
architecture of sPEG-PHB star-block copolymer are critical factors leading to such 
unique self-assembly behaviors. The highly stable nanogel-like LCMs are potential 
carrier materials for delivery applications of hydrophobic therapeutic agents in dilute 
solutions. We also believe that the host-guest approach of nanoparticle modification 
demonstrated here encompasses a robust and modular strategy that could be adopted 
for synthesis of other functional nanoparticles. 
 
 Chapter 4 
134 
4.5 References 
1. M. Lazzari and M. A. López-Quintela, Adv. Mater., 2003, 15, 1583-1594. 
2. Y. Wan and Zhao, Chem. Rev., 2007, 107, 2821-2860. 
3. S. Mann, Nat. Mater., 2009, 8, 781-792. 
4. D. E. Bergbreiter, J. Tian and C. Hongfa, Chem. Rev., 2009, 109, 530-582. 
5. D. Astruc, F. Lu and J. R. Aranzaes, Angew. Chem., Int. Ed., 2005, 44, 7852-
7872. 
6. Y. Kakizawa and K. Kataoka, Advanced Drug Delivery Reviews, 2002, 54, 
203-222. 
7. A. Taubert, A. Napoli and W. Meier, Current Opinion in Chemical Biology, 
2004, 8, 598-603. 
8. X. Yan, G. Liu and Z. Li, J. Am. Chem. Soc., 2004, 126, 10059-10066. 
9. X. Roy, J. K. H. Hui, M. Rabnawaz, G. Liu and M. J. MacLachlan, J. Am. 
Chem. Soc., 2011, 133, 8420-8423. 
10. D. J. Pochan, Z. Chen, H. Cui, K. Hales, K. Qi and K. L. Wooley, Science, 
2004, 306, 94-97. 
11. H. Cui, Z. Chen, S. Zhong, K. L. Wooley and D. J. Pochan, Science, 2007, 317, 
647-650. 
12. D. E. Discher and A. Eisenberg, Science, 2002, 297, 967-973. 
13. S. Yu, T. Azzam, I. Rouiller and A. Eisenberg, J. Am. Chem. Soc., 2009, 131, 
10557-10566. 
14. Z. Li, J. Ma, N. S. Lee and K. L. Wooley, Journal of the American Chemical 
Society, 2011, 133, 1228-1231. 
15. L. F. Zhang and A. Eisenberg, Journal of the American Chemical Society, 
1996, 118, 3168-3181. 
16. T. Azzam and A. Eisenberg, Angew. Chem., Int. Ed., 2006, 45, 7443-7447. 
17. R. K. Iha, K. L. Wooley, A. M. Nystrom, D. J. Burke, M. J. Kade and C. J. 
Hawker, Chem. Rev., 2009, 109, 5620-5686. 
18. C. J. Hawker and K. L. Wooley, Science, 2005, 309, 1200-1205. 
19. P. L. Golas and K. Matyjaszewski, Chem. Soc. Rev., 2010, 39, 1338-1354. 
20. S. Jain and F. S. Bates, Science, 2003, 300, 460-464. 
21. V. Percec, D. A. Wilson, P. Leowanawat, C. J. Wilson, A. D. Hughes, M. S. 
Kaucher, D. A. Hammer, D. H. Levine, A. J. Kim, F. S. Bates, K. P. Davis, T. 
P. Lodge, M. L. Klein, R. H. DeVane, E. Aqad, B. M. Rosen, A. O. Argintaru, 
M. J. Sienkowska, K. Rissanen, S. Nummelin and J. Ropponen, Science, 2010, 
328, 1009-1014. 
22. G. Chen and M. Jiang, Chemical Society Reviews, 2011, 40, 2254-2266. 
23. S. F. Williams and D. P. Martin, in Biopolymers, eds. Y. Doi and A. 
Steinbuchel, Wiley-VCH, Weinheim, 2002, vol. 4. 
24. D. Seebach and M. G. Fritz, International Journal of Biological 
Macromolecules, 1999, 25, 217-236. 
25. R. W. Lenz and R. H. Marchessault, Biomacromolecules, 2004, 6, 1-8. 
26. G. Q. Chen, Chem. Soc. Rev., 2009, 38, 2434-2446. 
27. J. Li, X. Li, X. P. Ni and K. W. Leong, Macromolecules, 2003, 36, 2661-2667. 
28. X. J. Loh, S. H. Goh and J. Li, Biomacromolecules, 2007, 8, 585-593. 
 Chapter 4 
135 
29. K. L. Liu, E. S. G. Choo, S. Y. Wong, X. Li, C. Bin He, J. Wang and J. Li, J. 
Phys. Chem. B, 2010, 114, 7489-7498. 
30. K. L. Liu, J. L. Zhu and J. Li, Soft Matter, 2010, 6, 2300-2311. 
31. C. Chen, C. H. Yu, Y. C. Cheng, P. H. F. Yu and M. K. Cheung, Biomaterials, 
2006, 27, 4804-4814. 
32. Q. Y. Liu, S. T. Cheng, Z. B. Li, K. T. Xu and G. Q. Chen, Journal of 
Biomedical Materials Research Part A, 2009, 90A, 1162-1176. 
33. J. Li, X. P. Ni, X. Li, N. K. Tan, C. T. Lim, S. Ramakrishna and K. W. Leong, 
Langmuir, 2005, 21, 8681-8685. 
34. X. Li, K. Y. Mya, X. P. Ni, C. B. He, K. W. Leong and J. Li, J. Phys. Chem. B, 
2006, 110, 5920-5926. 
35. X. J. Loh, Z. X. Zhang, Y. L. Wu, T. S. Lee and J. Li, Macromolecules, 2009, 
42, 194-202. 
36. D. Seebach, G. F. Herrmann, U. D. Lengweiler, B. M. Bachmann and W. 
Amrein, Angewandte Chemie International Edition in English, 1996, 35, 
2795-2797. 
37. G. Lapienis, Progress in Polymer Science, 2009, 34, 852-892. 
38. W. Wu, N. Mitra, E. C. Y. Yan and S. Zhou, Acs Nano, 2010, 4, 4831-4839. 
39. D. J. A. Cameron and M. P. Shaver, Chemical Society Reviews, 2011, 40, 
1761-1776. 
40. K. L. Liu, S. H. Goh and J. Li, Polymer, 2008, 49, 732-741. 
41. K. L. Liu, S. H. Goh and J. Li, Macromolecules, 2008, 41, 6027-6034. 
42. K. L. Liu, S. H. Goh and J. Li, Polymer, 2008, 49, 732-741. 
43. C. Wu, M. Siddiq and K. F. Woo, Macromolecules, 1995, 28, 4914-4919. 
44. M. Siddiq, H. H. Hu, M. X. Ding, B. Z. Li and C. Wu, Macromolecules, 1996, 
29, 7426-7431. 
45. M. Stepanek, M. Uchman and K. Prochazka, Polymer, 2009, 50, 3638-3644. 
46. N. P. Balsara, M. Tirrell and T. P. Lodge, Macromolecules, 1991, 24, 1975-
1986. 
47. C. Wu, J. Fu and Y. Zhao, Macromolecules, 2000, 33, 9040-9043. 
48. S. Tanodekaew, R. Pannu, F. Heatley, D. Attwood and C. Booth, 
Macromolecular Chemistry and Physics, 1997, 198, 927-944. 
49. A. George and W. W. Wilson, Acta Crystallogr., Sect. D: Biol. Crystallogr., 
1994, 50, 361-365. 
50. D. Harries, D. C. Rau and V. A. Parsegian, Journal of the American Chemical 
Society, 2005, 127, 2184-2190. 
 
 
 Chapter 5 
136 
CHAPTER 5 CYCLODEXTRIN-INDUCED 
MORPHOLOGY TRANSITION AND NANOVESICLE 
FORMATION THROUGH SELF-ASSEMBLY OF 
POLY[(R,S)-3-HYDROXYBUTYRATE]-BASED STAR-
BLOCK COPOLYMER FOR DRUG DELIVERY  
5.1 Introduction  
It is well known that amphiphilic block copolymers can form various ordered 
nanostructures via self-assembly in aqueous solution.
1-8
 Specific morphologies can be 
targeted according to a dimensionless packing parameter, p, originally developed for 
small amphiphilic molecules in aqueous solution.
9
 Based on geometric ideas of 
hydrophobic core volume versus hydrophilic surface area, as has been illustrated in 
section 2.1.2, membrane structures (vesicles) are favoured when 1/2 ≤ p ≤1, 
cylindrical micelles will be formed when 1/3 ≤ p ≤ 1/2, and p ≤ 1/3 yields spherical 
micelles.
10-12
 The trends are also followed by amphiphilic block copolymers, although 
block copolymers are generally preferred to be characterized by the more 
synthetically accessible block fraction. By adjusting the packing factor of block 
copolymers through changes in the hydrophilic block fraction (fhydrophilic), the 
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morphology of the resultant assemblies can be tuned to form vesicles when fhydrophilic is 
around 35±10 %, while micelle is formed when fhydrophilic > 45 %.
13
 
In the past two decades, the self-assembly of amphiphilic block copolymers in 
aqueous solution has been widely studied. Micelles and vesicles are found to be the 
most common structures formed by amphiphilic block copolymers.
10, 11, 14
 Both 
micelles and vesicles have attracted great interests due to their great potential to be 
used as nano-scale drug delivery systems (DDSs).
15-25
 The nano-scale DDSs are 
expected to enhance the therapeutic efficacy of drugs by augmenting their 
pharmacodynamic and pharmacokinetic profiles. The design of nano-scale DDS is 
built upon a solid understanding on the interactions amongst various segments in 
block copolymer and surrounding environment as well as the influence of these 
interactions on nanostructure morphology.
3, 26
 However, the relationship between 
polymer architecture and resultant self-assembled nanostructure is often not 
straightforward, more so with complex polymer architecture.
27, 28
 
In chapter 4, we reported the synthesis of novel amphiphilic PHB-based star-
block copolymers with sPEG cores and PHB-adamantyl peripheries, and their unique 
self-assembly behaviors forming nanogel-like large compound micelles and the 
supramolecular transformation to vesicles.
29
 However, the size and polydispersity of 
the vesicles are a little large (from 200 nm to 500 nm), which was attributed to the 
embedded sPEG segments and DM--CD in the vesicle wall. To improve the 
situation, we designed another star-block copolymer with a small α-CD core instead 
of sPEG core. In this chapter, we present the synthesis of PHB-based star-block 
copolymers through coupling PHB arms onto a small α-CD core, as shown in Scheme 
5.1. The self-assembly behavior of the star-block copolymers were modulated by 
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heptakis(2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD). The sufficient DM-β-CD 
binding have led to uniform nano-sized vesicles (100 ~ 200 nm). The vesicles were 
employed to load anticancer drug, doxorubicin hydrochloride (DOX), and the 
intracellular drug delivery behavior suggested their potential to be drug carriers. 
 
5.2 Experimental Section  
5.2.1 Materials  
(a) Chemicals 
α-Cyclodextrin (α-CD) was purchased from Sigma and dried under high 
vacuum at 100 °C for 24 h before use. (R,S)-β-butyrolactone (> 95 %, Tokyo Kasei 
Inc) was dried over and vacuum distilled from CaH2 twice before use. Doxorubicin 
hydrochloride (DOX, Apollo Scientific), sodium (R)-3-hydroxybutyrate (99 %, 
Aldrich), 2-Bromopropionic bromide (97 %, Aldrich), sodium azide (NaN3, ≥ 99.5 %, 
Sigma-Aldrich), 1-adamantaneacetic acid (98 %, Aldrich), propargyl bromide 
solution (80 wt.% in toluene, Aldrich), propargylamine (98 %, Aldrich), copper 
sulfate pentahydrate (CuSO4·5H2O, 98 %, Sigma-Aldrich), sodium ascorbate (≥ 99 %, 
Aldrich), heptakis(2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD, ≥ 98.0 %, Aldrich), 
Fluorescein 5(6)-isothiocyanate (FITC, ≥ 90 %, Fluka), N,N-dimethylacetamide 
(DMAc, anhydrous, 99 %, Aldrich), dimethylformamide (DMF, > 99 %, Tedia), 
methylene chloride (CH2Cl2, 99 %, Tedia) tetrahydrofuran (THF, > 99 %, Tedia), 
diethyl ether (Et2O, 99 %, Tedia) and n-hexane (95 %, Tedia) were used as received. 
 (b) Cells 
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Human cervical cancer cell line HeLa was purchased from ATCC (Rockville, 
MD) and maintained in Dulbecco‟s Modified Eagle‟s Medium (DMEM) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 100 units/mg 
penicillin, 100 g/mL streptomycin at 37 C and 5 % CO2.  
 
5.2.2 Synthesis Methods  
Synthesis of bromine-functionalized star α-CD-core (CD-s-Br). The 
bromine-functionalized star α-CD-core was synthesized following a similar method to 
previous reports.
30, 31
 α-CD (2.43 g, 2.5 mmol) was dissolved in 30 mL of anhydrous 
DMAc with stirring and cooled to 0 °C. Subsequently, a solution of 2-bromopropionic 
bromide (10.8 g, 50 mmol) in anhydrous DMAc (20 mL) was added dropwise to the 
α-CD solution for a period of 1 h at 0 °C under N2 atmosphere. After stirring at room 
temperature for 2 days, the reaction mixture was precipitated with 1 L of n-hexane. 
The resulting powder was collected by centrifugation and redissolved in CH2Cl2 (80 
mL), then the solution was successively washed with 1 M HCl (aq) solution, saturated 
NaHCO3 (aq) solution, 1 M NaCl (aq) solution, and water. The organic phase was 
dried over anhydrous MgSO4 and concentrated using a rotary evaporator after 
filtration. The residues were further purified by silica gel column chromatography 
using THF as eluent and dried under vacuum. Yield: 6.2 g (73.4 %, based on 
substitution degree of 18). 
1
H NMR (400 MHz, CDCl3):  1.84 (m, -CH(CH3)Br), 
3.55-6.00 (m, protons of α-CD and –CH(CH3)Br); 
13
C NMR (100 MHz, CDCl3): 
170.0 (C=O), 96.2 (C-2, C-3 of α-CD), 66.7-75.1 (C-1, C-4, C-5 of α-CD), 64.4 (C-6 
of α-CD), 39.9 (-CH(CH3)Br), 21.6 (-CH(CH3)Br).  
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Synthesis of azide-functionalized star α-CD-core (CD-s- N3). CD-s-Br (0.83 
g, 4 mmol) was dissolved in 10 mL DMF, 1.30 g of NaN3 (20 mmol) was added. 
After stirring at 60 °C for 2 days, the reaction mixture was precipitated with 200 mL 
of water. The resulting powder was collected by centrifugation, washed with water. 
The residues were further purified with Sephadex LH-20 using THF as eluent and 
dried under vacuum. Yield: 0.58 g (85.3 %, based on substitution degree of 13). 
1
H 
NMR (400 MHz, CDCl3):  1.49 (m, -CH(CH3)N3), 3.12-5.97 (m, protons of α-CD 
and –CH(CH3)N3); 
13
C NMR (100 MHz, CDCl3): 170.7 (C=O), 94.7-105.0 (C-2, C-3 
of α-CD), 67.9-75.1 (C-1, C-4, C-5 of α-CD), 63.9 (C-6 of α-CD), 57.8 (-CH(CH3)N3), 
17.0 (-CH(CH3)N3).  
Synthesis of -Adamantyl--alkynyl-poly(3-hydroxybutyrate) (PHB). The 
heterofunctionalised PHB was synthesized via anionic ring-opening polymerization of 
(R,S)--butyrolactone in DMSO at room temperature under dry N2 atmosphere, 
similar to the method reported previously.
32
 The initiator sodium adamantaneacetate 
(Ada-CH2CO2Na) was obtained from the neutralization of commercially available 
adamantaneacetic acid with sodium hydroxide in methanol. In a typical example, the 
ring opening polymerization was initiated by reacting 0.63 g of dried Ada-CH2CO2Na 
(2.9 mmol) with 2.38 mL of -butyrolactone monomer (30 mmol) in 80 mL of 
anhydrous DMSO at room temperature. With the aid of 
1
H NMR monitoring, the 
polymerization was quenched by adding an excess of propargyl bromide upon 
reaching a monomer conversion of >90 %. Solvent DMSO was then removed by 
rotary evaporation and the crude polymer sample was re-dissolved in chloroform, 
filtered and precipitated into n-hexane to afford the purified polymer. Yield: 2.5 g 
(82.2 %, based on theoretical yield computed using actual monomer conversion). 
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GPC (THF): Mn = 0.89 kDa, PDI = 1.13. 
1
H NMR (400 MHz, CDCl3):  1.26-1.31 (m, 
-OCH(CH3)CH2CO2- of PHB), 1.59-1.71 (m, methylene protons of adamantyl end 
group), 1.95 (br, methine protons of adamantyl end group), 2.02 (s, -OCCH2-Ada) 
2.43-2.62 (m, -OCH(CH3)CH2CO2- of PHB and –OCH2CCH of alkynyl end group), 
4.68 (s, -OCH2CCH), 5.23-5.32 (m, -OCH(CH3)CH2CO2- of PHB). 
13
C NMR (100 
MHz, CDCl3): 169.6-172.2 (-CO- of PHB and -COCH2-Ada), 75.5 (alkynyl group), 
67.9 (-CH- of PHB), 52.4 (-CH2-alkynyl), 49.3 (-CH2-adamantyl), 41.1 (-CH2- of 
PHB), 42.7, 37.0, 33.1, 28.9 (adamantyl group), 20.1 (-CH3 of PHB). 
Synthesis of α-CD-core star polymer (CD-s-PHB) via alkyne-azide 
coupling. CD-s-PHB was synthesized via alkyne-azide coupling in DMSO/H2O 
system. In a typical example, a bottle with an N2 inlet was charged with 1.01 g of 
PHB (Mn (EA) 1.01 kDa, 1 mmol), 0.22 g of CD-s-N3 (Mn (
1
H NMR and EA) 2.23 
kDa, 0.1 mmol) and 2 mL DMSO. A freshly prepared 23 wt% aqueous solution of 
CuSO4·5H2O (0.3 mmol) and 33 wt% aqueous solution of sodium ascorbate (0.63 
mmol) were then added sequentially. The reaction was allowed to stir at room 
temperature under N2 atmosphere for 2 days. The reaction mixture was diluted with 
THF and passed through alumina column to remove copper residue. Then, the 
polymer solution was precipitated into Et2O. The product was collected by filtration 
and purified twice by dissolution / precipitation with THF / Et2O, and dried under 
vacuum overnight. Yield: 0.90 g (73.2 %). 
1
H NMR (400 MHz, CDCl3):  1.00-1.55 
(m, -OCH(CH3)CH2CO2- of PHB and -CH(CH3)N-), 1.55-1.76 (m, methylene protons 
of adamantyl end group), 1.94 (br, methine protons of adamantyl end group), 2.01 (s, 
-OCCH2-Ada), 2.35-2.85 (m, -OCH(CH3)CH2CO2- of PHB), 3.20-5.90 (m, -
OCH(CH3)CH2CO2- of PHB and protons of α-CD), 7.73-8.03 (s, -C=CH-N- of 




C NMR (100 MHz, CDCl3): 165.4-172.8 (-CO- of PHB and -COCH2-Ada 
and -OCO-CHCH3N-), 143.0 (-CH=C- of triazole), 124.0 (-CH=C- of triazole), 48.4-
68.0 (-CH- of PHB and carbons of α-CD), 41.2 (-CH2- of PHB), 42.7, 37.1, 33.2, 29.0 
(adamantyl group), 20.2 (-CH3 of PHB), 17.0 (-CH(CH3)N-). 
Synthesis of FITC-labeled CD-s-PHB (CD-s-PHB-FITC). The synthesis 
method for CD-s-PHB-FITC is nearly the same as that for CD-s-PHB but adding one 
more reagent, FITC-alkyne. FITC-alkyne was synthesized by reacting FITC with 
propargylamine in anhydrous DMSO at room temperature under the dark for 48 h. 
The obtained FITC-alkyne was mixed with PHB and CD-s-N3 in DMSO. A freshly 
prepared 23 wt% aqueous solution of CuSO4·5H2O and 33 wt% aqueous solution of 
sodium were then added sequentially. The alkyne-azide coupling reaction was 
allowed to proceed for 2 days to produce CD-s-PHB-FITC. 
Synthesis of Hydroxyl-terminated CD-s-PHB (CD-s-PHB-OH) and CD-s-
PHB-MPEG. The synthesis method for CD-s-PHB-OH and CD-s-PHB-MPEG is 
nearly the same as that for CD-s-PHB but using different initiators in PHB synthesis. 
The synthetic routes of two initiators, HO-PHB-alkyne and MPEG-PHB-alkyne, were 
shown in Scheme 5.2. For the synthesis of CD-s-PHB-OH, sodium (R)-3-
hydroxybutyrate was used as initiator to produce heterofunctionalized PHB with 
telechelic hydroxyl moiety and alkynyl functionality, and finally obtain CD-s-PHB 
terminated with hydroxyl groups. For the synthesis of CD-s-PHB-MPEG, MPEG-
COONa was used as macroinitiator to produce MPEG-PHB with alkynyl functionality, 
and finally obtain CD-s-PHB-MPEG. The macroinitiator endowed with sodium 
carboxylate functionality on the end of MPEG chain was synthesized through two 
steps as reported previously,
33
 including a TEMPO-mediated oxidation of 
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commercially available hydroxyl-terminated PEG and subsequent neutralization with 
Na2CO3. 
Preparation of inclusion complexes. To prepare the inclusion complexes, 
900 µl of DI water was added into 100 µl of the mixture of CD-s-PHB (4 mg/mL) and 
DM-β-CD (various concentrations) in DMF. All the final solutions had the same CD-
s-PHB concentration of 0.4 mg/mL, and the concentration of DM-β-CD depended on 
the desired weight ratio of CD-s-PHB to DM-β-CD. The volume ratio of water to 
DMF is 9/1 in the final solution. 
 
5.2.3 Characterization Methods 
Molecular characterizations. Gel permeation chromatography (GPC) 
measurements were done at 40 
o
C on a Shimadzu SIL-10A and LC-20AD system 
equipped with two Phenogel 5 100 and 104 Å columns (size: 300 × 4.6 mm) 
connected in series and a Shimadzu RID-10A refractive index detector. THF was used 
as the mobile phase at a flow rate of 0.3 mL/min. Monodispersed PEG standards were 




C NMR spectra were obtained at room 
temperature on a Bruker Avance DRX 400 MHz NMR spectrometer operating at 400 
and 100 MHz, respectively. Chemical shifts are reported in ppm with reference to 
solvent peak (CHCl3: δ 7.26 ppm for 
1
H NMR and  77.2 ppm for 13C NMR). Fourier 
transform infrared (FTIR) spectra of polymers in KBr were recorded on a Perkin-
Elmer FTIR 2000 spectrometer in the region of 4000-500 cm
-1
. Elemental analyses 
(EA) were carried out using a Perkin-Elmer 2400 CHN/CHNS elemental analyzer. 
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Dynamic light scattering measurements. The size of aggregates was 
measured on a Zetasizer Nano ZS (Malvern Instruments Ltd., MA, USA), with a laser 
light wavelength of 633 nm at a 173 scattering angle. The particle size measurements 
were performed at 25 C in duplicate. 
Microscopy. Transmission electron microscopy (TEM) images were taken on 
a Philips CM300 FEG TEM, operating at 300kV. TEM sample was prepared by two 
steps. First, a drop of sample solution was placed onto a 200 mesh carbon coated 
copper grid and left for 2 min before excess liquid was removed by filter paper. Then 
1.5 μL of phosphotungstic acid (PTA, 1 wt%) was deposited onto the grid and left for 
30 seconds before excess liquid was removed by filter paper. The sample was kept in 
a dry box for 48 h at room temperature before TEM imaging. Analyses on TEM 
images were done using ImageJ software. Atomic force microscopy (AFM) samples 
were prepared by casting a drop of sample solution on silica substrate and dried at 
room temperature for 48 h in a dry box. AFM imaging was done on a multimode-
Digital Instrument using the tapping mode with setting of 512 pixels/line and 1 Hz 
scan rate. NANOSENSOR PPP-NCHR POINTPROBE Silicon-SPM-Probe, silicon 
cantilever for non-contact-/ tapping-mode was used for the measurement. The images 
were flattened and analyzed by cross-sectional study.  
 
5.2.4 Intracellular drug release and cytotoxicity assays  
Preparation of DOX-loaded nanovesicles. To prepare the DOX-loaded 
nanovesicles, 900 µl of water (pH=3) was added into 100 µl of the mixture of CD-s-
PHB-FITC (4 mg/mL), DM-β-CD (80 mg/mL) and DOX (0.67 mg/mL) in DMF. To 
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encapsulate DOX by pH gradient method and remove DMF, the mixture was dialyzed 
against water (pH=7) overnight using dialysis tube (MWCO 500). The solution was 
then transferred to dialysis tube (MWCO 1000) and dialysis was continued for a 
further 3 h to remove unencapsulated free DOX. The concentration of DOX loaded 
into nanovesicles was determined by measuring UV absorbance at 485 nm. 
In vitro cytotoxicity test. For each well in a 96-well plate, 100 L of Hela 
cells in DMEM, with a concentration of 1105 cells/mL, was added. The number of 
Hela cells in each well was 10000. After incubation for 24 h in incubator (37 °C, 5 % 
CO2), the culture medium was changed to 100 L of DMEM containing DOX-loaded 
nanovesicles or free DOX with various concentrations and the mixture was further 
incubated for 24 h. Then, DMEM with materials was replaced by fresh DMEM and 
10 L of MTT solution (5 mg/mL) was added to the cells. After incubation for 4 h, 
150 L of DMSO was added and shaken at room temperature. The optical density 
(OD) was measured at 570 nm with a microplate reader (Spectra Plus, TECAN). The 
viable rate was calculated by the following equation:  
Viable rate = (ODtreated / ODcontrol)  100 %                        (Eq 6.1) 
Where, ODcontrol was obtained in the absence of materials and ODtreated was obtained 
in the presence of materials. 
Evaluation of cellular uptake. For cell uptake study, Hela cells were cultured 
on lab-Tek 8-chambered coverglass (Nalge-Nane international, USA) at density of 
1.5104 cells/well in 300 L of complete DMEM with 5 % CO2 at 37 C. After 24 h 
incubation, DOX-loaded nanovesicles or free DOX diluted in the medium at a 
concentration of 4 g/mL were added into the chamber. Cells were washed thrice with 
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PBS after incubation for 1 h, 2 h, 4 h and 8 h. The cells were then fixed by 200 L of 
4 % paraformaldehyde (PFA) solution in PBS for 30 min. The cell were washed thrice 
with PBS and observed by confocal laser scanning microscope (CLSM) (Fluoview 
FV1000, Olympus, Japan). FITC and DOX were excited by the 488 nm laser and 
emissions for FITC and DOX were collected at 515-545 and 565-605 nm, 
respectively. 
 
5.3 Results and Discussion 
5.3.1 Synthesis and molecular characteristics of CD-s-PHB and its precursors 
The CD-s-PHB star polymers were synthesized through four steps (Scheme 
5.1), including bromine functionalization of α-CD, conversion of bromine to azide, 
preparation of heterofunctionalized PHB, and final alkyne-azide coupling reaction. 
Azide-functionalized α-cyclodextrin (CD-s-N3) was first synthesized by substitution 
reaction. The number of azide groups in each CD molecule was estimated to be 
around 13 by 
1
H NMR and EA measurements. The molecular weight of CD-s-N3 was 
evaluated to be 2.23 kDa.  
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Scheme 5.1. Synthetic route of PHB based star-block copolymer (CD-s-PHB) with 
peripheral adamantyl moiety. On the lower right corner are GPC traces of CD-s-PHB 
and its precursors. 
 
Heterofunctionalized PHB, with telechelic adamantyl moiety and alkynyl 
functionality, was synthesized in a one pot fashion by anionic ring opening 
polymerization (ROP) of racemic -butyrolactone. The ROP procedure proceeded 
with excellent control over the molecular weight, molecular weight distribution and 
end-group fidelity (Figure 5.1). This has allowed facile incorporation of 
heterofunctionality, through a judicious selection of anionic initiator and nucleophilic 
capping agent, onto a PHB precursor with desired molecular weight. 
Adamantaneacetate and propargyl bromide were chosen as the initiator and capping 
agent, respectively, to produce PHB that is able to participate in CD-binding as well 
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as alkyne-azide conjugation. The degree of polymerization (DP) and Mn of PHB were 
evaluated from 
1
H NMR spectrum (Figure 5.1) based on the intensity ratio of PHB 
methine proton at around δ 5.2 ppm to alkynyl end group protons at around δ 4.7 ppm. 
DP and Mn were estimated to be 9 and 1.01 kDa, respectively. In addition, both 
alkynyl and adamantyl end groups of the PHB polymers are clearly identified in 
1
H 
NMR spectrum. Together with the relatively narrow PDI as determined from GPC, all 





H NMR spectrum of heterofunctionalized PHB in CDCl3 with 
corresponding peak assignments. Alkynyl and adamantyl end groups can be clearly seen 
in the spectrum. The close agreement of Mns as determined from NMR and GPC as well 
as the narrow PDI of molecular weight confirm the well-defined nature of the two PHB 
polymers synthesized. 
 
The successful syntheses of the CD-s-PHB copolymers were first evidenced 
by size exclusion chromatography (GPC) analyses. As shown in Scheme 5.1, the 
molecular weight of CD-s-PHB shifted to higher molecular weight region as 
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compared to both its precursors. 
1
H NMR was used to elucidate the chemical structure 
of the obtained CD-s-PHB copolymer, as shown in Figure 5.2. All signals in the 
spectrum can be ascribed to protons belonging to either PHB, α-CD, linkage group or 
end group. The appearance of signal assigned to triazole proton can be clearly seen at 
δ 7.8~8.0 ppm. GPC measurement on the star-block copolymer gave narrow 
molecular weight distribution (PDI=1.07), which indicates that the alkyne-azide 
coupling proceeded well to give uniform star-block copolymers. The Mn and arm 
number of the star-block copolymer were evaluated to be 9.28 kDa and 7.0, 
respectively, based on the nitrogen content and the molecular weight of CD-s-N3 from 
elemental analyses (EA) measurements. The successful syntheses of all the 
macromolecules were confirmed by 
13




H NMR spectrum of CD-s-PHB in CDCl3 with corresponding peak 
assignments. Triazole linking group and adamantyl end group can be clearly seen in the 
spectrum. 
 





C NMR spectra of (a) CD-s-Br, (b) CD-s-N3, (c) PHB, and (d) CD-s-PHB in 
CDCl3. 
 
The successful alkyne-azide coupling was also confirmed by comparing the 
FTIR spectra of CD-s-Br, CD-s-N3, PHB, and CD-s-PHB, as shown in Figure 5.4. 
The presence of azide end-group of CD-s-N3 was confirmed by the characteristic 
azide signal at 2112 cm
-1
. After coupling reaction, the azide peak decreased a lot in 
the spectrum of CD-s-PHB. It should be noted that not all azide groups of CD-s-N3 
were reacted, which have been demonstrated by 
13
C NMR and FTIR spectra. These 
results correspond well with the estimation of 7 arms of CD-s-PHB and 13 azide 
groups of CD-s-N3. 
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Figure 5.4. FTIR spectra of CD-s-PHB and its precursors in the form of KBr discs. 
 
 
5.3.2 Synthesis and characterization of CD-s-PHB-OH and CD-s-PHB-MPEG 
In order to observe the self-assembly properties of CD-s-PHB, two control 
polymers, CD-s-PHB-OH and CD-s-PHB-MPEG were synthesized. The synthesis 
method was nearly the same as that for CD-s-PHB but using different initiators in 
PHB synthesis. The synthetic routes of two initiators, HO-PHB-alkyne and MPEG-
PHB-alkyne, were shown in Scheme 5.2. For the synthesis of CD-s-PHB-OH, sodium 
(R)-3-hydroxybutyrate was used as initiator to produce heterofunctionalized PHB 
with telechelic hydroxyl moiety and alkynyl functionality, and finally led to CD-s-
PHB terminated with hydroxyl groups. For the synthesis of CD-s-PHB-MPEG, 
MPEG-COONa was used as initiator to produce MPEG-PHB with alkynyl 
functionality, and finally led to CD-s-PHB-MPEG.  
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Scheme 5.2. Synthetic route of two initiators, (a) heterofunctionalized PHB with 
telechelic hydroxyl moiety and alkynyl functionality (HO-PHB-alkyne) and (b) MPEG-
PHB with alkynyl functionality (MPEG-PHB-alkyne). 
 
The chemical structures of CD-s-PHB-OH and CD-s-PHB-MPEG and their 
precusors were investigated by 
1
H NMR, as shown in Figure 5.5 and Figure 5.6. The 
degree of polymerization (DP) and Mn of PHB were evaluated from 
1
H NMR 
spectrum based on the intensity ratio of PHB methine proton at around δ 5.2 ppm to 
alkynyl end group protons at around δ 4.7 ppm. Mn was estimated to be 0.71 kDa and 
2.69 kDa of PHB-OH and PHB-MPEG, respectively. The alkynyl end group of the 
PHB polymers is clearly identified in 
1
H NMR spectrum. Together with the relatively 
narrow PDI as determined from GPC, all of the above characterization data attest to 
the well-defined nature of the control PHBs.  
 











H NMR spectrum of CD-s-PHB-MPEG (a) and its precursor PHB-MPEG 
(b) in CDCl3. 
 
All signals in the 
1
H NMR spectra of CD-s-PHB-OH and CD-s-PHB-MPEG 
can be ascribed to protons belonging to either PHB, α-CD, linkage group or end group. 
The appearance of signal assigned to triazole proton can be clearly seen at δ 7.8~8.0 
ppm. The Mn of the star-block copolymer was evaluated to be 8.67 kDa and 22.43 
kDa, respectively, based on the nitrogen content and the molecular weight of CD-s-N3 
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from elemental analyses (EA) measurements. The successful synthesis of the two 
control polymers were further confirmed by 
13









5.3.3 Self-assembly properties of CD-s-PHB/DM-β-CD 
Due to the highly hydrophobicity of PHB, CD-s-PHB with a high fraction of 
PHB can‟t be dissloved in water directly. To prepare micellar solutions, CD-s-PHB 
was first dissolved in DMF, then diluted with water to induce self-assembly. As CD-
s-PHB is terminated by adamantane (Ada), β-CD derivatives are supposed to 
influence the self-assembly behavior of CD-s-PHB in aqueous solution via host-guest 
interaction.
34-36
 Here we choose a highly hydrophilic heptakis(2,6-di-O-methyl)-β-
cyclodextrin (DM-β-CD) which has a donut-shaped molecular structure with a 
hydrophobic cavity that binds strongly to Ada. A series of CD-s-PHB/DM-β-CD 
micellar solutions at various weight ratios were prepared by adding 900 μL water to 
100 μL of CD-s-PHB and DM-β-CD in DMF. The final CD-s-PHB concentration was 
 Chapter 5 
155 
fixed at 0.4 mg/mL and the volume ratio of DMF is 10 % in the final aqueous 
solution.  
The particle size of these samples were determined by measuring DLS 
immediatly after freshly prepared. Rh (z-average) of CD-s-PHB/DM-β-CD micellar 
solutions as a function of composition (weight ratio of DM-β-CD to CD-s-PHB) were 
plotted and shown in Figure 5.8. The aggregates formed in the intermediate weight 
ratios (1~7.5) were found to be unstable, so the measurements were repeated on four 
batches of samples. All the four measurements showed that the aggregates are stable 
in two cases, one case is in the absence of DM-β-CD, and the other case is when the 
weight ratio of DM-β-CD to CD-s-PHB is higher than 10. To understand this 
phonomenon, the morphologies of the stable aggregates were observed by TEM, as 
shown at th bottom of Figure 5.8. The CD-s-PHB star polymers were found to self-
assemble into spherical micellar morphology in the absence of  DM-β-CD (Figure 5.8 
– (a) 0). The particle size increases abruptly when the weight ratio of DM-β-CD to 
CD-s-PHB increases from 1 to 7.5, and the particles formed in between this ratio 
range precipitate quickly. In some batches, particles formed at ratio 1 and 7.5 are still 
stable, and their TEM images were shown in Figure 5.8. The morphologies of  DM-β-
CD/CD-s-PHB aggregates at ratio 1 and 7.5 were found to be irregular micellar and 
irregular hollow structures, respectively. DLS measurements showed that the particle 
size achieves plateau when the weight ratio is higher than 10. The TEM images of 
DM-β-CD/CD-s-PHB aggregates indicated the formation of hollow structures at ratio 
15, while more regular and spherical vesicles are formed at ratio 20 or higher. The 
mechanism of morphology transition and the vesicle formation will be discussed in 
the next section.  
 Chapter 5 
156 
 
Figure 5.8. Rh (z-average) of CD-s-PHB/DM-β-CD micellar solutions as a function of 
composition (weight ratio of DM-β-CD to CD-s-PHB). All the solutions have the final 
CD-s-PHB concentration of 0.4 mg/mL; The volume ratio of DMF is 10 % in the final 
aqueous solution; All the samples were measured after freshly prepared. The aggregates 
formed in the intermediate weight ratios are not stable, so the measurements were 
repeated four times by preparing four batches of samples ((a), (b), (c), (d)). TEM images 
of CD-s-PHB/DM-β-CD complexes in batch (a) and (c) at various weight ratios (a) 0, (a) 
1, (a) 15, (a) 20, (c) 7.5, (c) 20 were shown at the bottom. The scale bar represent 500 nm. 
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The DLS and TEM measurements of DM-β-CD/CD-s-PHB aggregates at ratio 
20 were repeated more than four times, and the results exhibited high reproducibility. 
AFM image (Scheme 5.3(c)) confirmed the vesicular structure of DM-β-CD/CD-s-
PHB(20:1) aggregates as has been indicated by TEM image (Scheme 5.3(b)). The 
cross-section profile of AFM image (Scheme 5.3(d)) showed that the height decreases 
from the outer edges to the center of the particles, indicating the hollow nature of the 
vesicles. Considering both the restrictive nature of the star architecture and the 
hydrophobic properties of PHB, we propose a possible model for the supramolecular 
self-assembly of DM-β-CD/CD-s-PHB(20:1), as illustrated in Scheme 5.3(a). The 
vesicle wall is formed by PHB aggregation with the embedded α-CD core of star CD-
s-PHB polymer while its exterior and interior surfaces are covered with hydrophilic 
DM-β-CD. It should be noted that the vesicles formed by DM-β-CD/CD-s-PHB 
(20:1) are nano-sized, which is favorable for their application as DDS. 
 
Scheme 5.3. (a) Schematic representation on the self-assembly of DM-β-CD/CD-s-PHB 
nanovesicles; (b) TEM image of DM-β-CD/CD-s-PHB(20:1) aggregates; (c) AFM image 
of DM-β-CD/CD-s-PHB(20:1) aggregates and (d) the corresponding cross-section profile. 
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In order to observe the influence of preparation methods on the vesicle 
formation, we prepared DM-β-CD/CD-s-PHB(20:1) self-assemblies by three other 
methods as compared with the above used method. The three methods are (a) by 
simply injecting DMF solution of DM-β-CD/CD-s-PHB into an aqueous solution, (b) 
by rehydrating CD-s-PHB film with DM-β-CD aqueous solution, (c) by adding water 
(pH=3) to DMF solution of DM-β-CD/CD-s-PHB and dialyzing against water (pH=7) 
for doxorubicin hydrochloride (DOX) loading and DMF removal. Compared to the 
common method we used in this study, we changed the adding sequence of DMF and 
water in method (a). The influence of solvent was excluded in method (b). Method (c) 
was developed for drug delivery. DLS and TEM measurements showed that 
nanovesicles are formed by any of these methods, as shown in Figure 5.9. 
 
Figure 5.9. TEM images and particle size distribution of DM-β-CD/CD-s-PHB(20:1) 
aggregates prepared using different methods  (a) by simply injecting DMF solution of 
DM-β-CD/CD-s-PHB into an aqueous solution, (b) by rehydrating CD-s-PHB film with 
DM-β-CD aqueous solution, (c) by adding water (pH=3) to DMF solution of DM-β-
CD/CD-s-PHB and dialyzing against water (pH=7) for DOX loading and DMF removal. 
The scale bar represent 200 nm. 
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5.3.4 Discussion on the morphology transition and vesicle formation 
In order to understand the self-assembly behavior of CD-s-PHB in the 
presense of DM-β-CD, two control polymers, CD-s-PHB-OH and CD-s-PHB-MPEG 
were synthesized. The influence of DM-β-CD on the self-assembly behavior of the 
two control polymers and the precursor of all the three polymers, CD-s-N3, was 
studied. All the samples were prepared at the same condition as that for CD-s-PHB.  
The TEM images and particle size distribution of CD-s-PHB-OH, CD-s-PHB-
MPEG, CD-s-N3 and and their complexes with DM-β-CD at weight ratio 20 were 
shown in Figure 5.10, Figure 5.11 and Figure 5.12, respectively. From DLS and TEM 
results, we can see that DM-β-CD has little influence on the self-assembly of CD-s-
PHB-MPEG and CD-s-N3, while the self-assembly behavior of CD-s-PHB-OH in the 
absence and presence of DM-β-CD is quite different. The phenomenon may be due to 
the complex formation between the terminal (R)-3-hydroxybutyrate and β-CD, as has 
been observed by Li et al.
37
 previously. Compared to the uniform nanovesicles 
formed by DM-β-CD/CD-s-PHB(20:1), the DM-β-CD/CD-s-PHB-OH(20:1) self-
assemble into the mixture of hollow structures and some other micellar structures 
(Figure 5.10(b)). It may be attributed to the very high complex association constant of 
β-CD/Ada which produces stable and uniform inclusion complexes. It is easily 
understood that DM-β-CD has little effect on CD-s-PHB-MPEG and CD-s-N3 since 
no complexation occurred in these systems. 
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Figure 5.10. TEM images and particle size distribution of (a) CD-s-PHB-OH and DM-β-
CD/CD-s-PHB-OH (20:1) aggregates. 
 
 
Figure 5.11. TEM images and particle size distribution of (a) CD-s-PHB-MPEG and 
DM-β-CD/CD-s-PHB-MPEG (20:1) aggregates. 
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Figure 5.12. TEM images and particle size distribution of (a) CD-s-N3 and DM-β-CD/ 
CD-s-N3 (20:1) aggregates. 
 
To observe the structure/property relationship of star polymers and their self-
assembly morphologies, the polymers in this study were arranged in ordering of 
hydrophilic fraction (fhydrophilic), as shown in Scheme 5.4. It has been reported that 
linear diblock copolymers self-assemble into vesicles when the fhydrophilic is around 
35±10 %, while micelle is formed when fhydrophilic > 45 %.
13
 In this study, CD-s-N3 
and DM-β-CD/CD-s-PHB(20:1) which have moderate fhydrophilic was found to form 
vesicles, while CD-s-PHB, CD-s-PHB-OH and CD-s-PHB-MPEG fomed micellar 
structures. The CD-s-PHB-MPEG which has fhydrophilic higher than 50 % is supposed to 
form traditional core-shell micelles, while CD-s-PHB and CD-s-PHB-OH with very 
high hydrophobicity are supposed to form large compound micelles (LCM).
3, 29, 38
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Scheme 5.4. The ordering of fhydrophilic of star polymers in this study and their 
corresponding self-assembled morphologies. 
 
5.3.5 Intracellular drug delivery of DOX-loaded nanovesicles  
The cytotoxicity effect of DOX-loaded FITC-labeled nanovesicles was studied 
in vitro with Hela cells using the MTT assay. For comparison, the cytotoxicity of free 
DOX and blank nanovesicles was also evaluated. The blank nanovesicles were 
prepared through the same process as that for DOX-loaded nanovesicles except of 
adding DOX, and the polymer concentration was adjusted to be the same after dialysis. 
The serial blank nanovesicles without DOX were prepared by stepwise dilution from 
blank nanovesicles with the same initial polymer concentration (Cinitial) as that of 
DOX-loaded nanovesicles. From Figure 5.13, it was found that the cytotoxicity of 
DOX-loaded nanovesicles was higher than the free DOX, while the blank 
nanovesicles showed no cytotoxicity within the test concentration. The reason that 
nanovesicles enhanced the cytotoxicity may be attributed to the increase of cellular 
uptake by a possible endocytosis mechanism,
39, 40
 compared to a passive diffusion 
mechanism employed by free DOX. For further demonstration, confocal microscope 
was used to observe the intracellular uptake behavior on Hela cells. 
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Figure 5.13. Cytotoxicity of DOX-loaded nanovesicles (), free DOX with equivalent 
concentrations ( ) and blank nanovesicles ( ) on Hela cells. The serial blank 
nanovesicles without DOX were prepared by stepwise dilution from blank nanovesicles 
with the same initial polymer concentration (Cinitial) as that of DOX-loaded nanovesicles. 
 
For cell uptake experiment, Hela cells were cultured with the DOX-loaded 
FITC-labeled nanovesicles over different periods of time. In Figure 5.14(a), time-
dependent confocal images were shown to investigate the intracellular DOX release 
from nanovesicles. The location of DOX can be tracked from the red fluorescence, 
and the information about nanovesicles can be obtained from the green fluorescence 
in the FITC channel. At the beginning (1 h), DOX was internalized into Hela cells 
with the nanovesicles, and the red fluorescence appeared where the nanovesicles were. 
After 2 h incubation, the increasing number of nanovesicles and DOX appeared inside 
the cells. It is noted that the red fluorescence was localized together with the green 
fluorescence in the cytoplasm at the early stages (1 h, 2 h), only weak red fluo-
rescence was observed in the nucleus at 2 h. After 4 h incubation, both cytoplasm and 
nucleus were dyed red, while green fluorescence was only seen in the cytoplasm, 
indicating that nanovesicles could not enter the nucleus. The red fluorescence in the 
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nucleus was attributed to the release of free DOX from nanovesicles. Then after 8 h 
incubation, most red fluorescence was found to locate in the nucleus, indicating that 
most DOX was released from nanovesicles and entered the nucleus. The gradual 





Figure 5.14. Confocal microscopy images of Hela cells treated with (a) DOX-loaded 
nanovesicles and (b) free DOX with equivalent concentrations (4 μg/mL) for 1 h, 2 h, 4 h 
and 8 h. 
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Compared to DOX-loaded nanovesicles, the fluorescence intensity of free 
DOX with equivalent concentrations was relatively weak (Figure 5.14(b)). The lower 
intracellular drug concentration of cells treated with free DOX may be attributed to 
two reasons. One reason may be due to the poor permeability of water-soluble drugs 
through the lipid-rich cell membranes. Another reason may be due to efflux of free 
DOX by a drug efflux pump, P-glycoprotein pump, also known as multidrug 
resistance pump. In contrast, DOX-loaded nanovesicles may overcome drug efflux 
pump by releasing DOX at a distance from cell-membrane-anchored P-glycoprotein 
via the endocytic pathway. The difference in the effect of multidrug resistance 
between polymeric DDS and free drug has been widely studied.
41, 44-46
 Both the 
cytotoxicity and cellular uptake data suggested that the CD-s-PHB/DM-β-CD 
nanovesicles could efficiently deliver the loaded drug into the cells. 
 
5.4 Conclusions 
In summary, well-defined star-block copolymers consisting of small α-CD 
cores and PHB arms with three kinds of peripheries have been successfully 
synthesized. The design of heterofunctionalized PHB precursors via well-controlled 
ROP of -butyrolactone is key to the facile synthesis of the star-block copolymers 
terminated with adamantyl, hydroxyl or MPEG periphery. The self-assembly behavior 
of the star-block copolymers and their complexes with DM-β-CD was investigated. 
The star-block copolymer terminated with adamantyl group was found to self-
assemble into uniform nano-sized vesicles (100 ~ 200 nm) in the presence of 
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sufficient DM-β-CD through Ada/β-CD host-guest interaction. The vesicles were used 
as drug carriers for an anticancer drug, doxorubicin hydrochloride (DOX). The 
intracellular uptake and cytotoxicity effect of DOX-loaded nanovesicles were studied 
in vitro with Hela cells. Compared to free DOX, DOX-loaded nanovesicles exhibited 
improved cellular uptake and cytotoxicity in Hela cells, suggesting their potential to 
be used as drug delivery system. 
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CHAPTER 6 CONCLUSIONS AND FUTURE WORK 
6.1 Conclusions 
This thesis presented research that revolves around PHB-based block 
copolymers and their supramolecular self-assemblies resulting from host-guest chemistry 
involving cyclodextrins.    
PHB-PEG-PHB triblock copolymer was carefully synthesized and characterized 
to ensure well-defined macromolecular architecture that favor formation of block-selected 
polypseudorotaxanes with α-CD molecules preferentially covering the middle PEG block. 
Hydrogels based on inclusion complexation of PHB-PEG-PHB triblock copolymer and -
CD was prepared. The hydrogels demonstrated better elastic response over the 
investigated frequency range than hydrogels obtained from MPEG of similar molecular 
weight. The study here provides insights on ways to modulate rheological properties 
through proper selection of guest polymer with respect to α-CD. 
The PHB-PEG-PHB triblock copolymers were able to form micelles due to 
the hydrophobic interaction of PHB in aqueous solution. The hydrophobic interaction 
leads to the formation of an extensive and strong hydrogel network, similar to 
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hydrogels formulated with high molecular weight PEG. The associative properties of 
PHB-PEG-PHB are responsible for faster structural recovery of the hydrogels after 
shear-induced structural destruction. In vitro drug release experiments revealed that 
the PHB-PEG-PHB triblock copolymer micelles and PHB-PEG-PHB/α-CD hydrogel 
have the potential to be used for controlled drug delivery. 
A series of well-defined PHB-based star-block copolymers with sPEG cores 
and PHB-adamantyl peripheries were synthesized through a combinatorial strategy 
consisting of controlled ring-opening polymerization and click chemistry. The 
amphiphilic star-block copolymers were found to self-assemble into very stable 
nanogel-like LCMs in aqueous medium. On the other hand, more remarkably, in the 
presence of DM--CD, the self-assembled particles took the form of vesicles. The 
favorable adamantane-CD host-guest interaction and the star architecture of sPEG-
PHB star-block copolymer are critical factors leading to such unique self-assembly 
behaviors. The highly stable nanogel-like LCMs are potential carrier materials for 
delivery applications of hydrophobic therapeutic agents in dilute solutions.  
The investigation of PHB-based star-block copolymers is the first report on 
their structure/self-assembly relations. In addition, the host-guest approach of 
nanoparticle modification demonstrated by the sPEG-PHB/DM--CD system 
encompasses a robust and modular strategy that could be adopted for synthesis of 
other functional nanoparticles. Further exploration on this strategy was carried out by 
investigating the supramolecular self-assembly of well-defined star-block copolymers 
consisting of small α-CD cores and PHB arms with three kinds of peripheries. The 
design of heterofunctionalized PHB precursors via well-controlled ROP of β-BL is 
key to the facile synthesis of the star-block copolymers terminated with various 
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peripheries. The star-block copolymer terminated with adamantyl group was found to 
self-assemble into uniform nano-sized vesicles in the presence of sufficient DM-β-CD 
through Ada/β-CD host-guest interaction. The in vitro cellular uptake and cytotoxicity 
studies revealed that the resulting nanovesicles can be easily internalized into cells 
and used as DDS.  
All in all, results of the present study have shown that with proper block copolymer 
design, various supramolecular self-assemblies could be accessed and used for 
potential drug delivery applications.  
 
6.2 Future work 
  Although the PHB-PEG-PHB/α-CD hydrogels can sustain drug release over 
a few days, it comes short when compared to our previous study with PEG-PHB-
PEG/α-CD hydrogels that went over 30 days.1 Future work can be carried out to 
modulate the drug release behavior from these supramolecular hydrogels by tuning 
the polymer composition and the compactness of their hydrogel network. Optimal 
hydrogel drug delivery systems could be developed by fully understanding the 
relationship between polymer composition, hydrogel network compactness and drug 
release behavior. 
The sPEG-PHB star-block copolymers demonstrated interesting self-assembly 
behaviors in forming nanogel-like large compound micelles (LCMs) or nanovesicles 
when complexed with DM-β-CD. Star-block copolymer of PHB/PEG had never been 
reported before this study,
2
 it is worthwhile to construct a series of PHB/PEG star-
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block copolymers varying in arm number and investigate their physicochemical 
properties and self-assembly behavior.  
It would be worthwhile to further investigate the host-guest interaction 
between CD-s-PHB star-block copolymers and some other β-CD derivatives. This 
would help us better understand the mechanism of CD-directed morphology transition 
and the nanovesicle formation. It is also of great interest to further develop the CD-s-
PHB/DM--CD nanovesicles towards carrier materials for co-delivery applications of 
both hydrophilic and hydrophobic therapeutic agents. 
The combinatorial strategy consisting of controlled ring-opening 
polymerization and click chemistry employed in this study provided us a powerful 
tool for the synthesis of well-defined star-block copolymers. Further work can be 
carried out to synthesize block copolymers with more complex architectures by 
utilizing this strategy. 
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